Mineralocorticoid receptor gene variants : implications for stress, blood pressure and personality by Leeuwen, Nienke van
 
 
 
 
 
 
 
MINERALOCORTICOID 
RECEPTOR GENE VARIANTS 
Implications for stress, blood pressure 
and personality 
 
 
 
Nienke van Leeuwen 
 
 
 
Promotie commissie 
 
Promotores:  Prof. dr. ER de Kloet 
   Prof. dr. FG Zitman 
 
Co-promotor:  Dr. RH de Rijk 
 
Overige leden:  Prof.dr. W Hoogendijk (VUmc, Amsterdam) 
   Prof.dr. AJW van der Does 
   Prof.dr. P Slagboom 
   Prof.dr. JWA Smit 
   Dr. JW Koper (Erasmus Universiteit, Rotterdam) 
   Dr. S Wüst (Central Institute of Mental Health, Mannheim, Duitsland) 
   Prof.dr. M Danhof (secretaris) 
 
 
 
 
 
 
 
ISBN: 978-90-8891-198-9 
Print: Boxpress BV, www.proefschriftmaken.nl 
Cover: Representation of DNA strands (Les Contamines, France) 
 
The research described in this thesis was performed at the division of Medical Pharmacology of the 
Leiden/ Amsterdam Center for Drug Research and the Leiden University Medical Center. This 
work was financially supported by Psychiatric Hospital Rivierduinen and the Royal Netherlands 
Academy of Arts and Sciences (KNAW). 
 
Financial support from the Netherlands Heart Foundation and the DFG-NWO International 
Research Training group (IRTG) Leiden-Trier (NWO-DN 95-420) for the publication of this thesis 
is gratefully acknowledged. 
 
Printing of this thesis was also sponsored by: 
Leiden/Amsterdam Center for Drug Research (LACDR) 
J.E. Jurriaanse stichting 
Berthold 
 
No part of this thesis may be reproduced or transmitted in any form or by any means without 
written permission from the author. 
 
 
 
 
 
MINERALOCORTICOID 
RECEPTOR GENE VARIANTS 
Implications for stress, blood pressure 
and personality 
 
 
Proefschrift 
 
ter verkrijging van  
de graad van Doctor aan de Universiteit Leiden, 
op gezag van Rector Magnificus Prof. mr. P.F. van der Heijden, 
volgens besluit van het College voor Promoties 
te verdedigen op dinsdag 9 november 2010 
klokke 13.45 uur 
 
door 
 
Nienke van Leeuwen 
geboren te Haarlem 
in 1975 
 
 
 
 
 
 
 
 
 
 
 
 
5 Contents 
 
Contents 
 
Chapter 1  7 
General Introduction  
  
Chapter 2 31 
Identification of genetic variation in the Mineralocorticoid Receptor  
  
Chapter 3   
In vitro functional polymorphisms in the human Mineralocorticoid 
Receptor gene are associated with morning cortisol levels after 0.25mg 
DEX 
35 
  
Chapter 4  51 
The functional -2 G variant of the mineralocorticoid receptor modulates 
basal and salt-dependent renin and aldosterone levels and associates with 
higher blood pressure 
 
  
Chapter 5 69 
Human Mineralocorticoid Receptor (MR) gene haplotypes modulate MR 
expression and transactivation: implication for the stress response 
 
  
Chapter 6  85 
Two haplotype blocks in the Mineralocorticoid Receptor (MR) associate 
with neuroticism but not with mood and anxiety disorders 
 
  
Chapter 7 95 
General discussion  
  
Summary in English 111 
Samenvatting in het Nederlands 115 
Reference list 119 
Publications & Presentations 131 
Curriculum vitae 133 
Dankwoord 134 
 
 
6  
 
 
7  
1 
 
 
General Introduction 
 
 
   
8 Chapter 1 General Introduction 
Contents 
 
1. Stress and the Hypothalamus Pituitary Adrenal (HPA) axis 
1.1. Corticosteroid receptors 
1.1.1. Glucocorticoid receptor 
1.1.2. Mineralocorticoid receptor 
1.2. Testing of the HPA axis 
1.2.1. Cortisol 
1.2.2. Cortisol Awakening Response 
1.2.3. Dexamethasone suppression test 
1.2.4. CRH test 
1.2.5. Dexamethasone/ CRH test 
1.2.6. Trier Social Stress Test 
1.3. Psychopathology 
1.3.1. Major Depressive Disorder 
1.3.2. PTSD 
1.3.3. Burnout 
 
2. Genetic variation  
2.1. Types of genetic variation 
2.1.1. Single Nucleotide Polymorphisms  
2.2. Human Mineralocorticoid Receptor 
2.2.1. Gene structure, splice and translational variants 
2.2.2. Genetic variation 
2.3. Human Glucocorticoid Receptor 
2.3.1. Gene structure, splice and translational variants 
2.3.2. Genetic variation  
 
3. Scope and outline of this thesis 
 
9 Chapter 1 General Introduction 
Everyone occasionally feels “depressed” but these feelings are usually temporary and pass within a 
couple of days. This is not what occurs when a person has a depressive disorder (e.g. major 
depression). The symptoms persist for at least two weeks and interfere with a person’s ability to 
work, study, sleep, eat and enjoy pleasurable activities. Depressive disorders are a leading cause of 
disability worldwide (Murray and Lopez, 1997). Major depression is therefore a serious illness and 
unfortunately a very common illness; over 15% of the Dutch population experiences a depression 
during their life (Bijl et al., 1998).   
 
A central question is “why do some persons get depressed while other persons thrive under similar 
adverse conditions?” A follow up question in line with this notion is “what are the biological 
mechanisms leading to a depression?” Unfortunately, we do not know the answers to these 
questions yet. Many studies have been performed and it has been shown that a stressful event often 
precedes depression; people who have experienced severe chronic stress develop a depression more 
easily than individuals who have not experienced stress. Therefore it has been hypothesized that the 
stress system is part of a biological mechanism involved in the development of the disease.  
 
However, after experiencing the same stressful life events, only some subjects develop clinical 
symptoms of depression. This indicates that these individuals are more vulnerable suggesting a 
genetic component or developmental disturbances. Indeed, the involvement of a genetic factor was 
shown by studying families. It is very clear that depression runs in families; however members of a 
family not only share their genetic background but also environmental factors, like financial status 
or the death of a family member. However, after correction for the environmental factors in these 
families, it was still found that there is a genetic part (estimated at ~ 40%) causing vulnerability to 
the disease. The model proposed to explain this vulnerability is the so called “three hit” model: 
genetic variation in interaction with early life experiences enhances vulnerability to a challenge in 
later life which precipitates depression.  
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Figure 1. Schematic overview of the three hit model. Genetic variation (first hit) in interaction with life experiences 
(second hit) influences the response of brain and body following a challenge (third hit) later in life.   
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The goal of this thesis is to elucidate genetic variation underlying stress-induced vulnerability to 
depression. For this purpose genetic variants of one of the receptors for the stress hormone cortisol, 
the mineralocorticoid receptor (MR) were studied. In the introduction of this thesis the 
Hypothalamus Pituitary Adrenal (HPA) axis, its end product cortisol and the different types of 
receptors are described first. Then, methods for testing HPA axis functioning are discussed and 
finally the current state of art in understanding the role of HPA axis dysregulation in mental health 
is evaluated. The second part of the introduction describes genetic structures and consequences of 
genetic variation of the corticosteroid receptors. The introduction is concluded with the scope, 
objective and outline of this thesis  
 
1. Stress and the  Hypothalamus Pituitary Adrenal (HPA) axis 
 
A stressor or ‘stress’ is any physical or psychological threat to homeostasis, which is the 
equilibrium in life processes. The stress response is the spectrum of physiological and behavioural 
adaptations to restore homeostasis. Physical stressors like an infection, tissue damage or pain 
activate aminergic neurons in the brainstem while psychological stressors require processing of the 
stressful information in limbic brain areas such as the amygdala, hippocampus and prefrontal 
cortex. Afferents from the brain stem and the limbic regions innervate the paraventricular nucleus in 
the hypothalamus which organizes the sympathetic, neuroendocrine and behavioural response to the 
stressor.  
 
The sympathetic activation leads to the release of adrenalin from the adrenal medulla into the 
bloodstream. Adrenalin increases heart rate and cardiac output and this in turn will lead to 
activation of skeletal muscles, elevation of blood glucose levels and suppression of the digestive 
and reproductive systems. The neuroendocrine response proceedes mainly via the HPA axis (Figure 
2). Neurons in the paraventricular nucleus of the hypothalamus secrete corticotropin releasing 
hormone (CRH) and its co-secretagogue arginine vasopressin (AVP) in the portal vessel system. 
These peptides stimulate the anterior pituitary to generate adrenocorticotropin hormone (ACTH) 
from the pro-opiomelanocortin (POMC) precursor for release in the circulation and this in turn 
stimulates the adrenal glands to produce and secrete glucocorticoids. In human the main 
glucocorticoid is cortisol while in rodents this is corticosterone. The glucocorticoids feed back on 
hypothalamic CRH neurons and pituitary corticotrophs to normalize stress-induced HPA axis 
activation. The limbic structures are also a prominent target of glucocorticoids, where the hormones 
modulate ongoing information processing related to the initial stressor that led to the production of 
the hormone. The most potent psychological stressors are conditions of uncertainty, no control and 
no information to predict upcoming events. During processing in the limbic brain, such severe 
psychological stressors lead during processing in the limbic brain to strong emotional reactions and 
a profound prolonged activation of the HPA axis.  
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Figure 2. Schematic representation of the HPA-axis  
 
In addition to the stress responsive mode, HPA axis activity displays a circadian rhythm. Highest 
levels of ACTH and cortisol are observed in the morning prior to the active period followed by a 
continuous decline resulting in low basal cortisol levels in the afternoon and evening (Schmidt-
Reinwald et al., 1999; Linkowski et al., 1993; Spath-Schwalbe et al., 1991). The circadian secretion 
pattern of cortisol is based on hourly pulses which have in man highest amplitude at the circadian 
peak in the morning (Lightman et al., 2008; Conway-Campbell et al., 2007). Superimposed on this 
rhythmic pattern is a one hour lasting surge in cortisol induced by awakening, the so called cortisol 
awakening response (CAR). There is a small anticipatory increase in cortisol around lunch 
(Wilhelm et al., 2007; Wüst et al., 2001; Wüst et al., 2000). The stress response is also 
superimposed on basal rhythmicity and it appeared that the magnitude of stress-induced HPA 
activation was much higher on the ascending than the descending phase of the ultradian pulse 
(Sarabdjitsingh et al., 2010) 
     
Cortisol exerts a dual action in the stress response. Cortisol promotes the initial reaction to the 
challenge and subsequently prevents this initial reaction from overshooting and becoming damaging 
itself. The latter action is best known. Cortisol and its potent synthetic glucocorticoid analogs such 
as dexamethasone and prednisone have a potent anti-inflammatory and immunosuppressive action. 
Also energy storage and mobilization is a critical function of cortisol (McEwen et al., 1979). During 
stress cortisol provides the body with energy through gluconeogenesis, the process of converting 
amino acids into readily useable glucose in the liver. Additionally, fat from storage depots is 
reallocated to fat cell deposits deep in the abdomen (Epel et al., 2000) while directing adipocytes to 
develop into mature fat cells (Tomlinson et al., 2002). During rest cortisol promotes glycogen 
production for storage of energy (Fig. 2). 
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Figure 3. Schematic overview of cortisol target tissues. 
 
Although the action of cortisol is protective in the context of a challenge, it can turn into a harmful 
signal if for example exposure is either prolonged or inadequate. Prolonged cortisol exposure can 
lead to suppression of the immune system, visceral obesity and muscle breakdown since amino 
acids are used for glucose production instead of muscle formation. The consequences are described 
in more detail in paragraph 1.3.  
 
In the control of basal rhythmic and stress-induced processes in the brain cortisol operates via two 
types of receptors: mineralocorticoid (MR) and glucocorticoid receptors (GR), which are best 
known as nuclear receptors regulating gene transcription. MR binds cortisol with high affinity. As a 
consequence MR always remains substantially occupied with cortisol throughout the ultradian and 
circadian cycle; this receptor is predominantly expressed in limbic structures. The widely 
distributed lower affinity GR only becomes occupied at ultradian peaks and after stress. Besides 
these nuclear receptors recent evidence has also identified MR and GR in the membrane of cells 
which responds to high stress levels of hormone. 
 
The two receptor types mediate the action of cortisol on the different phases of the processing of 
stressful information. While the nuclear MR is primarily involved in the maintenance of the 
integrity and stability of the stress circuitry, its membrane variant is implicated in the onset and 
progression of the psychological stress response. The GR mediated action by cortisol is concerned 
with termination of the stress response, the recovery from the stressful challenge and the facilitation 
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of behavioural adaptation in preparation for future challenges. Accordingly, the balance between 
MR and GR mediated actions plays an important role in the processing of stressful information (de 
Kloet et al., 1998). Changes in the balance of MR:GR mediated actions affect HPA axis reactivity 
and behavioural adaptation: we hypothesize therefore that the balance in MR:GR mediated actions 
is important for vulnerability and resilience to stress-related mental disorders.  
 
1.1. corticosteroid receptors 
 
In the classical view MR and GR are intracellular receptors which reside in the cytosol in the 
absence of ligand. After binding a ligand at the ligand binding domain (LBD) the receptors form 
dimers and translocate to the nucleus where they regulate the transcription of specific genes by 
binding to the DNA with the DNA binding domain of the receptor (DBD). Depending on the target 
gene this can be a positive or negative regulation. Additional levels of control have been identified 
contributing to the diverse effects of glucocorticoids. For example, translocation of the receptors is 
modulated by chaperone proteins, the conformation of the receptor can be modified by 
posttranslational changes, expression of coactivators (e.g. SRC1) or corepressors (NcoR, SMRT) 
while modifications of the DNA structure (methylation, acetylation) can confer additional 
specificity (Pascual-Le Tallec and Lombes, 2005) (fig 4). Finally, gene-variation in MR and GR can 
contribute to their function. In paragraph 2.2 of this chapter the gene structure and consequences of 
genetic MR and GR variation are summarized. 
 
Figure 4. Cellular mechanism corticosteroid receptors. Ligand binding to a nuclear receptor (NR) e.g. GR or MR 
results in dissociation from the heat shock protein (HSP), dimerization, transloction from the cytoplasm to the nucleus, 
binding to specific sequences of the DNA called hormone response elements (HRE), recruitment of cofactors and 
finally transcription of the gene downstream the HRE. 
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1.1.1. Glucocorticoid receptors  
 
GR are expressed throughout the whole body including the brain. The affinity of GR for cortisol is 
relatively low therefore cortisol is only bound to GR during stress and at the ultradian peaks when 
cortisol levels are elevated. Activated GR mediate the metabolic, immunological, cardiovascular 
and behavioural effects of cortisol in response to stress by mobilizing energy for tissues and cells to 
cope with a stressor. GR mediated effects are also are aimed at preventing the immunological, 
inflammatory, cardiovascular and neural responses from overshooting and becoming damaging 
themselves (Munck et al., 1984). GR is expressed in virtually every cell. 
 
 
1.1.2. Mineralocorticoid receptors 
 
Mineralocorticoid receptors do not only bind cortisol, they also bind aldosterone with high affinity. 
Aldosterone operates in the renin-angiotensin system which regulates water/salt homeostasis (see 
box 1).  In epithelial cells of the kidney, colon and sweat glands MR mediate the action of 
aldosterone on the retention of sodium. In the brain aldosterone selective MR are found in structures 
involved in maintenance of electrolyte balance such as the medial amygdala, organum vasculosum 
lamina terminalis (OVLT) and other periventricular brain regions. Epithelial cells express 11β-
steroid dehydrogenase type 2 which converts cortisol into cortisone, which has a weak affinity for 
the receptor, thereby rendering the MR specific for aldosterone (Funder et al., 1988; Edwards et al., 
1988).  
 
MR is also expressed in non-epithelial cells in heart, vascular wall and brain and sees in these cells 
predominantly the naturally occurring glucocorticoids because of their much higher concentration 
than aldosterone. Thus, the MR is expressed in adipose tissue where it probably mediates cortisol 
and aldosterone induced adipose tissue development (Zennaro et al., 2009; Caprio et al., 2007) and 
in heart where the physiological function is still unclear, but the MR seems to contribute to 
inflammation and fibrosis (Funder, 2009).  
 
In the brain MR is highly expressed in neurons of the limbic brain: hippocampus and amygdala. 
Due to its high affinity for cortisol, MR in these brain areas is already occupied under basal 
pulsatile cortisol levels. Therefore it was hypothesized that the MR has a role in regulating these 
basal cortisol levels; indeed administration of MR antagonists to rats induced elevated 
corticosterone levels suggesting a role of MR in basal HPA activity (Ratka et al., 1989). 
Furthermore, also in humans administration of a selective MR antagonist increases basal cortisol 
levels (Buckley et al., 2007; Wellhoener et al., 2004; Otte et al., 2003a; Otte et al., 2003b; Arvat et 
al., 2001; Heuser et al., 2000; Deuschle et al., 1998; Young et al., 1998; Born et al., 1997; Dodt et 
al., 1993b).  
 
Furthermore, MR can bind progesterone. Progesterone is an antagonist for MR and might compete 
with cortisol for binding under conditions of high circulating progesterone levels e.g. pregnancy, in 
utero and in the luteal phase of the menstrual cycle (Grossmann et al., 2004; Myles and Funder, 
1996).  
 
15 Chapter 1 General Introduction 
In addition to the intracellular localization of the receptors membrane bound MRs have been 
identified (Joels et al., 2008; Karst et al., 2005). These receptors have a lower affinity than the 
intracellular MRs. The membrane bound MR mediate fast non genomic actions of corticosterone on 
glutamate transmission in rat brain tissue. In addition, membrane MR decrease post-synaptic 
hyperpolarization by inhibition of K+ currents.  Probably these fast non-genomic actions mediate 
the fast negative feedback on pulsatile release of corticosteroids (Atkinson et al., 2008). 
 
Several studies demonstrated an influence of the MR on behaviour. For example, an effect was 
observed in the Morris water maze when the escape platform was removed after several trainings. 
The control group remained searching in the quadrant in which previously the platform had been 
located while the group treated with a MR antagonist searched the water maze for alternative escape 
routes. It was concluded that  MR blockade influenced coping strategy (Oitzl and de Kloet, 1992). 
Other studies demonstrated that MR blockade inhibits aggressive behaviour in male rats (Haller et 
al., 1998) and rainbow trout (Schjolden et al., 2009). Furthermore, transgenic mice with increased 
levels of MR in the forebrain showed decreased anxiety-like behaviour and enhanced memory (Lai 
et al., 2007). In addition, female transgenic mice, with MR overexpression in the forebrain / 
hippocampus, show a moderate suppression of the corticosterone response to restraint stress 
(Rozeboom et al., 2007).  
 
Due to the high affinity of the MR for cortisol, the MR will remain mostly occupied during the 
hourly pulses of the hormone. Therefore, changes in expression of the MR will be an important 
level of control of its function. Expression of hippocampal MR is influenced by stress, ageing and 
corticosteroid treatment (van Eekelen et al., 1992). In addition, estrogens decrease the expression 
while progesterone increases the expression in rat (Carey et al., 1995; Turner, 1990). It is expected 
that MR-mediated functions are modulated by ageing, gender and prolonged stress through changes 
in MR-expression. 
 
1.2. Testing the HPA axis 
 
Several methods are developed to test the different aspects of the HPA axis in humans. Testing the 
reactivity can be performed by applying a physical or psychosocial stressor or more directly by the 
administration of ACTH or CRH. Synthetic glucocorticoids can be used to test the negative 
feedback of the system while inhibition of the HPA axis during basal non stressful situations can be 
tested by measuring cortisol levels during the day. In this paragraph frequently used and new 
promising methods for testing the different aspects of the HPA axis are described. 
 
1.2.1. Cortisol 
 
Cortisol can be measured in blood, urine, saliva or hair. In the circulation 80-90% of cortisol is 
bound to cortisol binding globulin (CBG), 6-15% to albumin and the remaining 4-5% is unbound. 
The albumin bound and free cortisol fractions are directly available to cells and therefore represent 
biological active fractions (Rosner, 1990). Reference values for blood cortisol are 0,2 - 0,6 µmol/l 
in the morning and  0,1 - 0,4 µmol/l in the afternoon. In saliva and urine only the unbound cortisol 
is present. Usually 24 hours of urine is collected for assessment of cortisol levels, the adult (18 
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years or older) reference range is 24-108 µg/24 hours. The upper limit of normal for children 
between 0 and 17 years old is 91 µg/24 hours. 
 
1.2.2. Cortisol Awakening Response 
 
The cortisol awakening response (CAR) is a distinct rise in cortisol levels occurring in response to 
morning awakening (Wilhelm et al., 2007). Peak values are mostly observed during the first 15-30 
minutes. Across several studies in healthy adults, it was reported that salivary cortisol levels 
increase from about 50% up to over 100% (Clow et al., 2004). In the last decade, the cortisol 
awakening response (CAR) has been established as a useful marker of HPA axis activity. The 
function of the CAR is still unclear; a recent review hypothesizes that the cortisol rise after 
awakening may accompany an activation of prospective memory representations at awakening 
enabling the individual's orientation about the self in time and space as well as anticipation of 
demands of the upcoming day (Fries et al., 2009).  
 
The CAR is a relatively easy to measure marker and is assessed by taking saliva samples in the first 
hour after awakening. A standard procedure has been established with four to five sampling time 
points, directly after awakening, i.e. 15, 30, 45, and 60 minutes after awakening. The assessment of 
the CAR by saliva samples has many advantages compared to other methods. The method is non-
invasive and can be performed at home; this prevents stress as compared to invasive methods such 
as needles. Moreover, storage and mailing of samples is possible since cortisol in saliva is quite 
stable over time. The major disadvantage is the compliance of the participants to follow the strict 
sampling procedure. With the help of electronic monitoring devices (MEMS track caps) it was 
demonstrated that the absence of a CAR in a remarkable part of the samples did not reflect absent 
morning increases but measurement error based on participant’s non-compliance with the saliva 
sampling procedure (Kudielka et al., 2007b; Broderick et al., 2004; Kudielka et al., 2003). 
 
Recent review papers show an overview of findings related to the CAR (Fries et al., 2008; Chida 
and Steptoe, 2008; Clow et al., 2004). Factors influencing the CAR include gender, depressive 
symptomatology, PTSD, primary insomnia, chronic fatigue as well as neuroticism and perceived 
chronic stress (Wessa et al., 2006; Portella et al., 2005; Backhaus et al., 2004; Roberts et al., 2004; 
Rohleder et al., 2004; Schlotz et al., 2004; Bhagwagar et al., 2003; Pruessner et al., 2003; Wüst et 
al., 2000a). Moreover, there is a medium-sized, yet distinct heritability of the CAR observed 
(Bartels et al., 2003; Wüst et al., 2000b). 
 
1.2.3. Dexamethasone suppression test  
 
The dexamethasone suppression test (DST) is used to test the negative feedback of the HPA axis 
(Carroll et al., 1968). Dexamethasone is a synthetic glucocorticoid that provides negative feedback 
to suppress the secretion of ACTH. Dexamethasone at low concentrations is relatively unable to 
pass the blood brain barrier due to transport by P-glycoprotein therefore it is thought that 
dexamethasone acts predominantly at the pituitary level (de Kloet et al., 1975; de Kloet et al., 
1974). Moreover, in MDR-/- mice, which are lacking the P-glycoprotein at the blood brain barrier, 
dexamethasone was very well capable of entering the brain and binding to both GR and MR (Meijer 
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et al., 1998). It is proposed that in intact animals and humans, dexamethasone depletes the brain of 
its endogenous ligand corticosterone / cortisol, by inhibition of ACTH production (Karssen et al., 
2005; Karssen et al., 2001).    
 
1.2.4. CRH Stimulation Test 
 
The CRH stimulation test is used to asses the responsivity of the pituitary to ACTH. CRH is given 
intravenously as a bolus injection and directly after the injection blood samples are taken every 5-10 
minutes for ACTH and cortisol measurements. In healthy individuals the increase in ACTH is 
observed 5-15 min after the CRH administration and the increase in cortisol is observed after 30-60 
minutes (Gold et al., 1988). In depressed individuals this CRH-induced cortisol response is blunted 
(Holsboer, 1986). 
 
1.2.5. Dexamethasone-CRH Test 
 
The dexamethasone-CRH (Dex-CRH) test was developed as a refined DST procedure. The test 
combines the dexamethasone suppression and the CRH stimulation tests. Dexamethasone is 
administered orally at 11pm, then on the next day CRH is injected and blood samples are taken 
every 15 minutes. The advantage of this procedure is that at the moment of CRH administration the 
HPA axis is downregulated due to the feedback inhibition by dexamethasone (Heuser et al., 1994; 
Bardeleben and Holsboer, 1989). There is a strong correlation between the cortisol responses in the 
DST and the Dex-CRH test, however the sensitivity of the Dex-CRH test is better (Watson et al., 
2006). For instance during severe depression the escape of cortisol from dexamethasone 
suppression is enhanced by CRH; this effect could be a result of increased vasopressin (AVP) 
expression in the PVN. Hence depressed patients are showing an exaggerated Dex-CRH response 
(Watson et al., 2006).  
 
1.2.6. ACTH stimulation test 
 
The ACTH stimulation test (also called the cosyntropin test or tetracosactide test) is used to assess 
the functioning of the adrenal glands. A small amount of synthetic ACTH (cosyntropin) is injected 
which stimulates the adrenals to release cortisol and sometimes aldosterone.  
 
1.2.7. Trier Social Stress Test 
 
The Trier Social Stress test (TSST) is a psychological procedure that induces stress under laboratory 
conditions. The TSST is a motivated performance task consisting of a brief preparation period (3 
minutes) followed by a test period in which the subject has to deliver a free speech (5 minutes) and 
perform mental arithmetic (5 minutes) in front of an audience. Outcome variables range from 
subjective-verbal stress reports to objective behavioral and biological stress responses including 
parameters of the HPA axis like ACTH and cortisol, the cardiovascular, immunological, and blood 
coagulation system. The TSST can be applied in younger and older adults, in children as well as in 
clinical populations reviewed by (Kudielka et al., 2009). The TSST combines elements of 
uncontrollability and high levels of social-evaluative threat. Stress tasks containing the two 
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components ‘uncontrollability’ and ‘social-evaluative threat’ are associated with the largest stress 
responses and the longest recovery times (Dickerson and Kemeny, 2004). 
 
1.3. Psychopathology and the HPA axis 
 
Stress had been implicated in the etiology of several psychiatric disorders and disregulation of HPA 
axis regulation has been reported frequently in patients with psychiatric disorders. The “three hit 
model” proposes that genetic variation (hit 1) in interaction with early life experiences (hit 2) 
determines vulnerability or resilience to develop a psychiatric disorder after a stressful event (hit 3) 
later in life (Figure 1). Three stress-related psychiatric disorders are discussed in more detail in this 
paragraph. 
 
1.3.1. Major depressive disorder 
 
Major depressive disorder (also known as clinical depression, major depression, unipolar 
depression, or unipolar disorder) is a mental disorder characterized by an all-encompassing low 
mood accompanied by low self-esteem, and loss of interest or pleasure in normally enjoyable 
activities. It is a disabling condition which adversely affects a person's family, work or school life, 
sleeping and eating habits and general health.  
 
The term "major depressive disorder (MDD)" was selected by the American Psychiatric Association 
to designate this symptom cluster as a mood disorder in the 1980 version of the Diagnostic and 
Statistical Manual of Mental Disorders (DSM-III) classification, and has become widely used since. 
The general term depression is often used to describe the disorder, but as it is also used to describe a 
more temporarily depressed state of mind, more precise terminology is preferred for the disorder in 
clinical and research use. The most widely used criteria for diagnosing depressive conditions are 
found in the American Psychiatric Association's revised fourth edition of the Diagnostic and 
Statistical Manual of Mental Disorders (DSM-IV), and the World Health Organization's 
International Statistical Classification of Diseases and Related Health Problems (ICD-10), which 
uses the name recurrent depressive disorder. 
 
The lifetime prevalence of MDD is at least 10% with the risk in women twice as high as in men. 
Hereditability is determined based on twin studies and is 40 to 50%. Environmental risk factors 
include childhood abuse and neglect and life stress (Kendler et al., 2004; Kendler et al., 2002) 
 
In 1976 Carroll et al tested different aspects of the HPA axis in patients with MDD. Patients 
frequently have high cortisol levels but the diurnal rhythm is usually maintained and they usually do 
not develop the physical signs of Cushing’s syndrome. However, depression is a common symptom 
of Cushing’s syndrome. The feedback mechanism of the HPA axis was tested in depressed patients 
with the dexamethasone suppression test using 1 mg dexamethasone. Forty percent of the patients 
showed an abnormal HPA axis feedback inhibition with an early escape from dexamethasone 
suppression. However, not all studies show such a high percentage non-suppressors. It is quite 
possible that specific subgroups of depressed patients, such as patients with comorbid psychotic 
features account for the non-suppression. 
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1.3.2. PTSD 
 
Posttraumatic stress disorder (PTSD) is an anxiety disorder; it is a severe and ongoing emotional 
reaction that can develop after exposure to an extreme stressor. This stressor may involve a threat to 
the patient's or someone else's life, serious physical injury, an unwanted sexual act, a threat to 
physical or psychological integrity or overwhelming psychological defenses. In some cases it can 
also result from profound psychological and emotional trauma, without any actual physical harm. 
Symptoms include re-experience such as flashbacks and nightmares, avoidance of stimuli 
associated with the trauma, increased arousal such as difficulty falling or staying asleep, anger and 
hyper vigilance. Per definition, the symptoms last more than six months and cause significant 
impairment in social, occupational, or other important areas of functioning e.g. problems with work 
and relationships. 
 
Many studies investigated the reactivity of the HPA axis in patients with PTSD (reviewed by (de 
Kloet et al., 2006)). Baseline studies in adult PTSD patients report high CRH in cerebrospinal fluid, 
while diurnal plasma cortisol levels on average are decreased. Single point plasma and 24 hours 
urine cortisol levels reveal mixed results. Lower plasma and 24 h cortisol levels have been reported 
in some but not in other studies (Yehuda, 2002). In most studies PTSD patients show an enhanced 
suppression of cortisol after 0.5 or 1 mg dexamethasone. 
 
1.3.3. Burnout 
 
Burnout is a psychological term for the experience of long-term exhaustion and diminished interest. 
Service and people oriented professionals such as teachers, health practitioners, care givers, fire 
fighters and police men seem more prone to burnout than others (Melamed et al., 2006; Maslach et 
al., 2001). 
  
Burnout is not a recognized disorder in the DSM-IV. The most extensively studied measurement of 
burnout in the literature is the Maslach Burnout Inventory. Maslach and her colleague Jackson first 
identified the construct "burnout" in the 1970s, and developed a measure that weighs the effects of 
emotional exhaustion and reduced sense of personal accomplishment. This indicator has become the 
standard tool for measuring burnout in research on the syndrome. People who experience all three 
symptoms have the greatest degrees of burnout, although emotional exhaustion is the hallmark of 
burnout. 
 
There are several studies testing HPA axis functioning in burnout. However the results are 
inconsistent, some studies report no association between basal cortisol levels and burnout 
(Langelaan et al., 2006; Mommersteeg et al., 2006) while others find higher (Grossi et al., 2005; De 
et al., 2003) or lower (Sonnenschein et al., 2007; Pruessner et al., 1999) levels. Also studies on 
HPA axis feedback tested with 0.5 mg dexamethasone gave contradictory results. 
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Box 1 The MR and the Renin Angiotensin System 
Text and figure adapted from www.wikipedia.org 
 
The renin-angiotensin-aldosteron system (RAS) is a hormone system that regulates blood 
pressure and water (fluid) balance.  
When blood volume is low, the kidneys secrete renin, in turn renin stimulates the production 
of angiotensin that causes blood vessels to constrict, resulting in increased blood pressure. In 
addition to the effect on the blood vessels, angiotensin stimulates the secretion of the hormone 
aldosterone from the adrenal cortex. Aldosterone promotes Na+ and water retention, and 
lowers plasma K+ which also increases blood pressure concentration by different mechanisms 
First of all, aldosterone acts on the MR within the principal cells of the distal tubule and the 
collecting duct of the kidney nephron, this up regulates and activates the basolateral Na+/K+ 
pumps, stimulating ATP hydrolysis leading to phosphorylation of the pump and a 
conformational change in the pump exposes the Na+ ions to the outside. The phosphorylated 
form of the pump has a low affinity for Na+ ions, hence reabsorbing sodium (Na+) ions and 
water into the blood, and secreting potassium (K+) ions into the urine. Secondly, aldosterone 
up regulates epithelial sodium channel (ENaC) increasing apical membrane permeability for 
Na+, Cl- is reabsorbed in conjunction with sodium cations to maintain the system's 
electrochemical balance. Furthermore, aldosterone stimulates uptake of K+ into cells and H+ 
secretion by intercalated cells in the collecting duct, regulating plasma bicarbonate (HCO3−) 
levels and its acid/base balance. In addition aldosterone stimulates Na+ and water 
reabsorption from the gut salivary and sweat glands in exchange for K+ and aldosterone may 
act on the central nervous system via the posterior pituitary gland to release vasopressin 
(AVP), which serves to conserve water by direct actions on renal tubular reabsorption 
If the RAS is too active, blood pressure will be too high. There are many drugs that interrupt 
different steps in this system to lower blood pressure. These drugs are one of the main ways to 
control high blood pressure (hypertension), heart failure, kidney failure, and harmful effects 
of diabetes. 
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1.1. Testing of the renin angiotensin system 
The RAS can be tested under basal conditions and there are several methods for testing 
activation of the system. The most common used measures and tests are described here. 
 
1.1.1. Blood pressure 
Blood pressure (BP) is a force exerted by circulating blood on the walls of blood vessels, and 
is one of the principal vital signs. During each heartbeat, BP varies between a maximum 
(systolic) and a minimum (diastolic) pressure. The mean BP, due to pumping by the heart and 
resistance in blood vessels, decreases as the circulating blood moves away from the heart 
through arteries. It has its greatest decrease in the small arteries and arterioles, and continues 
to decrease as the blood moves through the capillaries and back to the heart through veins. 
Gravity, valves in veins, and pumping from contraction of skeletal muscles, are some other 
influences on BP at various places in the body. 
The term blood pressure initially refers to the pressure measured at a person's upper arm. It is 
measured on the inside of an elbow at the brachial artery, of which the measurements can be 
conclusive, which is the upper arm's major blood vessel that carries blood away from the 
heart.  
While average values for arterial pressure could be computed for any given population, there 
is often a large variation from person to person; arterial pressure also varies in individuals 
from moment to moment. Additionally, the average of any given population may have a 
questionable correlation with its general health, thus the relevance of such average values is 
equally questionable. However, in a study of 100 subjects with no known history of 
hypertension, an average blood pressure of 112/64 mmHg was found (Pesola et al. 2001) 
which is in the normal range. 
Various factors influence a person's average BP and variations. Factors such as age and 
gender (Reckelhoff et al. 2001) influence average values. In children, the normal ranges are 
lower than for adults and depend on height (http://www.nhlbi.nih.gov/guidelines). As adults 
age, systolic pressure tends to rise and diastolic tends to fall  (Pickering et al. 2005). In the 
elderly, BP tends to be above the normal adult range (Pickering et al. 2005) largely because of 
reduced flexibility of the arteries. Also, an individual's BP varies with exercise, emotional 
reactions, sleep, digestion and time of day. 
 
Classification of blood pressure for adults 
Category systolic, mmHg diastolic, mmHg 
Hypotension < 90 < 60    
Normal  90 – 120 60 – 80    
Prehypertension 121 – 139 or 81 – 89   
Stage 1 Hypertension 140 – 159 or 90 – 99   
Stage 2 Hypertension ≥ 160 or ≥ 100   
 
All levels of arterial pressure put mechanical stress on the arterial walls. Higher pressures 
increase heart workload and progression of unhealthy tissue growth (atheroma) that develops 
within the walls of arteries. The higher the pressure, the more stress that is present and the 
more atheroma tend to progress and the heart muscle tends to thicken, enlarge and become 
weaker over time. Persistent hypertension is one of the risk factors for strokes, heart attacks, 
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heart failure and arterial aneurysms, and is the leading cause of chronic renal failure. Even 
moderate elevation of arterial pressure leads to shortened life expectancy. At severely high 
pressures, mean arterial pressures 50% or more above average, a person can expect to live no 
more than a few years unless appropriately treated (Guyton & Hall) 
In the past, most attention was paid to diastolic pressure; but nowadays it is recognised that 
both high systolic pressure and high pulse pressure (the numerical difference between systolic 
and diastolic pressures) are also risk factors. In some cases, it appears that a decrease in 
excessive diastolic pressure can actually increase risk, due probably to the increased 
difference between systolic and diastolic pressures 
 
1.1.2. 24 Hours sodium excretion 
Urine is collected for 24 hours and sodium concentrations are measured. Reference values 
are: 40-100 mmol/24h. Lower than normal urine sodium levels may indicate: Aldosteronism, 
Congestive heart failure, Diarrhea and fluid loss, Kidney failure. Greater than normal urine 
sodium levels may be caused by too much salt in the diet or certain medications. High 
concentrations sodium are associated with higher blood pressure. 
 
1.1.3. Plasma aldosterone  
Aldosterone is measured in plasma reference values are: lying down: 2 to 16 ng/dL and 
upright: 5 to 41 ng/dL. Lower than normal levels of aldosterone may indicate: Addison's 
disease (rare), Congenital adrenal hyperplasia, Hyporeninemic hypoaldosteronism or a very 
high-sodium diet. Higher than normal levels of aldosterone may indicate: Bartter syndrome 
(extremely rare), Primary hyperaldosteronism (rare), Secondary hyperaldosteronism from 
heart or kidney disease or a very low-sodium diet  
 
1.1.4. Renin activity 
The enzyme activity in plasma is measured and normal values range from 1.9 to 3.7 
ng/mL/hour. Normal value ranges may vary slightly among different laboratories. Higher than 
normal levels may indicate: Addison's disease, Cirrhosis, Dehydration, Hemorrhage 
(bleeding), High blood pressure, Hypokalemia, Malignant hypertension, Nephrotic syndrome, 
Renin-producing renal tumors, Renovascular hypertension. Lower than normal levels may 
indicate: ADH therapy, Sodium-retaining steroid therapy, Sodium-sensitive high blood 
pressure. 
 
1.1.5. Acute salt loading and salt depletion 
Acute salt-loading (constant rate intravenous infusion of 2 L of 0.9% NaCl carried out over 4 
hours) and salt-depletion protocol (sodium restriction 50 mmol plus three doses of 37.5 mg of 
furosemide) is used to evaluate the distribution of blood pressure sensitivity to salt (strazullo 
2000). If the difference between the mean arterial pressures at the end of the salt-loading and 
salt-depletion period was greater than the median (10 mmHg), the patient was classified as 
“salt-sensitive” otherwise he or she was considered “salt-resistant. Post-load plasma 
aldosterone and renin activity were measured 4 h after the beginning of the salt-load. 
 
1.1.6. Low Na+ and high K+ or  high Na+ and low K+ diet 
Salt sensitivity is tested with a crossover study with low Na+ and high K+ /  high Na+ and 
low K+ for 1 week. Individuals receive both a low Na+ (less than 20 mmol NaCl/day) and 
high K+ (more than 140 mmol Kcl/day; low Na+–high K+ diet) or  high Na+ (more than 250 
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mmol NaCl/day) and low K+ (less than 50 mmol Kcl/day; high Na+–low K+ diet) for 1 week. 
Controlled Na+/K+ diet periods were separated by a 7-day washout period. On the ad libitum 
Na+ and K+ diet at baseline  and on day 7 of each controlled Na+/K+ diet period, blood was 
sampled at 0900 in the fasting state after 1 hour of rest in the sitting position for plasma 
immunoreactive active and total renin and plasma aldosterone and ANP determinations. Urine 
was collected in 2 12-hour periods from 0800 to 2000 and from 2000 to 0800 and plasma 
active renin, total renin, atrial natriuretic peptide (ANP) and aldosterone were measured. 
 
 
 
2. Genetic variation 
 
2.1. Types of genetic variation 
 
Human genetic variation underlies the total amount of genetic characteristics observed within the 
human species. Genetic differences are observed between humans at both the individual and the 
population level. There are multiple variants of one gene in the human population and these variants 
of the gene are called alleles.  
 
Several events can lead to genetic variation including random mutations of one nucleotide in the 
DNA and the exchange of genes during meiosis. There are two reasons why genetic variation exists 
between populations. First, there is natural selection in which a specific allele may confer an 
advantage to individuals in a specific environment and this can lead to an advantage in reproduction 
of this individual. The second reason is the neutrality of most mutations. Most mutations do not 
have a direct obvious effect on the body and will therefore be passed on without any selection or 
prevalence. However, it cannot be ruled out that under certain extreme or specific conditions 
changes in function will appear.  
 
Genetic variation among individual humans occurs on many different scales, ranging from complete 
duplications of a chromosome to single nucleotide changes.  
 
2.1.1. Single nucleotide polymorphisms 
 
A single-nucleotide polymorphism (SNP, pronounced snip) is the most common DNA variation. It 
is a single nucleotide difference in the genome between members of a species or between the two 
chromosomes of an individual. The nucleotide can either be substituted, deleted or inserted. The 
nucleotide diversity between humans is about 0.1% resulting in approximately 3 million nucleotide 
differences since the human genome has around 3 billion nucleotides.  
 
Most of the SNPs are neutral but some are functional and influence phenotypic differences between 
humans. SNPs may fall within coding sequences of genes, non-coding regions of genes, or in the 
intergenic regions between genes. SNPs within a coding sequence will not necessarily change the 
amino acid sequence of the protein that is produced, due to degeneracy of the genetic code. A SNP 
in which both forms lead to the same amino acid sequence is termed synonymous; if a different 
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amino acid sequence is produced they are nonsynonymous. A nonsynonymous change may either be 
missense or nonsense, where a missense change results in a different amino acid, while a nonsense 
change results in a premature stop codon. SNPs that are not in protein-coding regions may still have 
consequences for gene splicing, transcription factor binding, mRNA binding or stability of the 
mRNA. 
 
2.2. Human Mineralocorticoid Receptor gene 
 
2.2.1. Gene structure, splice and translational variants 
 
The gene coding for the human MR (hMR) is located on chromosome 4 at position q31.1. The gene 
consists of 10 exons (Figure 6).  Exons 2 to 9 form the coding region with exon 3 and 4 coding for 
the DNA binding domain, exon 5, 6, 7, 8 and the first part of exon 9 coding for the ligand binding 
domain. There are two known 5'-untranslated exons named 1α and 1β, generating the mRNA 
isoforms hMRα and hMRβ. Two different promoter regions named P1 and P2 are located upstream 
of exon 1α and 1β, respectively. The complete human MR protein is composed of 983 amino acids 
and has a molecular mass of 107 kDa.  
 
Several mRNA splice variants have been described. The variant hMRΔ5,6 lacks exons 5 and 6 
resulting in a protein of 75 kDa lacking the entire hinge region and the ligand binding domain of the 
receptor (Zennaro et al., 2001). The use of an alternative splice site after exon 3 results in a variant 
containing four extra amino acids in the first zinc finger of the DNA binding domain (Bloem et al., 
1995).  
 
In addition to the mRNA splice variants, hMR protein diversity is also created by the translation 
from two translation start sites resulting in the 107kDa MR-A and the 15 amino acid smaller 
105.4kDa MR-B (Pascual-Le Tallec et al., 2004) (Figure 6). 
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     Figure 6. 
  Schematic representation of the 
human MR gene, MR mRNA and 
the two translational protein 
variants of the MR, named MR-A 
and MR-B. In the MR DNA the 
intronic regions are indicated in 
light gray, the dark gray areas 
indicate the exonic regions and 
correspond to the dark gray areas in 
the mRNA. In the mRNA UTR= 
untranslated region, NT= N-
terminal domain and DBD= region 
coding for the DNA binding 
domain. The two black lines below 
the mRNA indicate the two 
possible translated areas of the 
mRNA resulting in the 107KDa 
MR-A and the 105.4kDA MR-B  
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2.2.2. Genetic variation 
 
Genetic variation in the MR is reported in several studies (Figure 7). Associations with low frequent 
(<1% in the population) MR mutations have been found to be associated with rare genetic disorders 
while the more frequent (>1% in the population) single nucleotide polymorphisms have been found 
to be associated with common variation in healthy individuals. 
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Figure 7. structure of the MR gene, intronic DNA regions are displayed as the black line in the middle, exonic regions 
are displayed as the boxes on the line. SNPs are indicated below the DNA, while the protein structure and mutations are 
displayed above. 
 
The rare MR mutations called R947X, C436X, c.1132-1133insT, c.315del8bp, C645X, G633R, 
Q776R and L979P have been associated with pseudohypoaldosteronism type I (PHA1). 
Pseudohypoaldosteronism type 1 is a rare condition characterized by electrolyte disorders caused by 
the kidney's inability to respond to mineralocorticoids. There are two forms: an autosomal recessive 
form which tends to be more severe than the autosomal dominant form. The recessive form tends to 
persist into adulthood whereas the dominant form is milder and symptoms tend to improve with 
age. In vitro studies showed that the mutations involved in PHA1 give a loss of the MR 
transactivation capacity (Fernandes-Rosa et al., 2006; Riepe et al., 2004; Nystrom et al., 2004; 
Riepe et al., 2003).  
 
The S810L (rs414511344) mutation has been associated with hypertension  in young women which 
increases during pregnancy resulting in the medical condition pre-eclampsia (Geller et al., 2000). 
However, other studies did not find an association with this mutation and hypertension or severe 
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pre-eclampsia (Martinez et al., 2009; Tempfer et al., 2004; Sugiyama et al., 2001). In vitro studies 
demonstrated that this mutation creates a gain of transactivational capacity of the MR (Geller et al., 
2000). 
 
Two SNPs in the MR were tested for in vitro functionality.  One of these SNPs is called MRI180V 
(rs5522) and is located in exon 2.  This SNP results in an isoleucine to valine amino acid change in 
the N-terminal domain of the protein. One study found that the SNP decreased the transactivation 
capacity of the MR in vitro using cortisol as a ligand while in this study no differences were found 
with aldosterone (DeRijk et al., 2006). However, another study demonstrated significant differences 
in transactivation using aldosterone (Arai et al., 2003). In that study the maximal transactivation of 
MR180V is observed at a concentration of 10-10M aldosterone and is 20% lower compared to the 
maximal transactivation of MRI180 which is observed at 10-8M aldosterone. MR180V is associated 
with enhanced cortisol, and autonomic responses to an acute psychosocial stressor measured with 
the TSST (DeRijk et al., 2006), more feelings of depression (Kuningas et al., 2007) and protection 
against hypertension (Martinez et al., 2009). Other studies did not find an association with blood 
pressure (Tobin et al., 2008). Also the enhanced cortisol response to the TSST could not be 
confirmed in a smaller study, however in this study there was an association between MR180V and 
higher ACTH responses and anxiety during the second TSST performed in this group (Ising et al., 
2008).   
 
The second SNP studied in the MR was MR-2G/C (rs2070951), this SNP has hardly been tested; 
therefore in this thesis the functionality of this SNP will be further demonstrated. The SNP is 
located 2 nucleotides before the first translational startsite of the MR in the Kozak consensus 
sequence and it is hypothesized that this SNP changes the translation and/or the MR-A / MR-B 
balance. One in vitro study demonstrated a decrease in transactivational capacity using aldosterone 
with the C variant compared to the G variant (Arai et al., 2003). Furthermore, the C variant of MR-
2G/C is associated with lower basal cortisol levels (Kuningas et al., 2007). No associations were 
found between this SNP and hypertension (Martinez et al., 2009)  or blood pressure (Tobin et al., 
2008). 
 
Two studies tested multiple SNPs covering the whole MR for an association with blood pressure. In 
one study only the in vitro tested MRI180V was associated with hypertension (Martinez et al., 
2009). In the other study four SNPs located in intron 4 (rs6844155, rs3843410, rs6565584 and 
4835491) were associated with clinical diastolic blood pressure (DBP), a SNP in intron 3 and a SNP 
in intron 2 (rs3846322 and rs17484259) were associated with clinical SBP, one SNP in intron 3 
(rs3857080) was associated with mean night time DBP and SBP and one SNP in intron 2 was 
associated with mean night DBP (Tobin et al., 2008).  These studies indicate involvement of the 
MR in blood pressure, which was already known based on other studies. The mechanism of action 
of these SNPs is still unclear since they were not tested in vitro for functionality. In addition, the 
associations need replication in a second cohort because these findings are only exploratory due to 
the large number of analysis performed. 
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Furthermore a genome wide association study revealed an association between SNP rs1490453 
located in intron 2 and fibrinogen levels (Zemunik et al., 2009). Again this finding is only 
explorative and needs replication in a second cohort. 
 
2.3. The glucocorticoid receptor gene 
  
2.3.1. Gene structure, splice and translational variants 
 
The gene coding for the human GR (hGR) is located on chromosome 5 at position q31.32. The gene 
consists of the translated exons 2 to 9 and at least seven 5'-untranslated exons 1 named 1A to 1F. In 
accordance with the MR exons 3 and 4 are coding the DNA binding domain, exons 5, 6, 7, 8 and a 
part of exon 9 are coding for the ligand binding domain. Several splice variants have been 
described. Exon 9 consists of two parts, 9α and 9β and this can result in a mRNA containing 9α 
mRNA, 9β or both 9α and 9β (Oakley et al., 1996). 
 
2.3.2. Genetic variation 
 
Many studies investigated the role of SNPs in the GR in HPA axis functioning and stress-related 
disorders.  
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Figure 8. Structure and haplotypes of the hGR gene. Intronic DNA regions are displayed as the black line in the midle, 
exonic regions are displayed as the boxes on the line. SNPs and haplotypes are indicated below the DNA 
 
In the promoter region of the GR gene, between exon 1A and 1D is a SNP changing a TthIII 
restriction site (rs100529570). This SNP has not been tested for functionality in vitro but is 
associated with higher basal cortisol levels in men (Rosmond et al., 2000). A more recently 
described SNP in the promoter region is NR3C1-1 (rs10482605). This SNP is located 30bp 
downstream of exon 1F. In vitro tests demonstrated that the minor allele (C) results in a lower 
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transcriptional activity and this C allele is associated with higher post dexamethasone (0.25mg) 
plasma ACTH and cortisol in men, but with lower levels in women (Kumsta et al., 2008; Kumsta et 
al., 2007).  
 
In exon 2 there are two SNPs that always occur together, they are located in codon 22 and 23 and 
the sequence change in codon 23 results in an Arginine (K) to lysine (R) amino acid change. These 
SNPs are named EK22/23ER (rs6189 and rs6190) and in vitro they change the transactivation 
capacity but not the repression capacity of the GR. They are associated with higher post-
dexamethasone cortisol levels (corticosteroid resistance), low insulin, glucose and CRP levels, 
beneficial body composition, more muscle strength, better survival, less dementia and white matter 
lesions and higher risk for major depression (Van Rossum et al., 2006; Van Rossum et al., 2004a; 
Van Rossum et al., 2004b; Van Rossum et al., 2002).   
 
Further upstream in exon 2 the Asparagine to Serine changing SNP N363S is located. This SNP 
changes the transactivation capacity in both transfection experiments (in vitro) and in lymphocytes 
of carriers of the SNP (ex vivo). N363S is associated with lower post dexamethasone morning 
cortisol, higher cortisol levels following the TSST in males, in contrast to females who show lower 
cortisol levels following the TSST. Some studies found associations with body mass index, but 
others did not.  
 
In intron B, 647 nucleotides downstream of exon two is the BclI restriction site changing SNP, BclI 
(rs41423247), located. This SNP is associated with increased corticosteroid sensitivity using the 
skin bleaching test with the synthetic glycocorticoid beclomethasone (Panarelli et al., 1998), while 
there was no effect on dexamethasone suppression of LPS-stimulated interleukin-6 production in 
whole blood cells. Furthermore, this SNP is associated with increased morning cortisol suppression 
after a low dose dexamethasone (0.25mg), heterozygotes of the SNP had higher cortisol and ACTH 
responses following the TSST and higher cortisol responses after administration of ACTH 
compared to both homozygote groups while homozygotes of the minor allele had an increased risk 
of developing major depression compared to heterozygotes and homozygotes of the common allele 
(Van Rossum et al., 2006).  
 
SNP 9 (rs6189) is located in exon 9 in the untranslated region of the mRNA. The SNP changes 
the stability of 9 mRNA resulting in an increased 9 protein expression (DeRijk et al., 2001). The 
SNP is associated with higher cortisol and ACTH levels in males after administration of 
dexamethasone (0.25mg) and during the TSST, but in females the SNP was associated with lower 
levels (Kumsta et al., 2007). 
 
Most studies report the effects of single SNPs. However, some SNPs are linked to each other 
completely or to a certain extent. The promoter SNP NR3C1-1 is always observed together with the 
9 SNP. This is reflected in the associations found with the single SNPs since similar associations 
were found for NR3C1-1 and 9. The minor allele of EK22/23EK is always observed with the 
minor alleles of Tth111I, NR3C1-1 and 9. However, the minor alleles of Tth111I, NR3C1-1 and 
9 are also observed without EK22/23ER. In addition to these frequently tested SNPs, additional 
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GR SNPs are reported on the NCBI website. These SNP might be linked to the reported GR SNPs 
and might be functional as well.  
 
 
3. Scope and outline of this thesis 
 
The project was designed to test if genetic variation in the MR gene is a risk factor for developing 
major depression. To establish this, several steps were taken.  
 
First the MR gene was screened for genetic variation in the form of Single Nuclotide 
Polymorphisms (SNPs) (chapter 2). Based on location, two SNPs were selected and tested for in 
vitro functionality because in vitro functional SNPs are expected to have in vivo effects. The in vitro 
functionality of MR gene SNPs was tested at different levels; on protein and mRNA expression 
(chapter 5), on transactivation capacity (assay explained in Box 2 and chapter 3, 4 and 5) and on 
ligand binding (chapter 4 and 5).  
 
Box 2 Transactivation assay MR 
In the transactivation assay cells with no endogenous MR are transfected with a plasmid containing the MR 
gene. MR will be formed in the cells and a ligand is added to activate the formed MR. Activated MR will 
activate the reporter plasmid that was co-transfected. The reporter plasmid contains a MR responsive 
promoter (TAT3) and luciferase reporter gene (Luc) ativated MR will activate this promoter and luciferase is 
formed. Luciferase is measured and this luciferase expression is a measure of transactivational capacity of 
the MR. 
MR
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Second, the two selected functional SNPs were subsequently tested for their influence on stress 
responsiveness and electrolyte regulation. In a cohort with healthy individuals (n=218) the two 
SNPs were tested for an association with the cortisol awakening response (CAR) with and without 
administration of a low dose of the synthetic glucocorticoid dexamethasone (chapter 3). 
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Furthermore, in a group of healthy school teachers (n=157) the SNPs were tested for associations 
with chronic stress (chapter 5) and the response to psychosocial stress measured with the TSST 
(chapter 5). In addition, one SNP was tested for its influence on blood pressure and salt regulation 
since the MR is not only an important receptor in de HPA axis it is also involved in the Renin-
Angiotensin Aldosterone system, regulating salt/water homeostasis (chapter 4).  
 
Finally, the functional MR SNPs modulating HPA axis regulation were tested for association with 
mood, anxiety and somatoform disorders. This was performed in an extensively phenotyped group 
of controls and patients in which several psychological and biological markers are also available 
(chapter 6). 
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Introduction 
Genetic variation in the mineralocorticoid receptor (MR) is reported in several studies. Associations 
with low frequent (<1% in the population) MR mutations have been found to be associated with 
rare genetic disorders while the more frequent (>1% in the population) single nucleotide 
polymorphisms (SNPs) have been found to be associated with common variation in healthy 
individuals, this is described in more detail in chapter 1, paragraph 2.2 of this thesis.  
In this study we tried to identify SNPs in the MR, therefore the exonic regions of the MR were 
screened in fifty individuals from the Leiden population. In addition we performed a computer 
screening on the genetic variation in the MR to predict possible functionality, we checked if the 
genetic variation was linked and if haplotypes exist in the MR.  
 
Materials and Methods 
 
Screening exonic regions MR  
Fifty anonymous EDTA blood samples were obtained from the general physician laboratory in 
Leiden, the Netherlands. DNA was isolated using a standard NaCl salting out procedure (Miller et 
al. 1988). Eighteen primer pairs were developed for PCR reactions covering all exonic regions 
using Primer3 software (Steve Rozen and Helen J. Skaletsky, 2000; primer sequences on request). 
All PCR reactions were performed with 50ng DNA, 8.0pM of each primer and AmpliTaq Gold 
(Applied Biosystems Nieuwekerk a/d IJssel, The Netherlands), according to the manufacturer’s 
protocol.  Sequencing of the PCR product was done with BigDye Terminator Sequencing Kit v3.1 
(Applied Biosystems Nieuwekerk a/d IJssel, The Netherlands) on an ABI Prism 3100-Avant 
Genetic Analyzer, according to the manufacturer’s instructions, while sequences were analyzed 
using Chromas Lite (Technelysium Pty Ltd) and Vector NTI (Invitrogen). 
 
Computer screening DNA sequences  
The program TFSEARCH (http://www.rwcp.or.jp/papia/ Heinemeyer 1998) was used to identify 
transcription factor binding sites, UTR-scan was used to identify regulatory regions in the 
untranslated regions and targetscan (http://www.targetscan.org) was used to identify microRNA 
target regions. 
DNA sequences with and without the SNPs were subjected to the computer programs to reveal a 
possible effect of the SNP on transcription factor binding sites, regulatory regions and microRNA 
target regions.  
 
Results 
 
MR SNP identification  
The exonic regions of the human MR gene were screened for genetic variation by direct sequencing 
fifty individuals from the Dutch population. There were no drop outs, all exonic regions were 
measured in all individuals. Seven SNPs were found in the exonic regions, rs2070951 (Minor allele 
frequency (MAF) 47%), rs5522 (MAF 11%), rs5523 (MAF 1%), rs5525 (MAF 11%), rs5528 (MAF 
1%), rs5534 (MAF 44%) and rs2871 (MAF 22%). No new SNPs were identified, all SNPs were 
described in the NCBI database (December 2008).  
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Computer screenings showed that rs2070951 is located in the first Kozak sequence of the gene; this 
region determines translation of the protein. Other SNPs were not located at predicted transcription 
binding sites, regulatory regions or microRNA target regions. However rs2871 appeared to be 
located at a region that is prone to loop formation. This was identified by the primer design 
software, during development of primers the primer design software indicated possible loop 
formation of the sequence. 
 
 
MR genotypes and haplotypes 
Linkage Disequilibrium (LD) and haplotype analyses revealed two haplotype blocks. One, 
containing the three high frequent SNPs in exon 2 rs2070951, rs5522 and rs5525. The other, 
contains the two high frequent SNPs in exon 9 rs5534 and rs2871 (Fig 1 and 2). 
 
 
 
Figure 1. LD between MR SNPs in r2. Black squares indicate r2= 1 and shades of grey indicate  r2<1 
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Discussion 
 
Screening the coding region of the MR gene revealed seven single nucleotide polymorphisms 
(SNPs), single nucleotide changes with a frequency of more than 1% in the population. No new 
SNPs were identified; these seven SNPs were already described on the NCBI website 
(http://www.ncbi.nlm.nih.gov/snp). There were no SNPs observed or previously described in the 
DNA and ligand binding domain. Genetic variation in these regions has probably too severe 
consequences for physiological processes to occur frequently in a healthy population. This 
assumption is supported by the finding that if rare genetic mutations occur in these regions, they 
invariably result in pseudohypoaldosteronism type I (PHA1).  
 
Two haplotype blocks were identified in the MR. One containing the SNPs in exon 2, the other 
containing SNPs in exon 9. Block 1 contains the previously tested, in vivo and in vitro functional 
SNPs MR-2G/C and MRI180V.  Functionality of haplotype block 2 or the separate SNPs in 
haplotype block 2 has not been reported but SNPs in this region might influence mRNA stability, 
since this has been demonstrated for other genes, including the closely related GR gene. 
 
The frequencies of rs5523 and rs5528, two of the seven SNPs in the coding region, were very low, 
only 1%, therefore these SNPs can not be used for future association studies in small patient-control 
cohorts.   
Figure 2. Structure and haplotypes of the hMR gene. Intronic DNA regions are displayed as the black line in the 
middle; exonic regions are displayed as the boxes on the line. Gray boxes represent the untranslated exons. White 
boxes indicate translated exons. SNPs and haplotypes are indicated below the DNA 
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 Summary  
 
Stress causes activation of the hypothalamic-pituitary-adrenal (HPA) axis and results in secretion of 
corticosteroids, which facilitate behavioral adaptation and promote the termination of the stress 
response. These actions exerted by cortisol are mediated by two brain corticosteroid receptor types: 
the high affinity mineralocorticoid (MR) and the lower affinity glucocorticoid receptor (GR). 
Dexamethasone is a potent GR agonist with affinity to MR. Administration of dexamethasone in the 
evening results in a significant suppression of the morning cortisol awakening response (CAR).  
 
Here we tested the involvement of MR variants in this effect of dexamethasone in 218 young 
healthy subjects (125 females, all using oral contraceptives). For this purpose we determined two 
single nucleotide polymorphisms (SNPs) in the MR gene, the previously described MRI180V 
(rs5522) and the MR-2G/C (rs2070951), which both affect in vitro the transactivational capacity of 
the MR in response to either cortisol or dexamethasone. 
 
Administration of a low dose dexamethasone (0.25mg) at 2300h resulted in a significant 
suppression of the cortisol awakening response (CAR). Both SNPs modulated the suppression of 
the CAR after dexamethasone significantly and in a sex specific manner. Suppression of the CAR 
was highest in the female MR-2G/C GG subjects while in male GG subjects the dexamethasone 
suppression of the CAR was attenuated compared to the MR-2G/C GC and CC groups. For the 
MRI180V, male AA subjects showed after dexamethasone a higher CAR than AG subjects while 
this effect was not observed in females. The SNPs had no significant influence on the CAR without 
prior dexamethasone treatment.  
 
The association of the CAR with functional MR gene variants only in dexamethasone treated 
subjects suggests the involvement of MR in dexamethasone induced suppression of morning 
cortisol.  
 
Key words: mineralocorticoid receptor, genetic variation, HPA axis, dexamethasone, cortisol 
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Introduction 
 
Corticosteroids, secreted by the adrenals, have metabolic, immunological and cardiovascular effects 
and facilitate behavioural adaptation (de Kloet et al., 2005). As corticosteroid dysregulation is 
potentially harmful for the body, the secretion of corticosteroids as end product of the 
hypothalamic-pituitary-adrenal (HPA) axis is strictly regulated at several levels including the 
hippocampus, hypothalamus, pituitary and adrenals. Regulation of the HPA axis by cortisol is 
mediated in complementary fashion by two brain corticosteroid receptor types, the low affinity 
glucocorticoid receptor (GR, NR3C1) and the high affinity mineralocorticoid receptor (MR, 
NR3C2). The MR is substantially occupied under basal conditions and studies in rats suggest a role 
of MR in basal HPA activity (Ratka et al., 1989), particularly in feedback regulation of the pulsatile 
release of corticosteroids (Atkinson et al., 2008). In humans administration of a selective MR 
antagonist increases basal cortisol levels (Dodt et al., 1993; Born et al., 1997; Deuschle et al., 1998; 
Young et al., 1998; Heuser et al., 2000; Arvat et al., 2001; Otte et al., 2003a; Otte et al., 2003b; 
Wellhoener et al., 2004; Buckley et al., 2007). In most of these studies ACTH levels were 
unchanged or decreased.  
 
The GR is mainly assumed to control feedback regulations after stress. The potent synthetic 
glucocorticoid dexamethasone is thought to act predominantly on the GR at the level of the pituitary 
gland to inhibit stress-induced HPA axis activation (De Kloet R et al., 1975). This steroid is 
commonly used in the dexamethasone suppression test (Carroll et al., 1968) as well as in the 
combined dexamethasone-CRH test. In both tests dexamethasone suppresses the HPA axis and the 
brain becomes depleted of the naturally occurring glucocorticoid cortisol. It is hypothesized that 
under those conditions the remaining low concentrations of cortisol occupy only brain MR and not 
GR. These tests have been frequently used to assess HPA axis regulation in psychiatric diseases. 
Patients with major depression do often show reduced cortisol suppression after a low dose of 
dexamethasone, whereas post traumatic stress disorder has been associated with an increased 
suppression after dexamethasone (Yehuda, 2002). 
 
In the current study we addressed the question if the MR contributes to morning HPA axis activity 
and the effects of dexamethasone on this morning HPA axis activity by measuring saliva cortisol 
and plasma ACTH levels. There are two possibilities that may explain how the MR can influence 
this effect of dexamethasone. First, the residual MR occupancy after low dose dexamethasone 
treatment could control the drive from higher brain regions to the HPA axis (Holsboer, 2000). The 
second possibility is that dexamethasone, which has affinity for MR (Rupprecht et al., 1993; 
Grossmann et al., 2004) binds brain MR, but that this usually remains unnoticed because of the 
manifold higher potency of dexamethasone at the pituitary GR.  
 
Two common functional MR gene variants, MRI180V and MR-2G/C were used to investigate the 
involvement of the MR on morning HPA axis activity with and without dexamethasone. Previously, 
we described the MR gene variant MRI180V (rs5522), a single nucleotide polymorphism (SNP) in 
exon 2, which results in an amino acid change in the N-terminal domain of the protein. This SNP 
decreases the transactivation capacity of the MR in vitro and was associated with enhanced cortisol 
and autonomic responses to an acute psychosocial stressor (DeRijk et al., 2006). In the current study 
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we tested a second MR gene variant called MR-2G/C, for its influence on the in vitro 
transactivation capacity with cortisol and dexamethasone as ligands. This SNP is located two 
nucleotides before the translation start site of the MR and might affect the translation of the MR 
protein.  
 
We then tested if these two MR gene variants are associated with the cortisol awakening response 
(CAR) either with or without dexamethasone treatment. The CAR is a distinct rise in cortisol levels 
occurring in response to morning awakening (Wilhelm et al., 2007). This measure is increasingly 
used as an indicator of adrenocortical activity and, amongst others, the CAR was shown to be 
related to gender, depressive symptomatology, PTSD, primary insomnia, chronic fatigue as well as 
to neuroticism and perceived chronic stress (Wüst et al., 2000a; Wüst et al., 2000b; Bhagwagar et 
al., 2003; Pruessner et al., 2003; Backhaus et al., 2004; Roberts et al., 2004; Rohleder et al., 2004; 
Schlotz et al., 2004; Portella et al., 2005; Wessa et al., 2006). A moderate, yet significant 
heritability of the CAR was found (Wüst et al., 2000a; Wüst et al., 2000b; Bartels et al., 2003). In 
recent review papers a comprehensive overview of findings related to this measure and a discussion 
of potential mechanisms mediating the CAR can be found (Clow et al., 2004; Fries et al., 2008; 
Chida and Steptoe, 2009). 
 
Thus, we investigated the association of the two MR gene variants with the CAR and early morning 
ACTH levels with and without dexamethasone administration.   
 
Materials and methods 
Subjects  
In the present study we investigated 218 healthy subjects, 125 females and 93 males (mean age 25.1 
years, standard error of mean (SEM) of  0.26 years; BMI 24.3  0.28), who were recruited from a 
Trier-based community sample and from the student body of the University of Trier. All 
participants were non-smokers. Ethnicity was assessed by asking for the geographical origin of the 
subjects’ parents and grandparents. Except some grandparents who originated from Poland, all 
subjects, parents and grandparents originated from Germany. Except for ethinyl-estradiol/progestin 
containing oral contraceptives (used by all females; see below for a discussion), all subjects 
reported to be medication free. Absence of acute or chronic diseases was confirmed in a medical 
examination prior to the experimental session. The protocol was approved by the ethics committee 
of the German Psychological Association, and written informed consent was obtained from all 
participants. The 218 subjects were initially selected for testing genetic variation in the GR (for 
details see Kumsta et al., 2007). 
 
Cortisol awakening response (CAR) 
Subjects were asked to collect saliva samples on two consecutive weekdays immediately after 
awakening and 30, 45, 60 minutes after the first sample using Salivette sampling devices (Sarstedt, 
Nuembrecht, Germany). They were instructed to refrain from food, drinks other than water and 
brushing their teeth before completion of saliva sampling. 
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Dexamethasone suppression test 
Participants were instructed to ingest 0.25mg dexamethasone (Par Pharmaceutical, Spring Valley, 
USA) at 2300h and to collect saliva samples as described above for the assessment of the CAR after 
dexamethasone ingestion. Moreover, one EDTA blood sample was obtained to assess ACTH and 
dexamethasone levels when the subjects reported to the laboratory 60 to 90min after awakening 
between 0800 and 0830h. 
 
Biochemical analyses 
Saliva samples were stored by the subjects in their freezers and returned to the laboratory after 
completion of sampling. Salivary cortisol was analyzed with a time-resolved immunoassay with 
fluorescence detection as described elsewhere (Dressendorfer et al., 1992). EDTA blood samples 
were immediately stored on ice and centrifuged within 30min at 2000 x g and 4°C for 10min. 
Plasma was stored at -80°C until analysis. ACTH was measured in EDTA plasma with a 
chemoluminescence immunoassay (Nichols institute, Bad Nauheim, Germany). Plasma 
dexamethasone was assessed with an in-house RIA at the Institute of Pharmacology, University of 
Heidelberg. Inter-assay and intra-assay coefficients of variance were below 10% and 12%, 
respectively, for all analyses. 
 
DNA extraction and genotyping 
DNA was extracted from 10ml peripheral venous blood following a standard NaCl salting out 
method (Miller et al., 1988). All subjects were genotyped for the MR-2G/C and MRI180V SNPs in 
duplicate using TaqMan pre-designed SNP genotyping assays, assay ID C12007869_20 and 
C1594392_10 respectively, in combination with TaqMan universal PCR master mix (Applied 
Biosystems, Nieuwekerk a/d IJssel, The Netherlands). Reaction components and amplification 
parameters were based on the manufacturer’s instructions. In addition, all the samples were 
genotyped with direct sequencing, therefore a PCR reaction was performed with 50ng DNA, 8.0pM 
of each primer (Forward: TCGCTTCTCTTGTTCT GACA, Reverse: 
CTGGACTCATGCTTCCTTGT) and AmpliTaq Gold (Applied Biosystems Nieuwekerk a/d IJssel, 
The Netherlands), according to the manufacturer’s protocol.  Sequencing of the PCR product was 
done with BigDye Terminator Sequencing Kit v3.1(Applied Biosystems Nieuwekerk a/d IJssel, The 
Netherlands) on an ABI Prism 3100-Avant Genetic Analyzer, according to the manufacturer’s 
instructions, while sequences were analyzed using Vector NTI (Invitrogen). 
 
Site directed mutagenesis of hMR 
The recombinant pRSV human MR plasmid, containing the last 30 base pairs of exon 1α into the 
nontranslated region of exon 9, was obtained from Dr. R. Evans (gene expression laboratory and 
HHMI, The Salk Institute for Biological Studies, La Jolla, Ca). The rs2070951 site was mutated 
from G to C with the Quick Change Site Directed Mutagenesis kit (Stratagene, La Jolla, CA) using 
the primers 5’-GGCCGAGGCAGCGATGGAGACCAAAG-3’ and 5’-
CGCTGCCTCGGCCCTTTGGTCTCCAT-3’ according to the manufacturers protocol. After 
mutagenesis the hMR insert of the plasmid was sequenced to assure absence of other mutations. 
Plasmids were purified from DH5α E-coli bacterial cultures using the Pure Yield purification 
system (Promega, Leiden, The Netherlands).  
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Transfections and luciferase assays 
Cos-1 cells (African green monkey kidney cells) were cultured in DMEM high glucose 
supplemented with 10% FCS (Gibco, Paisley, UK). Cells were seeded in 24-well plates (Greiner 
Bio-One, Alphen a/d Rijn, The Netherlands) at 3 x 104 cells/well in DMEM supplemented with 
charcoal-stripped serum. The cells were transfected the next day using SuperFect (Qiagen, Venlo, 
The Netherlands). Plasmids containing one of the hMR variants or no hMR (control) and the 
reporter plasmid TAT3-Luc (tyrosine amino transferase triple hormone response element) were 
used at 100 ng/well. The control plasmid pCMV-R (Promega, Leiden, The Netherlands) coding for 
Renilla luciferase controlled by cytomegalovirus (CMV) promoter was used (10 ng/well) for 
normalization purposes. One day after transfection, the cells were treated with either cortisol 
(Sigma-Aldrich, Zwijndrecht, the Netherlands) or dexamethasone (Sigma-Aldrich, Zwijndrecht, the 
Netherlands) in the concentrations 0, 10-11, 3.10-11, 10-10, 3.10-10, 10-9 and 10-8 M. After 24h of 
incubation the cells were harvested in passive lyses buffer (Promega) and firefly and Renilla  
luciferase activity was determined using the dual label reporter assay (Promega) and a luminometer 
(CENTRO XS3 LB960, Berthold, Bad Wildbad, Germany).   
 
Statistical analyses 
In the in vitro assays the firefly/renilla luciferase ratios were normalized to both the lowest and 
highest luciferase ratio for each hMR variant, background expression was subtracted and 
differences between the hMR variants were analyzed with a two-way ANOVA with Bonferroni 
posttest and by comparing the EC50 and slope of the dose response curves with a t-test using 
GraphPad prism 4 (GraphPad software Inc, San Diego, CA). Haploview (Barrett et al., 2005) was 
used to calculate Hardy Weinberg equilibrium (HWE) and linkage disequilibrium among the two 
MR SNPs (estimated with D’ and r2). To test if the MR genotypes are equally distributed in the 
different GR genotype groups a 2 test was computed. Cortisol data were log transformed to yield 
unskewed outcome variables. The two CAR measurements (without prior dexamethasone 
administration) were averaged in order to enhance the reliability of the measure (Wüst et al., 2000b; 
Hellhammer et al., 2007). General linear models (GLMs) were computed to assess the repeated 
measures effect time, the between-subjects effect genotype as well as the interaction time x genotype 
for the CAR with and without dexamethasone pretreatment. In order to reveal sex x genotype 
interactions, sex was also included as predictor in the GLMs. Greenhouse-Geisser corrections were 
applied where appropriate, and only adjusted results are reported. One-way ANOVAs were 
performed to compare mean plasma dexamethasone and ACTH levels after dexamethasone 
administration between comparison groups. All results shown are the mean  SEM unless otherwise 
stated. Apart from the exceptions stated above statistical analyses were performed using SPSS 14.0 
(Chicago, IL, USA). While statistical analyses of cortisol levels were based on log-transformed 
data, figures show untransformed means in order to provide a more naturalistic impression of 
cortisol levels. 
 
Results 
 
In vitro functionality testing 
Cos-1 cells were transfected with plasmids containing either no MR, the MR-2C or MR-2G 
nucleotide. Each plasmid was three times cultured, purified and tested to exclude variation due to 
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impurity or concentration of the plasmid. In each of the three experiments the plasmids were tested 
in triplicate. After incubation with either cortisol or dexamethasone at 7 concentrations in the range 
from 0 to 10-8M luciferase activity was measured. The negative control, cells transfected with 
plasmids containing no MR, showed only with the highest (10-8M) dexamethasone concentration an 
induction of 12%. For the other dexamethasone concentrations and all the cortisol concentrations 
there was no induction of luciferase in the negative control. After normalization of the luciferase 
data the 12% background induction was subtracted. 
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The MR-2C variant showed significantly higher transcriptional activity than the MR-2G variant 
using either cortisol or dexamethasone (F1,86=52.3,  p<0.001 for cortisol and F1,86 =7.3, p=0.01 for 
dexamethasone, Figure 1a & b). Post hoc analysis showed significant genotype effects at cortisol 
concentrations of 3.10-11, 10-11, 10-10 and 3.10-10M (t=4.265, t=5.770, t=5.297, all p<0.001 and 
t=3.11 with p<0.05, respectively) and at a dexamethasone concentration of 10-10 (t=3.26 and 
p<0.05). Analysis of the dose response curves showed a significant difference in the EC50 between 
the two MR variants (cortisol t14=5.816, p<0.0001 and dexamethasone t14=2.747, p=0.016) but no 
difference in the slope of the curves. For cortisol the EC50 was 6.6.10-11 for MR-2 G and 1.7.10-11 
for MR-2 C and for dexamethasone the EC50s were 2.3.10-10 and 9.9.10-11 respectively. 
 
Genotyping 
The 218 subjects were genotyped for the polymorphisms MRI180V and MR-2G/C with a Taqman 
assay and by direct sequencing yielding identical genotype frequencies (Table 1). Observed allele 
frequencies corresponded to those previously reported (DeRijk et al., 2006; Kuningas et al., 2007). 
While the MRI180V SNP was in Hardy Weinberg equilibrium (HWE) a deviation from HWE was 
detected for the MR-2G/C (p=0.0153; see below for a discussion). Estimated linkage between 
MRI180V and MR-2G/C was D’=1 (conf bounds 0.76-1) and r2=0.114. Although the genes for the 
GR and the MR are located on different chromosomes (5q31.3 vs 4q31.1) a 2 test was computed 
Figure 1 a) Cortisol and b) dexamethasone driven transactivation capacity of the MR -2G/C variants on a TAT-3 
promoter in Cos-1 cells displayed as percentage of the maximal transactivation capacity (SD) – the background 
activity when no MR is present. Cortisol and dexamethasone concentrations are indicated in log units. The MR-2G 
variant (dashed circle) showed a lower transactivation capacity compared with the MR-2C variant (black triangle) 
(cortisol p<0.001; dexamethasone p<0.01). 
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confirming that the investigated MR SNPs were not statistically related to the GR SNPs that were 
determined in the same cohort (2(20)=19.72, p=0.475; see Kumsta et al., 2007).  
 
Table 1  
Observed genotypes 
 
 MRI180V ∑ 
 AA AG  
MR-2 CC  
Male 12 6 18 
Female 17 13 30 
Total 29 (13.3%) 19 (8.7%) 48 (22.0%) 
 
MR-2 CG 
   
Male 43 11 54 
Female 59 15 74 
Total 102 (46.8%) 26 (11.9%) 128 (58.7%) 
 
MR-2 GG 
   
Male 21 0 21 
Female 21 0 21 
Total 42 (19.3%) 
 
0 (0%) 
 
42 (19.3%) 
 
∑ 173 (79.4%) 45 (20.6%) 218 (100%) 
 
Cortisol awakening response (CAR) with and without prior dexamethasone administration 
As previously described the CAR differed significantly between males and females, with males 
showing higher responses. Therefore sex was included as a predictor in all further analyses. The 
CAR without prior dexamethasone treatment showed the expected mean rise. However, we did not 
find any significant association between MR genotypes or haplotypes and the cortisol increase after 
awakening. The only noteworthy statistical trends were the interaction genotype x sex (F2,204=1.62, 
p=0.20) for the MR-2G/C (Fig. 2b) and the interaction time x genotype x sex (F1.98, 408.6=2.38, 
p=0.09) for MRI180V (Fig. 2a), suggesting a somewhat higher CAR in male MRI180V AA 
subjects (see also Table 2 for an overview of effects). 
 
The assessment of plasma dexamethasone levels confirmed that all participants had ingested the 
dexamethasone tablet and no significant difference between males and females was observed 
(males: 168 ± 51, females 174 ± 40 ng/100 ml, F2,212=.863, p=0.4). Moreover, individual 
dexamethasone levels were not associated with the MR genotypes (all F<1.05 and all p>.39). After 
0.25mg dexamethasone the CAR was still observed but cortisol concentrations were significantly 
lower then without prior dexamethasone treatment (main effect treatment: F1,189=597.8, p<.001). 
The average starting level was reduced from 11.2  5.1 to 2.9  1.8 nmol/l (74% suppression) and 
the average peak level from 17.0  6.9 to 4.5  2.3 nmol/l (74% suppression). Furthermore, cortisol 
levels in females (all using OCs) were significantly lower than in males (main effect sex: 
F1,196=36.69, p<.001) 
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Both MR SNPs were associated with post-dexamethasone cortisol levels, measured as the CAR, in 
a sex specific way (see Fig. 3a & b). In males MRI180V AA subjects (homozygotes major allele) 
showed a clearly higher (i.e. less suppressed) mean CAR than MRI180V G carriers, while this 
effect could not be observed in females resulting in a significant genotype x sex interaction 
(F1,193=4.34, p=0.039). Also independent of the subjects’ gender we found a trend towards a main 
effect genotype (F1,193=2.84, p=0.093) but this trend was obviously driven by the large difference in 
males. Accordingly, this main effect genotype was significant when females were excluded in a 
supplementary analysis (F1,80=5.06, p=0.027).  For the MR-2G/C an even clearer sex specific effect 
was detected with GG subjects showing the largest CAR in males and the most suppressed CAR in 
females (interaction genotype x sex: F2,191=4.23, p=0.016). 
 
As MRI180V and MR-2G/C are in linkage disequilibrium an additional analysis based on 
haplotypes was performed (see Fig. 3c). Three haplotypes were detected, MR-2-G/I180V-A, MR-2-
C/I180V-A and MR-2-C/I180V-G and the results of the haplotype analysis confirmed the genotype 
based comparisons. A significant genotype x sex interaction was detected (F4,187=2.84, p=0.026) and 
again this interaction was primarily based on the difference between male and female MR-2G/C GG 
subjects. A remarkable comparison group in this analysis were the male MR-2CC/I180V-AG 
subjects who showed a virtually completely suppressed CAR (see also Table 2 for an overview of 
effects). 
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Table 2.  General linear model effects for the CAR with and without dexamethasone pre-treatment 
 
  CAR CAR DEX 
 Effect df F p df F p 
MR-2G/C Genotype 2;204 1.53 .220 2;191 0.26 .974 
 Sex 1;204 2.14 .145 1;191 37.18 <.001 
 Genotype x Sex 2;204 1.62 .200 2;191 4.23 .016 
 Time 1.96;400.73 77.57 <.001 2.15;410.01 66.89 <.001 
 Time x Genotype 3.93;400.73 0.70 .593 4.29;410.01 1.36 .244 
 Time x Sex 1.96;400.73 16.90 <.001 2.15;410.01 10.07 <.001 
 Time x Genotype x Sex 3.93;400.73 0.68 .601 4.29;410.01 1.57 .179 
MRI180V Genotype 1;206 0.56 .457 1;193 2.84 .093 
 Sex 1;206 0.31 .575 1;193 10.94 .001 
 Genotype x Sex 1;206 0.67 .414 1;193 4.34 .039 
 Time 1.98;408.56 71.13 <.001 2.16;416.02 49.14 <.001 
 Time x Genotype 1.98;408.56 0.49 .610 2.16;416.02 1.83 .158 
 Time x Sex 1.98;408.56 8.61 <.001 2.16;416.02 3.63 .024 
 Time x Genotype x Sex 1.98;408.56 2.38 .094 2.16;416.02 0.98 .38 
Haplotypes Genotype 4;200 1.30 .270 4;187 1.02 .40 
 Sex 1;200 0.66 .416 1;187 15.01 <.001 
 Genotype x Sex 4;200 0.93 .448 4;187 2.84 .026 
 Time 1.98;395.98 69.03 <.001 2.14;399.94 48.51 <.001 
 Time x Genotype 7.92;395.98 0.77 .625 8.56;399.94 1.60 .117 
 Time x Sex 1.98;395.98 9.55 <.001 2.14;399.94 3.82 .020 
 Time x Genotype x Sex 7.92;395.98 1.13 .340 8.55;399.94 1.29 .244 
 
ACTH levels, assessed between 0800h and 0830h after dexamethasone administration were 
significantly more suppressed in females (all using OCs) than in males (main effect sex: 
F1,213=21.56, p<.001). We did, however, not detect any significant association between ACTH 
levels and MR genotype (MRI180V: meansSEM: 31.181.80 for AA, 35.355.33 for AG; main 
effect genotype: F1,212=0.95, p=0.33; interaction genotype x sex: F1,212=1.28, p=0.26; MR-2G/C: 
meansSEM: 28.684.23 for CC, 33.062.94 for GC, 32.685.17 for GG; main effect genotype: 
F2,212=0.17, p=0.84; interaction genotype x sex: F2,212=0.56, p=0.95; haplotypes: meansSEM: 
32.026.05 for CC/AA, 30.363.02 for GC/AA, 32.685.17 for GG/AA, 23.495.54 for CC/AG, 
43.578.54  for GC/AG; main effect genotype: F4,212=1.29, p=0.27; interaction genotype x sex: 
F4,212=0.24, p=0.92). 
 
Figure 2 (next page) Mean cortisol awakening responses ( SEM) in males and females with the MR genotype (a) 
I180V AA (males n= 76, females n= 97) and I180V AG (males n= 17, females n= 28);  (b) -2CC (males n= 18, females 
n= 30), -2GC (males n= 54, females n= 74) and -2GG (males n= 21, females n= 21); (c) MR haplotypes -2CC/ I180V 
AA (males n= 12, females n=17), -2GC/ I180V AA (males n= 43, females n= 59), -2GG/ I180V AA (males n= 21, 
females n=21), -2CC/ I180V AG (males n= 6, females n= 13) and -2GC/ I180V AG (males n= 11, females n= 15). 
 
Figure 3 (next page) Mean cortisol awakening responses ( SEM) after 0.25mg dexamethasone at 2300h the evening 
before in males and females with the MR genotype  (a) I180V AA (males n= 76, females n= 97) and I180V AG (males 
n= 17, females n= 28) ; (b) -2CC (males n= 18, females n= 30), -2GC (males n= 54, females n= 74) and -2GG (males 
n= 21, females n= 21); (c) MR haplotypes -2CC/ I180V AA (males n= 12, females n=17), -2GC/ I180V AA (males n= 
43, females n= 59), -2GG/ I180V AA/ (males n= 21, females n=21), -2CC/ I180V AG (males n= 6, females n= 13) and 
-2GC/ I180V AG (males n= 11, females n= 15). Please note the different y-axes scales in Fig. 2 and 3. 
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Discussion 
Two in vitro functional MR gene variants, MRI180V and MR-2G/C were associated with 
suppression of the cortisol awakening response following administration of 0.25mg dexamethasone. 
This effect was sex specific and was also observed with the haplotype of both SNPs. Moreover, 
when males were analyzed separately, a main effect for the MRI180V was observed. However, 
neither the two SNPs nor the haplotype were significantly related to awakening cortisol responses 
without prior dexamethasone treatment. 
 
Previously, we showed that the minor allele of the MR180V results in a relative loss of function in 
vitro using cortisol as ligand and although we did not show the data, we observed this as well with 
our assay. The present study demonstrates that the MR-2C variant has a significantly higher 
capacity in the activation of TAT-3 regulated gene transcription, as compared to the MR-2G, using 
either cortisol or dexamethasone as ligands. MR-2G/C is located two nucleotides before the first 
translation startsite in the kozak region, which is important for translation of the MR. The MR 
contains two translation start sites resulting in the isoforms MR-A and MR-B (Pascual-Le Tallec et 
al., 2004). MR-A is more potent in activating a MMTV or a GRE containing promoter than MR-B 
when aldosterone is used as a ligand. The wild type plasmid, expressing both MR-A and MR-B, has 
an even higher transactivation capacity than MR-A. Therefore, it can be hypothesized that the ratio 
MR-A/ MR-B might be important. This MR-2G/C SNP might change this MR-A / MR-B ratio and 
thereby the transactivation capacity. The observed effects of the studied SNPs in vitro indicate that 
they can be functional in vivo, although the sex specific effects observed in the association study 
indicate that a precise prediction of in vivo consequences from in vitro data is very difficult. On the 
other hand, these functional genetic variants provide natural tools to study the involvement of the 
MR in HPA axis regulation. 
 
Dexamethasone activates GR exerting long lasting genomic effects on negative feedback. This 
occurs predominantly at the pituitary level and it causes suppression of HPA axis activity until the 
next morning. However, the differential effects of functional MR gene variants on dexamethasone 
suppression of cortisol levels indicate the involvement of the MR. Several mechanisms can account 
for this observation.  
 
First, the MR gene variants, as in vitro, are expected to react differently in vivo to stimulation with 
dexamethasone and thus also differentially affect HPA axis suppression. This is a likely 
explanation, since without dexamethasone there was no genotype effect on the CAR.  Moreover, 
dexamethasone has an appreciable affinity fir the MR (Rupprecht et al., 1993; Grossmann et al., 
2004). Although likely, a mechanism assuming direct MR binding of dexamethasone needs further 
investigation. Central brain MR are less accessible for dexamethasone since Pg-p hampers the 
penetration of the steroid into the brain (Meijer et al., 1998). In spite of this some dexamethasone 
might pass the blood brain barrier and activate MR, while the pituitary gland also contains some 
MR.  
 
Second, 0.25mg dexamethasone results in lower, but still appreciable levels of saliva cortisol (Fig. 
3). The levels are comparable with the levels normally observed in the afternoon and are probably 
sufficient to activate MR (Meijer et al., 1998; Karssen et al., 2005; Droste et al., 2008). It is 
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hypothesized that under these conditions the differential effects of the MR gene variants appear, 
with subsequent effects on the input from higher limbic brain regions on the hypothalamic AVP 
(and/or CRH) drive to pituitary ACTH release (Bradbury et al., 1994; Tajima et al., 1999; Kovacs et 
al., 2000). Since limbic MR has inhibitory effects on the HPA axis, a reduced MR activation may 
result in this enhanced drive (Holsboer, 2000).  However, we did not observe a significant 
association with ACTH levels collected between 0800h and 0830h, the reason for this inconsistency 
is not clear. As the subjects awoke at least one hour prior to blood sampling the ACTH measures 
reflect hormonal levels after the CAR. It could thus be speculated that an association with the MR 
genotype can be detected when the awakening response (cortisol or ACTH) is assessed but not 
when single early morning levels are considered.  
 
Finally, fast non-genomic actions of membrane bound MR have been described. This membrane 
bound MR has much lower affinity for corticosterone then the classic MR with its genomic actions 
(Karst and Joels, 2005; Joels et al., 2008) and was recently shown in rats to mediate fast feedback 
during the ultradian pulse (Atkinson et al., 2008). These membrane bound MR have low affinity for 
corticosteroids and require rising corticosteroid levels for activation which makes a role for this 
non-genomic mechanism less likely.  
 
Changes in cortisol suppression after dexamethasone have been associated with psychopathology 
such as PTSD and major depression. The involvement of MR variants in the dexamethasone 
induced suppression of the CAR is an indication that those MR variants might be involved in 
psychopathology as well. A previous study by Kuningas et al supports this hypothesis since they 
found an association between MRI180V and feelings of depression in a cohort consisting of elderly 
(Kuningas et al., 2007). However, we used the CAR as a more precise measure of dexamethasone 
induced suppression of cortisol instead of one cortisol sample taken in the morning. The 
functionality of the CAR (with or without dexamethasone administration) for pathology is not 
completely understood yet, making it difficult to draw more far-reaching conclusions.  
 
Sex differences in HPA axis basal activity, regulation and reactivity are well known (Kudielka and 
Kirschbaum, 2005). Our previous study using the same cohort revealed a sex specific association 
between the GR BclI SNP and cortisol responses to a psychosocial stressor (Kumsta et al., 2007). 
Moreover, the GR SNP 9βAG was significantly associated with morning ACTH levels after 
dexamethasone administration, but only in males. In the current study, the association with post 
dexamethasone cortisol concentrations in males seems to be due to the MRI180V SNP. In contrast, 
the MR-2G/C SNP had the largest effect in females with the MR-2GG group showing a suppressed 
CAR. Thus it seems that the different variants of the MR gene can have opposite effects in males 
and females.  
 
Since the MR has high affinity for aldosterone, cortisol, deoxycortisol and progesterone (Rupprecht 
et al., 1993), female hormones may interfere with actions mediated by cortisol. For example, 
expression of the MR is influenced by estrogens, while progesterone affects the binding of 
corticosterone in rat hippocampus (Carey et al., 1995). In rats, estrogens decrease the expression of 
the MR in the pituitary (Turner, 1990) and progesterone treatment increased the activity of the MR 
promoter in cell lines (Castren et al., 1995). Interestingly, after adrenalectomy in rats testosterone 
 
48 Chapter  3 Funtional MR SNPs influence the CAR after Dex 
rather then corticosterone regulates AVP expression (Viau et al., 1999). Furthermore, we recently 
showed that MRI180V interacts differentially with different ligands. While the MRI180V 
modulates cortisol dependent transactivation in vitro, no difference was observed with aldosterone 
as a ligand (DeRijk et al., 2006). Thus both unique ligand – MR gene variant interactions and sex 
hormone modulation of MR gene expression could underlie the gender specific interactions of MR 
gene variants on post-dexamethasone cortisol levels. 
 
It is a certain limitation of our study that we could not control for the subjects’ compliance with the 
saliva sampling protocol. In studies that used collection devices equipped with electronic sensors it 
was revealed that strict compliance with instructions cannot be granted in ambulatory settings 
(Kudielka et al., 2003; Broderick et al., 2004). However, such an inaccuracy usually affects only a 
relatively small proportion of measurements, on average the ambulatory CAR is identical with the 
CAR assessed under sleep laboratory conditions (Wilhelm et al., 2007) and – most importantly - it 
is extremely unlikely that possible sampling time inaccuracies are systematically associated with 
our MR genotype groups. 
 
Another limitation of our study concerns the interpretability of the observed sex by genotype effects 
since all female participants used oral contraceptives (OCs). We chose to investigate only oral 
contraceptive using women as the complete study protocol included the exposure to a laboratory 
stress protocol (for details see (Kumsta et al., 2007) and in order to avoid a modulation of cortisol 
and ACTH responses to acute stress by the menstrual cycle phase (Kirschbaum et al., 1999). 
 
It is well known that ethinyl-estradiol leads to increased corticosteroid binding globulin (CBG) 
synthesis, which in turn influences total serum cortisol levels and the availability of free cortisol. 
Indeed, CBG was shown to modulate hormonal responses to TSST exposure in oral contraceptive 
using females, as well as in males (Kumsta et al., 2007). However, the CAR (without 
dexamethasone pretreatment) was found to be not significantly affected by OCs in a relatively large 
cohort of 509 subjects (319 females, 29% used OCs) (Wüst et al., 2000b).  
 
Data on a potential influence of OCs on HPA axis hormones after dexamethasone administration 
are surprisingly scarce and we cannot rule out such an effect in our study. However, after 1mg 
dexamethasone at 2300h free cortisol levels at 1600h did not significantly differ in women taking 
contraceptives compared to women in various stages of the menstrual cycle (Ansseau et al., 1993). 
Furthermore, at least the absolute levels of CBG per se are likely not responsible for our observed 
genotype by sex interactions, since we did not observe different CBG levels in the MR genotype 
groups (data not shown).  
 
It could be argued that different OC brands differing in compositions could have differential effects 
on our measures. However, it appears rather unlikely that the usage of different OC brands was a 
major confounder in the present study. Females in our sample used 14 different OC brands (all 
monophasic) with 11 different compositions and we did not even detect a weak trend for a 
significant association between OC composition and the CAR, the CAR after dexamethasone or 
ACTH levels after dexamethasone administration. All main effects and interactions had a p value 
>.38. As most OC preparations contain .03mg ethinyl-estradiol we performed a further 
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supplementary analysis and compared females using OCs with .03mg, with less than .03mg and 
with more than 0.03mg ethinyl-estradiol. Again, we did not detect a significant effect on our 
measures (lowest p value: .25). 
 
Generalization of our findings on women not taking oral contraceptives is not possible and this is a 
clear weakness of our study, which was accepted on the basis of feasibility considerations when the 
study was designed. It should be noted though, that more than 60% of young females (16-30 yrs) in 
Germany use OCs (von Have et al., 2005) and similar frequencies can be found in other 
industrialized countries. We thus think that studying OC females is a relevant topic. 
 
The two investigated SNPs in the MR, MRI180V and MR-2G/C showed linkage disequilibrium 
(D’=1 (conf bounds 0.76-1) and r2=0.114). This observed linkage has implications for the analysis 
because a combination of SNPs, a so called haplotype, can respond differently compared to isolated 
SNPs. Again a sex by genotype interaction was found for the association with post dexamethasone 
cortisol levels. Females with the MR-2/I180V GG/AA haplotype showed the lowest CAR, with no 
significant rise in cortisol at all, while men with this haplotype had the highest CAR. No 
unexpected interaction of the two SNPs, MRI180V & MR-2G/C, making the haplotypes was 
observed; both male MRI180V AG and MR-2G/C CC carriers showed lowest cortisol levels as well 
as the haplotype MRI180V AG/MR-2CC. In females the MR-2G/C made the difference, in contrast 
to the MRI180V, with its effect coming back in the haplotype, with the MR-2GG showing lowest 
cortisol levels. However, due to the rather small size of the haplotype groups these observations 
should be interpreted with caution. Subjects with MR-2 GG/MRI180V AG or MR-2 GG/MRI180V 
GG genotype combinations were not observed in this population and as part of a different study we 
sequenced several hundreds additional subjects and again these genotype combinations were not 
found (unpublished). This is reflected in the LD that was observed between the two SNPs.  
 
The MR-2G/C SNP deviated from Hardy Weinberg equilibrium in the current cohort. This is often 
a result of a genotyping error but in this study we used two different methods for genotyping and 
found identical results, excluding a technical error. Furthermore, all individuals reported to be from 
central European descent making population stratification unlikely. The remaining explanations are 
random sample variation or the non-random selection of the cohort. The cohort was selected based 
on GR polymorphisms. The genes for the GR and the MR are located on different chromosomes 
(5q31.3 vs 4q31.1) therefore it is not expected that this selection influences the MR genotype 
distribution and indeed a 2 test confirmed that the investigated MR SNPs were not statistically 
related to the GR SNPs. We only compared the genotype and haplotype effects on cortisol within 
this group and we did not perform a case-control study with a comparison between groups. In 
addition, the genotypes and haplotypes were used in the analysis instead of alleles. Therefore it is 
unlikely that this deviation from HWE had a major confounding impact on the findings. (Minelli et 
al., 2008).   
 
In summary, the data suggest a role of the MR in the control of negative feedback of the HPA axis 
as tested with dexamethasone, but how the MR variants precisely modulate this feedback action 
remains to be established. The observed effects of these common functional variants of the human 
MR gene are gender specific.
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Abstract 
 
Context: The mineralocorticoid receptor (MR) is essential in the regulation of volemia and blood 
pressure. Rare mutations in the MR gene cause type 1 pseudohypoaldosteronism and hypertension. 
Objective: Characterize the common MR polymorphism c.-2G>C (rs2070951) in vitro, and test its 
influence on parameters related to blood pressure regulation and the renin-angiotensin system. 
Design: In vitro studies were performed to assess the influence of the polymorphism on MR 
expression and transcriptional activity. Association studies were performed with several outcome 
variables in three independent cohorts: a mild hypertensive group subjected to a salt sensitivity test, 
a healthy normotensive group included in a crossover study to receive both a high and low Na/K 
diet and a large cohort (the Netherlands Study of Depression and Anxiety (NESDA)), in which 
blood pressure was measured. 
Results:  The G allele was associated with decreased MR protein levels and reduced transcriptional 
activation compared to the C allele. Subjects with the GG genotype had significant higher plasma 
renin levels both in the mild hypertensive group and in normal volunteers compared to homozygous 
C carriers. The GG genotype was also correlated with higher plasma aldosterone levels in healthy 
subjects. In both the mild hypertensive group and the NESDA cohort the genotype GG was 
associated with higher systolic blood pressure in males. 
Conclusions: The G allele of the common functional genetic polymorphism c.-2G>C in the MR 
gene associates with increased activation of the renin-angiotensin-aldosterone axis and with 
increased blood pressure, probably related to decreased MR expression.  
 
Keywords: mineralocorticoid, aldosterone, hypertension, nuclear receptor, sodium balance 
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Introduction 
 
The mineralocorticoid receptor (MR) mediates aldosterone effects on electrolyte balance and blood 
pressure (BP). Sodium handling is highly variable between individuals and genetic factors are 
involved in the development of hypertension (Halushka et al., 1999). Genetic variation in the MR 
might be responsible for the variability in sodium handling and vulnerability for hypertension. 
Classical MR-expressing tissues include the distal parts of the nephron, colon, salivary and sweat 
glands. In these tissues the MR regulates trans-epithelial sodium transport. However, MR are also 
expressed in non-epithelial tissues, including the cardiovascular system, the central nervous systems 
and adipose tissue (Caprio et al., 2007); in these tissues, glucocorticoids represent the predominant 
endogenous ligand (Funder, 2009). 
  
The MR belongs to the nuclear receptor superfamily and acts as a ligand-activated transcription 
factor regulating expression of a coordinate set of genes ultimately eliciting physiologic aldosterone 
and cortisol responses. The gene coding for the human MR, NR3C2, is composed of 10 exons and 
spans over ~400 kb. By means of alternative promoter utilization, alternative splicing, use of 
different translational start sites and genetic polymorphisms, considerable variability in MR 
function has been observed (Pascual-Le Tallec and Lombes, 2005)(Zennaro et al., 1995). Rare 
mutations of the MR are responsible for Mendelian diseases characterized by disorders of renal salt 
handling associated with high or low BP. Loss of function mutations of the MR lead to type I 
pseudohypoaldosteronism (Pujo et al., 2007; Fernandes-Rosa et al., 2006; Sartorato et al., 2004; 
Riepe et al., 2003; Geller et al., 1998), while the rare activating mutation S810L (rs41511344) leads 
to juvenile hypertension exacerbated by pregnancy (Fagart et al., 2005; Pinon et al., 2004). Two 
recent studies showed associations between more common genetic variations, single nucleotide 
polymorphisms (SNPs), in the MR and BP (Martinez et al., 2009; Tobin et al., 2008). Previously we 
tested the amino acid changing SNP in exon 2, MRI180V (rs5522) in vitro and showed that the 
rs5522 G allele leads to a lower transactivational capacity (DeRijk et al., 2006). However, in a 
group of mild hypertensive individuals we did not find an association with BP and MRI180V 
(DeRijk et al., 2006) , and the frequency of the same polymorphism was similar between 
hypertensive subjects and controls from a Brazilian birth cohort (Fernandes-Rosa et al., 2009). 
 
MRc.-2G>C (rs2070951) is a frequent SNP located in the 5’-untranslated region of the NR3C2 
gene, two nucleotides upstream of the first translation start site. The C allele of MRc.-2G>C has 
been associated with lower basal cortisol levels (Kuningas et al., 2007) and a decrease in MR-
dependent transcriptional activation in the presence of aldosterone (Arai et al., 2003). However 
MRc.-2G>C has not been tested for associations with salt handling and the precise mechanism of 
action of this SNP is currently unclear. 
 
In this study, we first investigated the functionality of MRc.-2G>C by testing its effect on MR 
protein expression, its influence on the MR-A/MR-B protein ratio and the transactivational activity 
in vitro with different ligands. We then assessed the effect of this polymorphism on sodium 
handling and regulation of the renin-angiotensin-system in normotensive healthy subjects included 
in a crossover study to receive a low Na-high K or a high Na-low K diet and in a group of mildly 
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hypertensive patients exposed to a salt sensitivity (Weinberger’s) test. Finally, we tested for an 
association between BP measures in a large multi-site cohort for depression and anxiety.  
 
Materials and Methods 
 
Construction of the plasmids 
The recombinant pRSV human MR (hMR) plasmid, containing the last 30 base pairs of exon 1α to 
the untranslated region of exon 9, was obtained from Dr. R. Evans (gene expression laboratory and 
HHMI, The Salk Institute for Biological Studies, La Jolla, Ca). The MR c.-2G>C site was mutated 
from G to C with the Quick Change Site Directed Mutagenesis kit (Stratagene, La Jolla, CA) using 
the primers 5’-GGCCGAGGCAGCGATGGAGACCAAAG-3’ and 5’-
GCTGCCTCGGCCCTTTGGTCTCCAT-3’ according to the manufacturers protocol (Fig. 1c). The 
plasmids expressing only MR-A or MR-B were generated by mutating the second or the first ATG 
into ATC by using the primers 5’TGAAGGTCTAGATACGGAAAGACGGTGG-3’ and 
5’CCACCGTCTTTCCGTATCTAGACCTTCAG-3’ or 
5’CCGAGGCAGGGACGGAGACCAAAGG-3’ and 5’CCTTTGGTCTCCGTCCCTGCCTCGG-
3’ respectively. After mutagenesis the hMR insert of the plasmid was sequenced to assure absence 
of other mutations. Plasmids were purified from DH5α E-coli bacterial cultures using the Pure 
Yield purification system (Promega, Leiden, The Netherlands). 
 
To generate pcDNA3_1α2G-luc and pcDNA3_1β2G-luc (Fig. 1a and b), human kidney and 
hippocampus (for pcDNA3_1α2G-luc) cDNA was amplified to generate fragments containing exon 
1α or 1β and 60 bp of exon 2 of the NR3C2 gene. The cDNA coding for luciferase was amplified, 
starting from codon 2, using the pGL2-basic vector (Promega, Madison, WI) as a template. Primers 
were designed containing specific restriction sites for subsequent cloning. All amplification 
fragments were subcloned into pGEMTeasy (Promega). The intermediate constructs 
pGEMTeasy_1α2 and pGEMTeasy_1β2 were digested with SpeI/XbaI, and ligated to the luciferase 
cDNA previously excised from pGEMTeasy_luc by digestion with SpeI. The chimeric construct 
1α2luc was excised from pGEMTeasy_1α2luc by digestion with BamHI and XhoI and inserted into 
pcDNA3 (Invitrogen, Paisley, Scotland) to obtain pcDNA3_1α2-luc and pcDNA3_1β2-luc. 
Oligonucleotides used for amplification of the different fragments are the following: 
5'-ATGGATCCAGAGGAAGCCCGTGCAGTCA 3' and 5'-CCCACCGTCTTTCCATATCT-3' 
1β2 : 5'-ATGGATCCCGCCGCTGCCTCGCCGCCTC-3' and 5'-CCCACCGTCTTTCCATATCT-
3' 
Luciferase: 5'-GCACTAGTCGAAGACGCCAAAAACATAAAGA-3' and 5'-
CCCTCGAGCATTTTACAATTTGGACTTTC-3' 
Different pcDNA3_1α2-luc and pcDNA3_1β2-luc clones were sequenced to verify the nucleotide 
rs2070951 (MR c.-2G>C). The G to C change was created by site-directed mutagenesis using the 
Quick change site-directed mutagenesis kit (Strategene, La Jolla, CA) on the recombinant plasmids. 
The following sense primer was used together with their corresponding antisense oligonucleotide. 
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Transactivation assays 
Rabbit RCSV3 cells derived from kidney cortical collecting duct (Vandewalle et al., 1989) (kindly 
provided by Pr. P. Ronco, Hôpital Tenon, Paris) were grown as described previously (Zennaro et 
al., 2001) and transfected using lipofectamine 2000 (Invitrogen) with 0.25 µg of plasmid containing 
either MR-2G or MR-2C pcDNA3, 0.625 µg of a GRE2_TATA_luc reporter plasmid plasmid 
(Asselin-Labat et al., 2004) and 0.25 µg of pSVβgal. The day after transfection, steroids were added 
at different concentrations and 48 hours after transfection, luciferase and β-galactosidase activities 
were assayed using the Dual-Light® System and the Galacton-Plus® Substrate (Applied 
Biosystems). Results were standardized for transfection efficiency and expressed as the ratio of 
luciferase activity over β-galactosidase activity in arbitrary units.  
 
Cos-1 cells (African green monkey kidney cells) were cultured as described previously(van 
Leeuwen et al., 2010) and seeded in 24-well plates (Greiner Bio-One, Alphen a/d Rijn, The 
Netherlands) at 3 x 104 cells/well in DMEM supplemented with charcoal-stripped serum. The cells 
were transfected the next day using SuperFect (Qiagen, Venlo, The Netherlands). Plasmids 
containing MR-2G or MR-2C or no MR (control) and the reporter plasmid TAT3-Luc (tyrosine 
amino transferase triple hormone response element) were used  at 200 ng/well. Construction of the 
plasmids is described in the data supplement available online. The control plasmid pCMV-Renilla 
(Promega, Leiden, The Netherlands) was used  at 2 ng/well. To exclude variation due to impurity or 
concentration of the plasmid each plasmid was cultured 3 times, purified and tested. In each of the 
three experiments the plasmids were tested in quadruplicate. One day after transfection, the cells 
were treated with different concentrations of either aldosterone or cortisol (both Sigma-Aldrich, 
Zwijndrecht, the Netherlands). After 24h of incubation the cells were harvested in passive lyses 
buffer (Promega) and firefly and Renilla luciferase activity was determined using the dual label 
reporter assay (Promega) and a luminometer (CentroXS, Berthold, Bad Wildbad, Germany).  
 
Protein expression studies  
For studies investigating the effect of the c.-2G>C SNP on protein synthesis, rabbit RCSV3 cells 
and COS-7 cells were seeded in six-well plates at a density of 3x105 cells per well at least 6 hours 
before transfection in fresh medium without any added steroid. Cells were transfected by the 
calcium phosphate method with 0.66 μg of plasmids pcDNA3_1 β 2G-luc, pcDNA3_1 β 2C-luc, 
pcDNA3_1α2G-luc or pcDNA3_1 α 2C-luc. Co-transfection of 0.16 μg pSV β gal (Clontech, Palo 
Alto, CA) was performed to normalize for transfection efficiencies.  Cells were rinsed twice with 
cold PBS, lysed in lysis buffer and cellular extracts assayed for luciferase and β -galactosidase 
activities as previously described(Zennaro et al., 2001). Results were expressed as the ratio of 
luciferase activity over β -galactosidase activity in arbitrary units.  
 
For Western blot Cos-1 cells were seeded in  6-well plates (Greiner Bio-One) at 2 x 105 cells/well. 
The cells were transfected the next day using Trans-it Cos transfection reagent (Mirus, Madison, 
USA). Plasmids containing one of the hMR variants, e.g. hMR-2G, hMR-2C, mutated hMR only 
expressing MR-A and mutated hMR only expressing hMR-B or no hMR (control) were used at 
2µg/well. Cells were harvested 48 hours after transfection. The Western blots using primary 
antibodies MR 1D5, detecting amino acid 1-18 and therefore only MR-A, and 2B7, detecting amino 
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acid 64-82 and therefore both MR-A and MR-B, (a generous gift by Gomez-Sanchez, Division of 
endocrinology, University of Mississippi, Jackson, MS) were performed as described 
previously(Conway-Campbell et al., 2007) The differences in intensity of the MR bands were 
quantified with Image J (ImageJ, U. S. National Institutes of Health, Bethesda, Maryland, USA, 
http://rsb.info.nih.gov/ij/) 
 
RNA isolation and real time quantitative PCR 
All reagents used were from Invitrogen unless otherwise specified. Transfections with plasmids 
containing one of the hMR variants, pcDNA3_1α2G-luc, pcDNA3_1β2C-luc, pcDNA3_1β2G-luc, 
pcDNA3_1β2C-luc and pSVgal were performed as described under the protein expression section. 
For the  hMR transfections 24 hours and for other transfections both 12 and 24 hours after 
transfection, total RNA was extracted in Trizol reagent according to manufacturer’s 
recommendations. Total RNA was treated with DNase I and quantified with the Ribogreen RNA 
quantitation kit as previously described (Zennaro et al., 2001). For the transfections with hMR 1μg 
and for the others 500 ng of RNA was used to generate cDNA. Amplification of the cDNA was 
performed using SYBRgreen (qPCR MasterMix Plus for SYBR® green I, Eurogentec, Seraing, 
Belgium) on a Chromo4 Continuous Fluorescence Detector (MJ Research, Bio-Rad laboratories, 
Waltham, MA), according to the manufacturers instructions. Primer sequences are available upon 
request. Controls without reverse transcriptase and without template were included to verify that 
fluorescence was not overestimated by residual genomic DNA amplification or from primer dimer 
formation. Moreover RT-PCR products were analyzed in a post-amplification fusion curve to ensure 
that a single amplicon was obtained. Ribosomal 18S RNA was used to normalize for RNA quality, 
quantity and RT-efficiency. Quantification of β gal was used to normalize for transfection efficiency. 
Quantification was done by the standard curve method. Standard curves were generated by serial 
dilutions of a linearized plasmid containing the specific amplicon, spanning six orders of magnitude, 
yielding a correlation coefficient of at least 0.98 in all experiments. For all experiments, PCR 
efficiency was close to 2 indicating a doubling of DNA at each PCR cycle, as expected.  
 
Subjects 
In all studies respondents provided written informed consent and all studies were performed in 
accordance with the Declaration of Helsinki guidelines. 
 
Mild hypertensive group. Ninety Italian patients (34 females, 56 males, mean age 46.0 yrs, mean 
body mass index 26.8) with mild essential hypertension , i.e. mean systolic blood pressure (SBP) 
152 mm Hg and mean diastolic blood pressure (DBP) 97.5 mm Hg were recruited by 9 medical 
centres. The patients were taken off antihypertensive medication 14 days prior to testing. After a 
normal sodium diet (150 mmol/day) for 3 days, patients were subjected to an acute salt-loading 
(constant rate intravenous infusion of 2 L of 0.9% NaCl carried out over 4 hours) and salt-depletion 
protocol (sodium restriction 50 mmol plus three doses of 37.5 mg of furosemide) to evaluate the 
distribution of BP sensitivity to salt (Strazzullo et al., 2000a). If the difference between the mean 
arterial pressures at the end of the salt-loading and salt-depletion period was greater than the median 
(10 mmHg), the patient was classified as “salt-sensitive” otherwise the patient was considered “salt-
resistant”. Twenty-four hours urinary sodium excretion, upright plasma aldosterone (after two hours 
orthostatism) and plasma renin activity were measured after three days of normal sodium diet (150 
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mmol/day) just before the salt-load. Post-load plasma aldosterone and renin activity were measured 
4 h after the beginning of the salt-load. Urine electrolytes analyses,  measurements of plasma renin 
activity and plasma aldosterone concentration were performed as previously described (Strazzullo et 
al., 2000b).  
 
Healthy group 
Forty healthy French Caucasian normotensive (BP less than 140/90 mmHg in the supine position 
after 5 minutes of rest) males (18–35 years) were included in a crossover study to receive both a low 
Na+ (less than 20 mmol NaCl/day) and high K+ (more than 140 mmol Kcl/day; low Na+–high K+ 
diet) or  high Na+ (more than 250 mmol NaCl/day) and low K+ (less than 50 mmol Kcl/day; high 
Na+–low K+ diet) for 1 week. The study design has been previously described in detail (Azizi et al., 
2005) and all subjects completed the study after giving written informed consent. Procedures were 
in accordance with institutional guidelines. Controlled Na+/K+ diet periods were separated by a 7-
day washout period. On the ad libitum Na+ and K+ diet at baseline and on day 7 of each controlled 
Na+/K+ diet period, blood was sampled at 0900 in the fasting state after 1 hour of rest in the sitting 
position for plasma immunoreactive active and total renin and plasma aldosterone and ANP 
determinations. Urine was collected in two 12-hour periods from 0800 to 2000 and from 2000 to 
0800 and was used for hormone and electrolyte determinations. The methods used for collecting 
blood samples and for quantifying plasma active renin, total renin, atrial natriuretic peptide (ANP) 
and aldosterone were as described previously (Azizi et al., 2005). 
 
Multi-site cohort for depression and anxiety 
Data were obtained from the Netherlands Study of Depression and Anxiety (NESDA), an 8-year 
longitudinal cohort study that includes 2,981 Dutch Caucasian participants, aged 18 through 65 
years, A detailed description of the study design and sample has been published previously 
(Penninx et al., 2008). NESDA is a multi-site cohort study to describe the long-term course and 
consequences of depressive and anxiety disorders in which cardiologic parameter such as blood 
pressure were analysed (Penninx et al., 2008). Participants were recruited from different locations in 
the Netherlands (Amsterdam, Leiden and Groningen). For the current study, data were used from 
the baseline interviews conducted between September 2004 and February 2007.  Of the 2981 
participants, 1860 subjects have been genotyped and after quality control  (previously described 
(Sullivan et al., 2009)), 1754 subjects (67.9% woman, mean age 42.35, SD 12.49 years) were 
included in the study. The cohort consisted predominantly of subjects with current or remitted 
anxiety and/or depressive disorders at time of BP assessment. However, the presence of psychiatric 
diagnosis was not associated with BP. BP was registered by the OMRON IntelliSense Professional 
Digital Blood Pressure Monitor, HEM-907XL (Omron Healthcare, Inc). SBP and DBP were 
measured twice during supine rest on the right arm and were averaged over the 2 measurements. A 
correction was made for all of the individuals on hypertensive medication, which was considered as 
being used if subjects frequently (50% of days in last month) used antihypertensives (ATC code 
C02), diuretics (ATC code C03), β-blocking agents (ATC code C07), or calcium channel blockers 
(ATC code C08). In accordance with earlier studies and based on the efficacy of antihypertensive 
drugs in randomized trials (Mancia and Parati, 2004; Cui et al., 2003) we added 10 mm Hg to SBP 
and 5 mm Hg to DBP for subjects who used antihypertensives. 
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Determination of genotypes 
Patients from the Italian cohort were genotyped by direct sequencing after PCR amplification using 
an ABI BigDye termination sequence kit v1.1 (Applied Biosystems Foster City, USA) on an ABI 
3700 DNA analyzer and the reaction was performed according to the manufacturer’s specifications. 
Patients from the French cohort were genotyped by direct sequencing of PCR products using the 
ABI Prism Big Dye Terminator v3.1 Cycle Sequencing Kit on an ABI Prism 3700 DNA Analyzer. 
Primers for PCR amplification are Primers used for genotyping are: 
Fw 5’-ATA TGT TTT GTG GCT TAG CAA AT-3’ 
Rv 5’AAC TTA GAG TGG AAG GAC GAT GG-3” 
Subjects from the Dutch NESDA cohort were genotyped by Perlegen Sciences (Mountain View, 
CA, USA) using a set of four proprietary, high-density oligonucleotide array , which had a call rate 
of 98.9% for this SNP. A detailed description of the genotype process is described elsewhere 
(Sullivan et al., 2009). 
 
Statistical analysis 
In cell culture experiments the difference between the two alleles was analyzed with a two-way 
ANOVA with Bonferroni post-hoc tests. For western blot the difference in protein expression was 
analyzed with t-test. In vitro results are shown as the mean ± SD or mean ± SEM. Statistical 
analysis of all the in vitro results was performed with Graph Pad Prism version 5 (GraphPad 
software Inc, San Diego, CA).  
 
In the Italian mild hypertensive group, the MR genotype effects were assessed using two-way 
(genotype/sex) ANCOVA with age and BMI as covariates. Skewed variables were log-transformed 
before statistical testing. When the interaction between genotype and sex was significant (blood 
pressure), analyses were separately performed in each sex. The statistical analysis was performed 
using Systat 11 statistical software.    
In the healthy volunteers group, differences between MR genotype groups were assessed by 
ANOVA for a crossover design for plasma parameters and by non parametric Kruskal-Wallis test 
for urinary parameters. Stata Statistical Software (version 7.0; StataCorp.) was used for statistical 
analysis.  
 
In the Dutch NESDA cohort, differences between MR genotype groups in SBP and DBP were 
analysed using general linear model (GLM).  We tested for gene gender interaction and performed 
the GLM for the entire sample and split for gender. The previous identified confounders related to 
BP in this cohort: gender, age, years of education, alcohol use, smoking, tricyclic antidepressants, 
noradrenergic and serotonergic working antidepressants, number of chronic disease, body mass 
index, depression and anxiety comorbidity and presence of significant life events (Licht et al., 2009) 
were included as covariates. SPSS 15.0 was used for the statistical analysis. Association study data 
are expressed as means ± SD or medians and interquartile ranges.  
Allele frequencies in the three cohorts were calculated and analyzed for deviation from Hardy-
Weinberg equilibrium (HWE) using Haploview. The groups consisting of mild hypertensive 
individuals and of healthy individuals did not deviate from HWE, as well as the healthy individuals 
from the NESDA cohort. However, deviation from HWE was observed in the patients with mood 
and/or anxiety disorders from the NESDA cohort (p=0.0053). Deviation from HWE in patients can 
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be interpreted as an indication of association of particular genes with disease (Lee, 2003; Deng et 
al., 2000). Under these circumstances, the lack of HWE arises as a result of selection according to 
the phenotype that results in allele and genotype distributions that are nonrandom. 
Data are expressed as mean ± SD or otherwise specified. A P-value of less than 0.05 was 
considered to be significant. 
 
Results  
 
MRc.-2G>C influences the transactivation activity of the MR.  
The influence of the MR-2G>C SNP on MR function was measured with an in vitro transactivation 
assay. Cos-1 cells and RCSV3 cells were transfected with plasmids containing either MR with the -
2 C nucleotide or MR with the -2 G nucleotide (Fig. 1c).  
 
 
 
After incubation with aldosterone (concentration range 0 to 10-7M) or cortisol (concentration range 
0 to 10-6 M) luciferase activity was measured. The -2C allele showed significantly higher 
transcriptional activity than the -2G variant using either aldosterone or cortisol  in both cell models 
(Cos-1 cells: p<0.05, p<0.001 S12a and S1b; RCSV3 cells: p<0.001 and p<0.001 for aldosterone 
and cortisol respectively, (Fig. 2).  
 
Figure 1. Presentation of the sequence context 
surrounding the SNP c.-2G>C, schematic 
representation of the chimeric gene constructs and 
schematic representation of hMR isoforms MR-A 
and MR-B . a) Alignment of the Kozak consensus 
sequence for translation initiation and the 
sequence upstream of the principal AUG codon 
(pos. +1) of the MR mRNA.  The SNP MRc.-
2G>C is located at position -2 with respect to the 
AUG. The human MR mRNA sequence is 
aligned with the rat and mouse MR mRNAs. b) 
Schematic representation of the chimeric 
constructs 1α2luc and 1β2luc (c) schematic 
representation of hMR isoforms MR-A and MR-
B and the location of the antibodies used in 
westenblot for detection of the two isoforms.  
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a) b)
c) d)
 
Figure 2. Aldosterone and cortisol-driven transactivation by MR c.-2C and MRc.-2G. Aldosterone (2a and 2c) and 
cortisol (2b and 2d) driven transactivation capacity of the MRc.-2G>C variants on a TAT-3 promoter in Cos-1 cells (2a 
and 2b) and RCSV3 cells (2c and 2d) displayed as percentage of maximal induction obtained with -2G (±SEM, c) and 
d)). The MR-2G variant showed a lower transactivation compared with the MR-2C variant. Results represent at least 
two independent experiments performed in triplicate. 
 
MRc.-2G>C affects protein expression independently of the 5’untranslated region.  
In the human NR3C2 gene, two 5’-untranslated (UT) exons are alternatively transcribed and 
generate two different mRNAs which code for a unique MR protein, since the translational start site 
is located at the beginning of exon 2. The c.-2G>C SNP is located 2 nucleotides upstream of the 
translation initiation site in the middle of the Kozak consensus sequence for translational initiation 
(Kozak, 1986) (Peri and Pandey, 2001) which is highly conserved among the NR3C2 genes from 
several species (Fig. 1a). In order to test a possible functional role of the c.-2G>C SNP, we have 
investigated its influence on translational efficiency, in the context of both 5’-UT exons 1α and 1 β. 
Using chimeric constructs, with exon 1 α  or 1β inserted together with the Kozak sequence 
containing either G or C immediately upstream of the coding sequence of the luciferase gene (Fig. 
1b), transient transfection assays were performed in renal RCSV3 cells and in COS cells, the 
amount of luciferase activity representing the amount of protein generated. In the presence of 
comparable mRNA levels 12 hs post-transfection, the C allele was associated with significantly 
higher protein levels compared to the G allele, both at 12 and 24h post-transfection in RCSV3 cells 
(p<0.0001, Fig. 3a) and Cos-7 cells (p<0.0001, Fig. 3b). This effect was observed in the presence of 
both the UT exons 1α or 1β. Interestingly, luciferase activity in the presence of the UT region 1 β 
was ~ 40% of that observed with exon 1 α  (p<0.0001).  
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Figure 3. Effects of MRc.-2G>C on protein expression. Effects of -2G>C variants on protein expression were measured 
with a recombinant MR-luciferase construct. Chimeric constructs containing exon 1α (white and dark gray bars) 
showed a higher luciferase expression compared to chimeric constructs containg exon 1β (light gray and black bars) in 
either RCSV3 cells (3a) or COS-7 cells (3b). The MR-2C variant (dark gray and black bars) showed a higher luciferase 
expression compared with the MR-2G variant (white and light gray bars) in either RCSV3 cells (3a) or COS-7 cells 
(3b).  
 
We then investigated the hypothesis that the -2G>C SNP may affect alternative translation of the 
previously described human MR isoforms MR-A and MR-B. Constructs containing either MR with 
the -2 C nucleotide or MR with the -2 G nucleotide and control constructs expressing only MR-A or 
MR-B were transiently transfected in Cos-1 cells. The MR mRNA levels after transfection were 
similar for MR -2C and MR-2G (Figure 4). 
  
 
 
Figure 4.  Effects of MRc.-2G>C on the expression of MR isoforms.  Constructs containing MR with either -2C or -
2G and control constructs expressing only MR-A or MR-B were transiently transfected in Cos-1 cells. The effect of the 
-2G or -2C allele on MR-A and B protein expression was measured by Western blot using two different antibodies 
recognizing aminoacids 1 to 18 (visualizing MR-A, Fig. S3a), or aminoacids 64 to 82, detecting both MR-A and B (Fig. 
S2b). c) Quantification of MR expression of multiple experiments using the MR-A detecting antibody (1D5).  
 
Two different primary antibodies were used in Western blots: 1D5 directed against aminoacids 1 to 
18 was used to visualize MR-A, while 2B7 directed against aminoacids 64 to 82 was used to detect 
MR-A and B (fig. 1c). Specificity of the antibodies was confirmed with the control constructs 
expressing only MR-A or only MR-B In Cos-1 cells transfected with the constructs MR -2G or MR 
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-2C only MR-A was expressed but not the MR-B. Western blots also confirmed the differences in 
MR-A protein expression between -2G and -2C containing constructs, the MR-2C resulted in 
significantly increased MR-A protein expression, the ratio between MR and the control tubulin was 
0.300 (±0.014) for MR-2G and 0.362 (±0.022) for MR-2C (Fig. 5) 
 
 
 
 
 
 
Consequences of MRc.-2G>C on renal sodium handling and blood pressure regulation  
The MRc.-2G>C SNP was determined in subjects from the three independent cohorts. Allele and 
genotype frequencies were not significantly different between the three groups (χ22= 5.36, p=0.07 
and χ24=6.57, p=0.16, resp.)  (Table 1).  
 
Table 1 Comparison of allele and genotype frequencies in the three different cohorts 
 
group Allele frequencies  Genotype frequencies 
 C G  CC GC GG 
Hypertensive 0.59 0.41  0.32 0.53 0.15 
Healthy 0.51 0.49  0.25 0.53 0.22 
NESDA 0.51 0.49  0.24 0.53 0.23 
 
Mild hypertensive group. After 3 days of high salt diet (150 mmol/day), plasma renin activity was 
significantly higher in mild hypertensive GG patients compared to the other genotypes (Table 2). In 
addition, the GG genotype was associated with significantly higher SBP levels in men, but not in 
women (Table 3). No association of the MRc.-2G>C genotypes was found with other parameters 
tested in the cohort, such as 24-hours urinary sodium excretion and plasma aldosterone or plasma 
aldosterone and plasma renin activity levels after salt loading. Following the Weinberger’s test, the 
ratio of salt sensitive to salt resistant subjects was not significantly different among genotypes 
(χ21=1.69, P=0.43) and there was no relationship between the genotypes and blood pressure 
response to the salt sensitivity test (p=0.21, data not shown). 
Figure 5.  Effects of MRc.-2G>C on the expression of MR isoforms.  Effect of -2G>C variants on MR-A and B 
protein expression was measured by Western bot using antibodies directed against a) the first 18 aminoacids of the 
MR, therefore only detecting MR-A  and b) aminoacid 64-82 detecting MR-A and MR-B. c) Quantification of MR 
expression. 
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Table 2.  Characteristics (mean ± SD ) or geometric mean (95%CI) in 90 mild hypertensive men 
and women from the Italian cohort according to the MR MR-2G/C genotype  
 
Italian cohort  3 days controlled salt intake (150 mmol/day) Weinberger’s test 
90 subjects Freq 
(%) 
24hr Urinary 
sodium 
excretion/crea
tine (mEq) 
Aldosteron
e (ng/dl) 
Plasma renin 
activity 
(ng/ml/h) 
Salt 
Resistant 
(ΔBP< 
10mm Hg) 
n 
Salt Sensitive 
(ΔBP >10 mm 
Hg) 
n 
MR c.-2CC  
(n=29)      
32.2 155.1 ± 54.3 
(n=25) 
12.8 (10.1-
16.2) 
(n=28) 
1.42 (1.07-1.88) 
(n=28) 
17 12 
MR c.-2GC  
(n=48) 
53.3 172.7 ± 83.7 
(n=39) 
12.8 (10.6-
15.4) 
(n=47) 
1.46 (1.20-1.79) 
(n=47) 
21 27 
MR c.-2GG  
(n=13) 
14.8 180.1 ± 50.6 
(n=11) 
12.9 (9.5-
17.6) 
(n=11) 
2.25 (1.33-3.79) 
(n=11) 
7 6 
P-value:  0.69* 0.65* 0.029† 0.43‡  
* genotype effect from 2-way (genotype, sex) ANCOVA adjusted for age, BMI. There was no interaction between sex 
and genotype for any variable. For aldosterone and renin, log values were used in the statistical tests. †Global test (2df): 
0.10, GG vs CC+GC. ‡χ2 = 1.69, df = 2 
 
Table 3.  Association analysis of the MR MR-2G/C genotype with diastolic and systolic blood 
pressure in 90 mild hypertensive men and women from the Italian cohort 
 
 Blood pressure Group MR-
2G/C 
Mean SD P* 
Men (n=56) CC (22) 
GC (26) 
GG (8) 
 
151.5 
147.8 
165.8 
11.6 
12.6 
9.8 
0.004 Systolic 
(mmHg) 
Women n=34 CC (7) 
GC (22) 
GG (5) 
 
151.0 
158.1 
141.0 
9.8 
18.9 
8.9 
0.21 
Men (n=56) CC (22) 
GC (26) 
GG (8) 
 
99.1 
96.5 
102.0 
5.1 
6.3 
5.3 
0.053 Diastolic 
(mmHg) 
Women n=34 CC (7) 
GC (22) 
GG (5) 
95.6 
98.1 
90.0 
8.3 
9.7 
3.5 
0.056 
BP: blood pressure; *genotype effect by ANCOVA adjusted for age and BMI in each sex separately.  
Interaction genotype X sex: P = 0.001 and P = 0.005 for PAS and PAD respectively. 
 
Normotensive subjects. On the ad libitum Na+/K+ diet, 156 mmol of Na+ (interquartile range, 126–
187 mmol) and 68 mmol of K+ (interquartile range, 59–81 mmol) were excreted in the urine in 24 
hours. By controlling the Na+/K+ intakes, it was possible to achieve the desired Na+ and K+ 
balances, as reflected by 24-hour urinary NaCl and KCl excretion rates (Table 4). The 24-hour 
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urinary Na+ and K+ excretion levels were identical for subjects of the 3 genotypes for all of the diets 
(Table 4). 
Plasma active and total renin and aldosterone, and ANP on the ad libitum Na+/K+ diet were within 
the physiological ranges and did not differ according to genotype (Table 4). As expected, plasma 
active and total renin and aldosterone concentrations increased with the low Na+–high K+ diet and 
decreased with the high Na+–low K+ diet. The changes in plasma ANP concentrations were in the 
opposite directions (Table 4). On the high Na+ – low K+ diet, GG subjects had significantly higher 
levels of plasma active and total renin and aldosterone concentrations than CC subjects, with 
heterozygous GC subjects presenting intermediate values. A similar trend was observed on the low 
Na+–high K+ diet, but differences between GG and CC genotypes were not significant.  
 
Table 4. Biological characteristics of normal volunteers according to the MR MRc.-2G>C genotype 
at baseline and after 7 days of High Na-Low K and Low Na-High K diet.  
 
  Baseline  High Na+ - Low K+ p Low Na+ - High K+ 
Plasma active renin (pg/ml)      
 CC (n=10) 13.8 [9.7;19.7]  5.8 [4.3;7.8] * 30.7 [24;39.2] 
 GC (n=21) 14.3 [11.6;17.6]  8.4 [6.5;11]  38.5 [32.6;45.4] 
 GG (n=9) 15.8 [11.7;21.4]  10.9 [6.7;17.7]  43.6 [30;63.3] 
Plasma total renin (pg/ml)      
 CC (n=10) 108.3 [83.2;141.1]  62.4 [47.4;82] * 142.3 [116;174.5] 
 GC (n=21) 125.4 [106.6;147.5]  91.7 [73.8;113.9]  169.3 [141.8;202.1] 
 GG (n=9) 112.5 [94.9;133.4]  83.2 [62.9;110]  156.9 [119.3;206.5] 
Plasma ANP (pg/ml)      
 CC (n=10) 23.3 ± 4.6  26.7 ± 8.9  17.9 ± 4.2 
 GC (n=21) 20.6 ± 4.6  25 ± 10.4  16.4 ± 3.3 
 GG (n=9) 20.3 ± 5.5  22.6 ± 8.4  16.4 ± 3.8 
Plasma aldosterone (pg/ml)      
 CC (n=10) 63.7 [47.7;85.1]  25.7 [18.3;36.1] * 295.1 [216.4;402.5] 
 GC (n=21) 73 [64.2;83.1]  38.6 [31.6;47.2]  319.9 [262;390.4] 
 GG (n=9) 69.3 [52.8;90.8]  38.5 [30.7;48.3]  338.9 [266.1;431.5] 
       
24 h urine volume (mL)      
 CC (n=10) 1663 (1227;1980)  2092 (1896;3110)  2415 (1777;3463) 
 GC (n=21) 1496 (1187;1943)  1910 (1540;2610)  2123 (1781;2711) 
 GG (n=9) 1563 (1188;2286)  2448 (1918;2662)  2401 (2259;2976) 
24h urinary sodium 
excretion (mmol/24h) 
     
 CC (n=10) 177 (153.6;237.5)  277.4 (253.5;300.4)  17.2 (13.9;20) 
 GC (n=21) 138.9 (108;167.1)  246.2 (218.8;278.5)  14.1 (11.7;21.9) 
 GG (n=9) 158.2 (133;188)  242.9 (230;298)  17.4 (11.3;30.6) 
24h urinary potassium 
excretion (mmol/24h) 
                 
 CC (n=10) 72.2 (65.8;86.6)  36.9 (26;47.2)  132.1 (96.5;144.9) 
 GC (n=21) 68.8 (55.3;83.1)  39.6 (34.3;43.1)  119.9 (106.1;140.8) 
 GG (n=9) 67.4 (57.6;72.2)  39.3 (29.9;42.6)  111.2 (94.5;132) 
* : p<0.05 vs GC and vs GG. Data are mean [95% CI], mean ± SD or median (interquartile range) 
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NESDA cohort. There was a significant association between SBP and MRc.-2G>C (p= 0.041), even 
after adjustment for counfounding factors (Table 5). GG subjects had significant higher systolic 
blood pressure than GC or CC subjects (mean SBP for GG: 138.2+1.9 mmHg, GC: 137.3+1.8 
mmHg and CC: 135.2+1.9 mmHg). Although we did not detect a gender x genotype interaction 
(p=0.36), we performed a separate analysis for both men and women. The association with MRc.-
2G>C and SBP was significant for men but not for women (Table 5). Men with the GG genotype 
had significant higher systolic pressure (5.17 mm Hg) than those with the CC genotype (p= 0.15). 
SBP among men was 147.0+21.2 mmHg for GG genotype, 143.8+17.6 mmHg for GC genotype and 
141.9 + 20.6 mmHg for CC genotype.  
 
Table 5.  Association analysis of the MR MR c-2G>C genotype with diastolic and systolic blood 
pressure in Dutch cohort 
 
 Blood pressure Group MR-2G/C Mean SD P* 
Men (n=563) CC (137) 
GC (304) 
GG (122) 
 
141.86 
143.81 
147.03 
20.64 
17.57 
21.23 
0.046 Systolic (mmHg) 
Women (n=1191) CC (262) 
GC (634) 
GG (295) 
 
129.53 
131.26 
131.03 
22.04 
18.96 
17.76 
0.195 
Men (n=563) CC (137) 
GC (304) 
GG (122) 
 
83.38 
84.83 
85.49 
12.24 
11.07 
12.71 
0.232 Diastolic (mmHg) 
Women (n=1191) CC (262) 
GC (634) 
GG (295) 
79.29 
80.01 
80.26 
13.17 
11.41 
11.08 
0.301 
BP: blood pressure; *genotype effect by GLM adjusted for age, presence of life events, years of education, smoking, 
alcohol abuse/dependence, use of tricycle antidepressant (TCA), use of noradrenergic serotonergic (NS) antidepressant, 
number of chronic disease and BMI in each gender separately.  
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Table 6. Results of General Linear Model with mean systolic pressure (medication adjusted) as 
outcome in the whole cohort (n=1754 subjects), and stratified for gender  
 
Parameter Gender 
 
complete cohort 
Male (n=563) Female (n=1191) 
 F test P R2 F test P  R2 F test P  R2 
Model   0.263   0.145   0.207 
MR c.-2>C 3.202 0.041  3.088 0.046  1.639 0.195  
Negative life 
events,  
1.104 0.294  0.327 0.568  0.895 0.344  
Gender 141.204 <0.001        
Age 246.499 <0.001  46.926 <0.001  198.771 <0.001  
Years of education 5.799 0.016  0.398 0.528  5.556 0.019  
Smoking 9.603 0.002  8.915 0.003  2.966 0.085  
Alcohol  0.728 0.394  0.187 0.665  0.417 0.519  
Use of a TCA 4.241 0.040  1.439 0.231  2.638 0.105  
NS antidepressant,  2.711 0.100  0.333 0.564  2.739 0.098  
chronic diseases 11.376 0.001  5.885 0.016  6.001 0.014  
BMI 9.427 0.002  4.747 0.030  5.584 0.018  
Abbreviations: TCA, tricycle antidepressant; NS, noradrenergic serotonergic; BMI, Body Mass Index 
 
 
Discussion  
In this study we have undertaken the functional analysis of the c.-2G>C polymorphism, a frequent 
SNP in the NR3C2 gene coding for the MR, and its selective genotyping in subjects from different 
cohorts.  The c.-2G>C variant is associated with differential expression of the MR in vitro; 
importantly, in vivo, this SNP influences circulating levels of plasma aldosterone and renin. 
 
A possible role of the MRc.-2G>C polymorphism on translational efficiency had been suggested 
based on its location 2 nucleotides upstream of the first translation initiation site in the middle of the 
Kozak consensus sequence for translational initiation (Kozak, 1986). First, we showed with two 
different endogenous ligands and in two different cell lines that MR translated from a construct 
carrying a C at position -2 was associated with a higher transcriptional response in vitro. These 
results are in contrast to previous work describing lower transactivation of a reporter gene by the -
2C allele using aldosterone (Arai et al., 2003). Differences in methodology or the cell line that was 
used might explain this result. Second, using three different approaches and two different cell lines, 
we showed that the C allele results in more abundant protein expression than the G allele. Since 
mRNA expression and the affinity of the MR are not modified by MRc.-2G>C it is concluded that 
this polymorphism influences translation. This is in accordance with data showing that a C at 
position -2 is probably more efficient for translation, since in 1534 human transcripts the sequence 
surrounding the initiation codon contains a C at position -2 in 40% of cases, while a G nucleotide is 
present in only 18% of transcripts (Peri and Pandey, 2001). Third, transcription of two different 
exons from alternative promoters on the NR3C2 gene can lead to different transcripts, with two 
different 5’-UT regions that can precede MRc.-2G>C. Our results demonstrate that the 5’UT has no 
influence on the observed effect of the SNP. With both exons 1α and 1β the -2C allele was 
associated with higher protein translation. However, protein expression in the presence of the UT 
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region 1 β was ~ 40% of that observed with exon 1α, indicating that the sequence of exon 1 β is less 
optimal for translation. Finally, the influence of MR -2G>C on the MR-A/MR-B ratio was 
investigated. In Western blot experiments the MR-A isoform, translated from the first translation 
start, was more abundant in the presence of the C allele. Transient transfection of MR containing 
either the -2 C or -2 G allele did not result in any detectable MR-B protein. As far as we know, only 
one study reported the MR-B isoform (Pascual-Le Tallec et al., 2004); in that study MR-B was 
detected with an in vitro translation assay. Our results suggest that MR-B is not translated, at least 
not in Cos-1 cells. Given that the Kozak region preceding the translation start of MR-B is weak, the 
existence of MR-B in vivo needs further clarification. Taken together, we conclude that the C allele 
increases MR-protein expression and thereby the in vitro transcriptional activity of the MR. 
 
Finding genetic variants involved in the regulation of BP offers mechanistic insights into the 
development of hypertension in the general population and helps in identifying novel targeted 
therapeutic strategies to prevent cardiovascular disease. The physiopathological relevance of our in 
vitro results was tested by studying the association of the MRc.-2G>C polymorphism with 
parameters of BP regulation and electrolyte homeostasis in two cohorts under different 
experimental settings. Individuals carrying the CC genotype in either a healthy cohort under a high 
Na+ - low K+ diet or a mild hypertensive cohort had significantly lower plasma renin 
concentration/renin activity levels, respectively. In parallel with the lower renin levels, the CC 
individuals in the healthy group also presented lower plasma aldosterone levels. The observed lower 
active renin, total renin and lower aldosterone levels suggest a more efficient tubulo-glomerular 
feed-back in individuals with the CC genotype. This effect might be due to more efficient sodium 
reabsorption due to higher levels of MR in the distal tubule which was unmasked in conditions of 
low aldosterone synthesis and concentration, i.e. on a high Na+ - low K+ diet (Menard et al., 2006). 
Indeed the C allele results in higher MR levels after transfection in a kidney collecting duct 
epithelial cell line (RCSV3) or a kidney fibroblast-like cell line (COS). There were trends in similar 
directions for these parameters in the healthy group at baseline or during the low Na+- high K+ diet 
but this did not reach significance. The absence of significant difference between genotypes may be 
due to a low power of the study which was not initially designed to test the effect of the MR 
polymorphism. Finally, both in the mild hypertensive group and in a large Dutch cohort, male GG 
carriers had a higher SBP. Taken together, these results indicate that the CC carriers may have a 
more favourable cardiovascular profile as compared to the CG and GG carriers. 
 
Aldosterone has emerged as a key hormone determining cardiovascular and renal damage and risk 
prognosis, in addition to its role in BP regulation and potassium and sodium homeostasis. Within 
the last ten years, blocking its effects with MR antagonists has been shown to have beneficial 
effects in congestive heart failure, especially after myocardial infarction, and proteinuric 
nephropathies (Mehdi et al., 2009; Pitt, 2005). Our data suggest that functional variants of the MR 
may be associated not only to different cellular responses to the hormone, but also, indirectly, to 
increased aldosterone levels that may activate both genomic and non-genomic pathways in non-
epithelial target tissues to promote deleterious cardiovascular effects. 
 
Only males carriers of the MRc.-2G>C GG genotype showed higher BP compared to males with 
the other genotypes in the mild hypertensive cohort, the polymorphism not being associated with 
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BP in women. The same gender dependent association was found with SBP in the large-scale Dutch 
cohort suggesting a sexual dimorphism. Many studies have reported gender-related differences in 
occurrence and severity of cardiovascular diseases, related to the hormonal status (Rosano et al., 
2007). Interestingly, it has been shown that ovarian hormones positively affect salt sensitivity, 
protecting pre-menopausal women from the development of hypertension. After menopause, 
responsiveness of renin-angiotensin-aldosterone system changes, with a net increase in salt 
sensitivity (Schulman et al., 2006). In addition, cortisol responses to stressors are different between 
men and women and as discussed above, cortisol might have an effect on epithelial MR as well.  
We hypothesise that the effect of the MR c-2G>C G allele, which leads to less MR, correlates with 
higher blood pressure only in men and not in women because of the interference of ovarian 
hormones. To further elucidate the role of sex hormones or differences in cortisol levels a cohort 
containing post menopausal women should be tested for an association with this SNP.  
 
In conclusion, the MRc.-2G>C C allele increases translation of the MR protein resulting in an 
increase in MR protein expression and a higher transactivational activity in vitro. In two 
independent studies, GG carriers of MRc.-2G>C showed higher renin and aldosterone levels 
compared to individuals with the other genotypes. Finally, male GG carriers showed higher SBP. 
We propose that the MR -2C variant could participate in protecting against high blood pressure 
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Abstract 
 
Stress causes activation of the hypothalamic-pituitary-adrenal (HPA) axis, resulting in secretion of 
corticosteroids which facilitate behavioural adaptation. These effects exerted by corticosteroids are 
mediated by two brain corticosteroid receptor types, the mineralocorticoid (MR) receptor, with a 
high affinity already occupied under basal conditions and the glucocorticoid receptor (GR), with a 
low affinity only activated during stress. 
Here, we studied MR gene haplotypes constituted by the two single nucleotide polymorphisms MR-
2G/C (rs2070951) and MRI180V (rs5522). In vitro the haplotypes showed differences in cortisol-
induced gene transcription and protein expression, while the structural variant MRI180V did not 
affect ligand binding. 
 
Moreover, in a well characterized cohort of 166 school teachers these haplotypes have been 
associated with perceived chronic stress (Trier Inventory for the Assessment of Chronic Stress, 
TICS) and, in a subgroup of 47 subjects, with ACTH, cortisol and heart rate responses to acute 
psychosocial stress (Trier Social Stress Test, TSST). MR haplotypes were significantly associated 
with the TICS scales “excessive demands at work” and “social overload”. Subjects homozygous for 
haplotype MR-2C/MRI180, which in vitro showed highest expression and transactivational activity, 
displayed the highest salivary cortisol (p=0.000), plasma cortisol (p=0.010), plasma ACTH 
(p=0.003) and heartrate (p=0.018) responses. 
 
It is concluded that the investigated MR haplotypes modulate cortisol-induced gene transcription in 
vitro. Moreover, these haplotypes may contribute to individual differences in perceived chronic 
stress as well as neuroendocrine and cardiovascular stress responses. 
 
Key words: Mineralocorticoid Receptor (MR), genetic polymorphisms, stress  
 
 
71 Chapter 5 MR haplotypes modulate stress responses  
Introduction 
 
Cortisol has profound effects in the brain, underlying behavioural adaptation to stress and feedback 
regulation of the hypothalamic-pituitary-adrenal (HPA) axis. These actions exerted by cortisol are 
mediated by a high affinity brain corticosteroid receptor, the mineralocorticoid receptor (MR; 
NR3C2) and a lower affinity glucocorticoid receptor (GR). The GR is widely expressed while the 
MR predominantly occurs in limbic brain areas including the hippocampus. Animal studies have 
shown that MR occupation is maintained at basal pulsatile cortisol levels, while the GR becomes 
only activated with rising cortisol levels in response to stress and at the peaks of the corticosterone 
pulses (Sarabdjitsingh et al., 2009; Lightman et al., 2008; Conway-Campbell et al., 2007). The MR 
and GR operate as transcription factors in the regulation of gene transcription, but recently these 
receptors were also found to mediate fast membrane-mediated actions (Karst et al., 2005; Di et al., 
2003). Through the MR cortisol regulates basal HPA pulsatility (Atkinson et al., 2008) and the 
threshold or onset of the HPA axis response to stress (Wellhoener et al., 2004; Arvat et al., 2001; 
Dodt et al., 1993a; Ratka et al., 1989), while the GR facilitates the suppression of stress-induced 
HPA activation and promotes adaptation.  
 
Two functional single nucleotide polymorphisms (SNPs) in the MR have been previously 
identified, namely MR-2G/C (rs2070951) located 2 nucleotides before the translation startsite and 
MRI180V (rs5522), a SNP resulting in an amino acid change in the N-terminal domain of the 
protein. Both SNPs affect transactivation in vitro (van Leeuwen et al., 2010; DeRijk et al., 2006). 
MR-2G/C is located outside the coding region of the MR but inside the Kozac translation regulatory 
sequence, and is expected to influence brain function via changes in MR protein expression. The 
structural variant MRI180V was previously found to be associated with HPA axis and autonomic 
nervous system reactivity (DeRijk et al., 2006). This effect exerted by MRI180V may occur through 
differences in ligand binding, translocation to the nucleus, dimerization or recruitment of 
coactivators. Furthermore, these two SNPs in the MR are in linkage disequilibrium resulting in 
three common haplotypes and one very rare (frequency less than 0.1%) haplotype (DeRijk et al., 
2008). The in vitro and in vivo effects of these haplotypes are currently not known.  
 
The main objective of the current study was to measure transactivation, ligand binding and protein 
expression of MRI180V, MR-2G/C and the resulting haplotypes. In addition, we sought to evaluate 
the association between these haplotypes and valid (endo)phenotypes for psychobiological stress 
regulation in a cohort that is independent of the samples that have previously been studied by our 
group (van Leeuwen et al., 2010; DeRijk et al., 2006). Therefore, we performed a genetic 
association analysis in a cohort of school teachers that has been characterized with the Trier 
Inventory for the Assessment of Chronic Stress (TICS) and the Trier Social Stress Test (TSST).  
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Materials and methods 
 
Functional characterization in vitro 
Construction of the hMR plasmids 
The expression plasmid containing human MR was obtained from Dr. R. Evans (gene expression 
laboratory and HHMI, The Salk Institute for Biological Studies, La Jolla, Ca) and is described 
elsewhere (Arriza et al., 1987).  
MR-2G/C (rs2070951) and MRI180V (rs5522) sites were mutated from G to C and from A to G, 
respectively using primers 5’-GGCCGAGGCAGCGATGGAGACCAAAG-3’ and  
5’-CGCTGCCTCGGCCCTTTGGTCTCCAT-3’ and primers  
5’-GGCGTCATGCGCGCCGTTGTTAAAAGCCCCTAT-3’ and  
5’-ATAGGGCTTTTAACAACGGCGCGCATGACGCC-3’ and the Quick Change Site Directed 
Mutagenesis kit (Stratagene, La Jolla, CA), according to the manufacturer’s protocol.  
After mutagenesis the hMR insert of the plasmid was sequenced to assure absence of other 
mutations. 
 
Transactivation assay 
Cos-1 cells (African green monkey kidney cells) were cultured in DMEM high glucose 
supplemented with 10% FCS (Gibco, Paisley, UK). Cells were seeded in 24-well plates (Greiner 
Bio-One, Alphen a/d Rijn, The Netherlands) at 3 x 104 cells/well in DMEM supplemented with 
charcoal-stripped serum. The cells were transfected the next day using SuperFect (Qiagen, Venlo, 
The Netherlands). hMR plasmids and the reporter pasmid TAT3-Luc (tyrosine amino transferase 
triple hormone response element) were used at 100 ng/well. The control plasmid pCMV-R 
(Promega, Leiden, The Netherlands) coding for Renilla luciferase controlled by cytomegalovirus 
(CMV) promoter was used (10 ng/well). One day after transfection, the cells were treated with 
cortisol (Sigma-Aldrich, Zwijndrecht, the Netherlands) in concentrations ranging from 0 to 10-8 M. 
After 24h of incubation the cells were harvested in passive lyses buffer (Promega) and firefly and 
Renilla luciferase activity was determined using a dual label reporter assay (Promega) and a 
luminometer (CENTRO XS3 LB960, Berthold, Bad Wildbad, Germany). Three separate 
experiments were performed and all three experiments were performed in triplicate. 
 
Western blot 
For western blot Cos-1 cells were seeded in 6-well plates (Greiner Bio-One, Alphen a/d Rijn, The 
Netherlands) at 2x105 cells/well in DMEM supplemented with charcoal-stripped serum. The cells 
were transfected the next day using Trans-it Cos transfection reagent (Mirus, Madison, USA). 
Plasmids containing one of the hMR variants or no hMR (control) were used at 2µg/well. Cells 
were harvested 48 hours after transfection. The primary antibody MR 1D5 (a generous gift by 
Gomez-Sanchez, Division of endocrinology, University of Mississippi, Jackson, MS) was diluted 
1:1000 in 0.5 % milk powder in Tris buffered saline and Tween 20 (TBST) and incubated for 1h at 
room temperature (RT). The secondary antibody goat anti-mouse IgG HRP was used in 1:5000 
dilutions in TBST with 0.5 % milk for 1 h at RT. Tubulin was used as a control for the amount of 
cells and the monoclonal anti -Tubulin was used at a 1:1000 dilution (T6557; Sigma-Aldrich, 
Zwijndrecht, the Netherlands). The ECL detection system (GE healthcare, Diegem, Belgium) was 
used for detection. The differences in intensity of the MR bands were quantified with Image J 
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(ImageJ, U. S. National Institutes of Health, Bethesda, Maryland, USA, http://rsb.info.nih.gov/ij/). 
Three separate experiments were performed. 
 
Ligand binding assay 
Cos-1 cells were seeded in 20 cm plates (Greiner Bio-One, Alphen a/d Rijn, The Netherlands) at 
2x106 cells/plate in DMEM supplemented with 5% charcoal-stripped serum. Cells were transfected 
the next day using Mirus TransIt- COS reagent according to the manufacturer’s protocol 
(Sopachem, Ochten, The Netherlands) and hMR plasmids were used at 30 µg/plate. After 24 hours 
medium was replaced with serum free DMEM and after another 24 hours cells were pelleted. All 
further steps are carried out at 0°C. Cells were resuspended in 3.5ml buffer (5mM Tris-HCl (pH 
7.4), 1mM EDTA, 1mM B-Mercaptoethanol, 10mM Na-Molybdate, 5% glycerol) per plate and 3 x 
15 seconds homogenised using an electric homogenizer (Pro200, Pro scientific, Oxford, CT, USA). 
The homogenate was centrifuged (100.000 x g, 2°C) to obtain cytosol.  
 
200µl cytosol was incubated with [3H]Cortisol (70 Ci/mmol, Amersham, Buckinghamshire, UK) to 
asses total binding or [3H]Cortisol and a 500 fold excess of dexamethasone (Sigma-Aldrich, 
Zwijndrecht, the Netherlands) to asses non-specific binding. [3H]Cortisol was used at 0.5nM, 1nM, 
1.5nM, 2.5nM, 3.5nM, 5nM. After vortexing and 3 hours incubation on ice bound and free 
[3H]Cortisol fractions were separated by Sephadex LH-20 as described previously (de Kloet et al., 
1975). Fractions containing the receptor bound radioligand were collected, vortexed with 3ml 
Ultima Gold scintillation fluid (Perkin Elmer, Waltham, Massachusetts, USA) and radioactivity was 
measured in a liquid scintillation analyzer (1900CA Packard, Perkin Elmer). Three separate 
experiments were performed and all three experiments were performed in triplicate. 
 
Statistical analysis 
The in vitro experiments were analyzed using GraphPad prism 4 (GraphPad software Inc, San 
Diego, CA). In the transactivation assays firefly/renilla luciferase ratios were normalized against the 
highest signal and background expression was subtracted. MR protein expression measured by 
western blot was normalized against -Tubulin. The differences between the four hMR variants 
were analyzed with one and two-way ANOVAs with Bonferroni posttests. In the radioligand 
binding assay one-binding-site curve fitting was used to determine the dissociation constant (Kd) 
and maximal binding (Bmax). The specific MR cortisol binding was obtained by subtracting the 
non-specific binding from the total binding. The difference in Kd and Bmax between MRI180 and 
MR180V was tested with a t-test. In vitro results are shown as the mean  SD.  
 
Genetic association study 
Recruitment 
We approached teachers of all major school types in the region of Trier (Germany) and 
Luxembourg by means of personal visits in local schools and by newspaper announcements. 
Teachers were entered into the study if they reported to be free of psychiatric disorders, diabetes, 
pregnancy, and corticosteroid or psychotropic medication. Written informed consent was obtained 
from all participants and the protocol was approved by the ethics committee of the University of 
Trier and the Rheinland-Pfalz State Medical Association. 
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DNA extraction and Genotyping 
DNA was extracted from 10ml peripheral venous blood following a standard method (Miller et al., 
1988). Subjects were genotyped for the MR-2G/C and MRI180V SNPs by both matrix-assisted 
laser desorption/ionization time-of-flight (MALDI-TOF) mass spectrometry (MS), using the 
Sequenom MassARRAYtm methodology (Sequenom Inc., San Diego, CA, USA) and by TaqMan 
pre-designed SNP genotyping assays, assay ID C12007869_20 and C1594392_10, respectively, in 
combination with TaqMan universal PCR master mix (Applied Biosystems, Nieuwekerk a/d IJssel, 
The Netherlands). Reaction components and amplification parameters were based on the 
manufacturer’s instructions. Genotyping the samples with two different genotyping methods 
decreases method specific genotyping errors. 
 
Assessment of perceived chronic stress 
Perceived chronic stress was measured using the short version of the Trier Inventory for the 
Assessment of Chronic Stress (TICS-S) (Schulz and Schlotz, 1999). The TICS covers nine 
dimensions of chronic stress, namely work overload, social overload, excessive demands at work, 
lack of social recognition, work discontent, social tension, performance pressure, social isolation 
and chronic worrying. For each item, the frequency of the experience in the last year had to be 
indicated on a 5-point rating scale, ranging from “never” to “very often.”  
 
Psychosocial stress protocol  
The Trier Social Stress Test (TSST) consists of a three minutes preparation phase followed by a five 
minutes free speech phase (job interview) and a five minutes mental arithmetic task in front of a 
panel and a camera (for a detailed description of this protocol see (Kudielka et al., 2007a; Kudielka 
et al., 2007b). Test sessions were only run in the afternoon, starting between 1500h and 1600h. 
Participants were instructed to refrain from physical exercise, a heavy lunch and alcoholic 
beverages on test days. Premenopausal women not taking oral contraceptives were invited during 
the luteal phase of the menstrual cycle. The menstrual phase was estimated on the basis of the first 
day of last menses and the subject’s usual cycle length. Only women with a regular cycle between 
28 and 35 days were included and the luteal phase was defined as the last 14 days of the cycle. In 
the laboratory, at first an intravenous catheter was inserted in the antecubital vein of the dominant 
arm for later blood draws and subjects were instrumented with heart rate monitors. Heart rate was 
measured at 5 second intervals using a transmitter belt with a wrist receiver (Polar Sport Tester; 
Polar Electro, Büttelborn, Germany). After a rest period of 40 min following canula insertion and 
10 min before the start of the stressor, subjects were asked to stand up. After TSST exposure 
subjects remained in an upright position for another 10 minutes.  
 
Blood and Saliva Sampling 
Blood samples for the assessment of ACTH and total plasma cortisol were collected in EDTA 
containing monovettes (Sarstedt, Nümbrecht, Germany)  
1 min before as well as 1, 10, 20, 30 and 90 min after cessation of the TSST. In parallel, subjects 
obtained native saliva in 2 ml reaction tubes (Sarstedt, Nümbrecht, Germany) for later assessment 
of salivary cortisol. Additional saliva samples were obtained at 45 and 60 min after cessation of the 
TSST.  
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Biochemical analysis 
Salivary cortisol was measured by an in-house DELFIA (intra- and inter-assay variation ≤11.5%). 
Blood samples were instantaneously stored on ice and centrifuged at 4ºC for 15 min at 2000 g and 
pipetted into aliquots. Aliquots for the analysis of plasma cortisol as well as saliva samples were 
stored at -20°C and aliquots for the analysis of ACTH were stored at -80°C until assayed. ACTH 
and total plasma cortisol were measured by ELISA assays (plasma cortisol: IBL Hamburg, 
Germany, intra- and inter-assay variation ≤6.9%; ACTH: Biomerica Newport Beach, USA, intra- 
and inter-assay variation ≤6.0%).  
 
Statistical analysis 
Haploview (Barrett et al., 2005a) was used to calculate Hardy Weinberg equilibrium (HWE) and 
linkage disequilibrium among the two MR SNPs (estimated with D’ and r2). Haplotypes were 
estimated and assigned to each individual using SNPHAP (http://www-
gene.cimr.cam.ac.uk/clayton/software/). In order to analyze the association between haplotypes and 
perceived chronic stress levels, we used the haplotype trend regression (HTR) approach as outlined 
by Zaykin et al (Zaykin et al., 2002). Assuming additive effects of the haplotypes on the trait, the 
HTR approach tests for the contribution of individual haplotypes rather than haplotype pairs. We 
applied a permutational approach to obtain empirical p-values utilizing the HTR function of the R-
package "gap", version 1.0-17 (R 2.7.2; http://www.R-project.org) with 10.000 simulations. HTR 
procedures provide a global p-value as well as p-values indicating the association between the trait 
and each haplotype. A two-stage strategy was applied to test for possible associations between 
haplotypes and neuroendocrine as well as autonomic TSST responses. First, the HTR approach was 
used as global significance test. Therefore, area under the response curve (AUC) measures were 
computed for salivary cortisol, plasma cortisol, ACTH and heart rate responses and entered into the 
HTR models. Secondly, post hoc tests were performed to further inspect the detected effects. To use 
the full information of the repeated measures design this was done with general linear models 
(GLMs) to assess the repeated measures effect time, the between-subjects effect haplotype as well 
as the interaction time x haplotype. In order to control for possible influences of gender, sex was 
included as additional predictor. Effect sizes were calculated for significant results by partial eta 
squared (η2). Greenhouse-Geisser corrections were applied where appropriate, and only adjusted 
results are reported. GLM procedures were performed using the PASW statistical software package 
(Version 18.0). Unless otherwise stated, results are expressed as mean ± standard error of the mean 
(S.E.M.). While cortisol, ACTH and heart rate values were log-transformed before statistical 
analyses to yield unskewed outcome variables, figures show untransformed means in order to 
provide a more naturalistic impression of endocrine levels.  
 
Results 
 
Functional characterization in vitro 
All four MR haplotypes were tested in vitro. According to the observed frequency in the population 
(DeRijk et al., 2008) the haplotypes are referred to as Hap 1 (GA), constituted by MR-2 G and 
MRI180V A, Hap 2 (CA), constituted by MR-2 C and MRI180V A, Hap 3 (CG), constituted by 
MR-2C and MRI180V G and the in vivo rarely observed Hap 4 (GG), constituted by MR-2 G and 
MRI180V G. 
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Transactivation assay 
The four different MR haplotypes showed differential cortisol-induced luciferase transcription from 
a triple tyrosine amino transferase (TAT-3) promotor (F3,26= 42.7; p<0.0001; η2= 0.06; Figure 1). 
The analysis of the dose response curves revealed a significant difference in the EC50 between the 
four MR haplotypes; Hap 1 (GA) EC50= 3.9x10-11, Hap 2 (CA) 1.7x10-11, Hap 3 (CG) 1.9x10-11 
and Hap 4 (GG) 7.3x10-11 (F3,44= 1651; p<0.0001; η2= 0.99) but no difference in the slope of the 
curves. Hap 1 (GA) and 4 (GG), the two haplotypes containing MR-2 G showed a significant lower 
maximal luciferase expression (Emax) than Hap 2 (CA) and 3 (CG), i.e. the two haplotypes 
containing MR-2 C (F3,28= 29.2; p<0.0001; η2= 0.76). Although the effect on transactivation was 
largest for the MR-2G/C SNP, MRI180V also influenced the transactivation with the A (MRI180) 
having a lower EC50 than the G (MR180V). 
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Western blot 
The MR haplotypes influenced MR protein expression in transfected COS-1 cells (F3,4= 7.07; 
p=0.03; η2= 0.80, Figure 2). Post hoc analysis revealed that protein expression was only influenced 
by MR-2G/C and not by MRI180V. Hap 2 (CA) and 3 (CG), the two plasmids containing MR-2C, 
showed higher MR protein expression compared to Hap 1 (GA) and 4 (GG), the two plasmids 
containing MR-2 G (all combinations p<0.05), while there was no significant difference between 
Hap 1 and 4 and between Hap 2 and 3. 
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Figure 1. Cortisol induced transactivation of the four 
MR haplotypes on a TAT-3 promoter in Cos-1 cells. 
Cortisol concentrations are indicated in log units and 
responses are displayed as reporter (fluc)/control 
(rluc) ratios. The four haplotypes showed 
significantly different responses (p<0.0001), with 
Hap 2 (triangle) being most efficient followed by 
resp. Hap 3 (square), Hap 1 (circle) and Hap 4 
(diamond). Figure 1 represents the data of three 
separate experiments, which did not show significant 
differences when compared to each other, and were 
therefore pooled. 
Figure 2. MR protein expression measuered in 
gray values on a western blot normalized against 
tubulin measured in gray values. The haplotypes 
Hap 2 and 3 had significantly higher MR 
expression than Hap 1 and 4 (* p<0.05) while 
there was no significant difference between Hap 
1 and 4 and between Hap 2 and 3.  
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Ligand binding 
Cortisol binding to the MR (Kd and Bmax) was not influenced by MRI180V. The Kds of MRI180 
and MR180V were not significantly different, being 0.86 0.20 and 0.930.16 nM, respectively. 
There was also no significant difference in Bmax, showing values of 6539 499 and 7112371 
binding sites/cell for the MRI180 and MR180V, respectively. As there was no significant difference 
between the three separate experiments, data of the three experiments were pooled for analysis.  
 
Genetic association study 
 
Genotypes and haplotypes 
The two employed genotyping methods yielded identical results and there were no drop outs. The 
distribution of both SNPs, MRI180V and MR-2G/C, did not deviate significantly from Hardy 
Weinberg equilibrium (HWE) (p=0.7 and p=0.2 resp). The estimated linkage between MRI180V 
and MR-2G/C was D’=1 (conf bounds 0.63-1) and r2=0.093. As expected, in this sample Hap 1 
(GA) showed with 48.8% the highest frequency followed by Hap 2 (CA) with a frequency of 41.9% 
and Hap 3 (CG) with a frequency of 9.3%. Consistent with previous studies Hap 4 (GG) was not 
observed in this cohort (see Figure 3). One subject showed the very rare genotype CGCG (i.e. 
homozygous for Hap 3) and was excluded from all association analyses.  
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Figure 3. Schematic overview of the human MR gene (not on scale) with the location of the MR SNPs MR-2G/C and 
MRI80V, the haplotypes and frequencies of the haplotypes formed by these SNPs. Dark gray boxes represent 
untranslated exonic regions, light gray boxes represent translated exonic regions and the black line represents the 
intronic regions of the gene. MR-2G/C is located in the untranslated exonic region just 2 nucleotides before the 
translation start and MRI180V is located in the translated region of exon 2. The frequency refers to the haplotype 
frequency observed in this cohort and the number of individuals in this cohort carrying 0, 1 (heterozygotes) or 2 
(homozygotes) copies of a haplotype is indicated.  
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Final sample 
The sample for the present analysis consisted of 166 healthy subjects (55 males and 111 females). 
Participants were between 23 to 63 years of age (mean age: 45.58 ± 9.8) and had a mean body mass 
index (BMI) of 25.9 ± 4.7. Fifteen of the subjects reported to be smokers. Questionnaire data from 
163 to 166 participants (due to a different number of missing values across scales) could be 
analyzed. Gender was included in all statistical analysis but there were no gender-haplotype 
interactions observed in any of the associations. Therefore we do not show the results of this 
predictor. 
 
Perceived chronic stress 
HTR models revealed associations between the MR haplotype structure and perceived chronic 
stress assessed with the TICS in respect to four subscales, namely “social overload”, “excessive 
demands at work”, “social tension”, and “social isolation” (Table 1). While global p-values were 
significant for “social overload” (F=3.21, p=0.042) and “excessive demands at work” (F=3.65, 
p=0.029), a trend was detected for “social tension” (F=2.39, p=0.095) and “social isolation” 
(F=2.63, p=0.076). Although the HTR approach controls for multiple comparisons of haplotype 
pairs within one TICS scale, it does surely not control for multiple testing across all nine TICS 
subscales. None of the significant global p-values would withstand such correction but nonetheless 
we performed post-hoc tests, in order to illustrate the direction of these exploratory results. 
Inspection of haplotype specific p-values for these four scales suggested that carriers of Hap 3 (CG) 
reported more chronic stress in terms of “excessive demands at work” (F=7.27; p=0.008) and 
“social overload” (F=4.17; p=0.045) than non-carriers. Furthermore, individuals with two copies of 
Hap 1 (GA) seemed to report more chronic stress in terms of “social isolation” (F=4.93; p=0.029) 
and “social tension” (F=4.80; p=0.032) than individuals with one copy or zero copies of Hap 1. 
Consistently, individuals with 2 copies of Hap 2 (CA) seemed to score lower on “social isolation” 
(F=4.95; p=0.027). 
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Table 1. Association between subscales of the Trier Inventory for the Assessment of Chronic Stress 
and MR haplotypes. 
 
0 Copies 1 Copy 2 Copies 
 MR Haplotypes Mean  (± Std) 
Global 
Test 
p [F] 
Haplotype 
Specific Test 
p [F] 
Work Overload     n.s.  
 GA 2.22 (0.91) 2.29 (0.81) 2.41 (0.98)   
 CA 2.48 (0.94) 2.21 (0.82) 2.19 (0.89)   
 CG 2.26 (0.88) 2.51 (0.88)    
Social Overload     .042 [3.21]*  
 GA 1.93 (0.91) 1.91 (0.94) 2.10 (0.87)  n.s. 
 CA 2.18 (0.96) 1.84 (0.85) 1.85 (0.90)  .056 [3.75] + 
 CG 1.90 (0.86) 2.28 (0.91)   .045 [4.17]* 
Excessive 
Demands at Work  
.029 
[3.65]*  
 GA 1.35 (0.77) 1.19 (0.79) 1.29 (0.80)  n.s. 
 CA 1.37 (0.86) 1.18 (0.75) 1.25 (0.73)  n.s. 
 CG 1.19 (0.91) 1.62 (0.79)    .008 [7.27]* 
Lack of Social 
Recognition  
n.s.  
 GA 1.60 (0.99) 1.63 (1.03) 1.84 (1.10)   
 CA 1.73 (1.12) 1.66 (1.02) 1.61 (0.95)   
 CG 1.71 (1.02) 1.50 (1.13)    
Work Discontent  n.s.  
 GA 0.95 (0.90) 0.99 (0.77) 1.12 (0.76)   
 CA 1.06 (0.72) 1.04 (0.86) 0.87 (0.82)   
 CG 1.01 (0.80) 1.00 (0.83)    
Social Tension   .095 [2.39]+  
 GA 1.13 (0.72) 1.17 (0.72) 1.45 (0.78)  .032 [4.80]* 
 CA 1.44 (0.77) 1.10 (0.72) 1.21 (0.70)  .071 [3.44] + 
 CG 1.26 (0.74) 1.16 (0.79)   n.s. 
Performance 
Pressure  
n.s.  
 GA 1.84 (0.70) 1.79 (0.74) 1.89 (0.70)   
 CA 1.91 (0.77) 1.77 (0.68) 1.83 (0.70)   
 CG 1.82 (0.69) 1.91 (0.84)    
Social Isolation  .076 [2.63] +  
 GA 1.28 (0.86) 1.71 (0.95) 1.73 (1.10)  .029 [4.93]* 
 CA 1.73 (1.02) 1.64 (0.95) 1.25 (0.87)  .027 [4.95]* 
 CG 1.59 (0.99) 1.69 (0.88)   n.s. 
Chronic Worrying  n.s.  
 GA 1.89 (1.02) 1.68 (0.84) 1.78 (1.09)   
 CA 1.80 (1.04) 1.74 (0.96) 1.75 (0.83)   
 CG 1.70 (0.92) 2.04 (1.15)    
 
(Table shows asymptotic F- and empirical p-values; *p<.05, +p<.10) 
 
ACTH, cortisol and heart rate responses to acute psychosocial stress 
A subsample of 54 participants (20 males and 34 females) agreed to also participate in the acute 
stress protocol. Participants of this subsample were between 25 to 63 years of age (mean age: 48.56 
± 8.8) and had a mean body mass index (BMI) of 25.9 ± 4.8. Haplotype frequencies of this 
subsample were very similar to frequencies in the main sample. Because of the well-known 
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intervening effects of oral contraceptive or sex steroid intake (Kudielka et al., 1999; Kirschbaum et 
al., 1999) as well as smoking (Rohleder and Kirschbaum, 2006) on acute HPA axis stress responses, 
we excluded three women taking oral contraceptives or receiving hormonal replacement therapy 
and two smokers from all further analyses. Two further subjects had missing data in the endocrine 
measures while six subjects had missing heart rate data due to technical problems. Thus, we 
included 47 subjects in the final analysis of endocrine and 41 subjects in the analysis of heart rate 
responses.  
 
Despite the small size of this subsample MR haplotypes were significantly associated with 
neuroendocrine and autonomic TSST responses in a rather consistent way. Regarding the global test 
HTR procedures revealed significant associations between the investigated MR haplotype structure 
and the area under the curve measures for salivary cortisol responses (F=6.80; p=0.005), plasma 
cortisol responses (F=3.34; p=0.046), and ACTH responses (F=4.03; p=0.029). The respective 
effect for heart rate responses showed a trend towards statistical significance (F=2.37; p=0.109). 
To use the full information of the repeated measures design, post hoc inspection of associations of 
specific haplotypes was done with general linear models. For Hap 2 (CA), significant main effects 
haplotype were observed for ACTH (F2,41=6.69, p=0.003, η2=0.25), plasma cortisol (F2,41=5.12, 
p=0.010, η2=0.20), salivary cortisol (F2,41=12.11, p=0.000, η2=0.37) as well as heart rate 
(F2,35=4.51, p=0.018, η2=0.21). Across all measures, individuals with two copies of Hap 2 showed a 
stronger response to the stressor than individuals with one copy or zero copies. In addition, 
significant time x haplotype interactions were found for ACTH (F3.76,76.39=4.58, p=0.003, η2=0.18) 
and salivary cortisol (F6.89,141.17=2.57, p=0.017, η2=0.11), while the respective interactions for 
plasma cortisol and heart rate were not significant (all p>.14). Mean responses are shown in Figure 
4a. 
 
A similar picture emerges for Hap 1 (GA), which is not surprising given that Hap 1 and Hap 2 are 
largely complimentary. Here, those individuals with zero copies of Hap 1 showed significantly 
elevated ACTH (main effect F2,41=7.73, p=0.001, η2=0.27), salivary cortisol (main effect F2,41=6.67, 
p=0.003, η2=0.25) and heart rate (main effect F2,35=4.96, p=0.013, η2=0.22) levels. The effect for 
plasma cortisol levels just missed the level of significance (main effect F2,41=2.90, p=0.066). A 
significant time x haplotype emerged for ACTH (F3.61,74.05=4.68, p=0.003, η2=0.19) and a trend was 
observed for salivary cortisol (F3.26,128.26=1,91, p=0.072), while the respective interactions for 
plasma cortisol and heart rate were not significant (all p>.19, Figure 4b). Finally, we did not detect 
a significant association between Hap 3 (GC) and neuroendocrine and autonomic TSST responses 
(p>.10 for all main effects haplotype and p>.15 for all interactions time x haplotype, Figure 4c). 
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Fig. 4b Hap 1 (GA)
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Fig. 4c Hap 3 (CG)
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Figure 4. ACTH , total plasma cortisol , 
salivary cortisol and heart rate responses 
to psychosocial stress (TSST) in subjects 
carrying 0, 1 or 2 copies of haplotype a) 
CA, b) GA and c) CG; data are expressed 
as mean ± S.E.M.  
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Discussion 
Here we described neuroendocrine and behavioral consequences of two common functional 
polymorphisms in the human MR, MRI180V and MR-2G/C, both in vitro and in vivo. The 
haplotypes of the two SNPs showed differences in cortisol-induced transcription of the reporter 
gene. From protein analysis of the haplotypes it can be concluded that MR-2G/C changes protein 
expression while MRI180V did not have this effect. Furthermore, MRI180V did not affect ligand 
binding. Our data suggest that the haplotypes are associated with stress-induced HPA axis and 
autonomic responses following a psychosocial stress test. Moreover, the haplotypes might be 
associated with several aspects of perceived chronic stress. 
 
Although transactivation assays have been performed with the two individual MR SNPs before (van 
Leeuwen et al., 2010; DeRijk et al., 2006), the combinations of the two SNPs, as occur in vivo as 
part of the observed haplotypes, have not been tested so far. It might be possible that the SNPs 
interact, resulting in an additional effect of the haplotypes (e.g. not effect size 2 =  effect size 1 + 
effect size1 but effect size 1 + effect size1 = effect size >2 or <2), therefore it is important to test 
haplotypes in addition to single SNPs. However, in this study statistical analysis did not reveal an 
interaction effect between the -2G/C and the MRI180V.  
 
MRI180V produces an amino acid change in the N-terminal domain, which is involved in recruiting 
co-regulators that selectively modulate transcriptional activity of the MR. As shown in the current 
study, this effect was not mediated by differences in cortisol binding characteristics, since no 
differences in maximal binding capacity (Bmax) or dissociation constants (Kd) were observed 
between MRI180 and MR180V. This suggests that other factors such as differences in translocation 
to the nucleus, dimerization of the MR or binding of co-regulators might be responsible for the 
observed differences in transactivation.  
 
In contrast to the MRI180V, the MR-2 G/C is not changing the primary structure of the receptor and 
is therefore less likely to have an effect on MR protein characteristics. In this study we showed that 
both haplotypes containing MR-2 C had a higher MR protein expression as compared to the two 
haplotypes containing MR-2 G while the MRI180V did not influence the protein expression. This 
finding explains the higher transactivational capacity of the two haplotypes containing MR-2 C, as 
occurring in haplotypes 2 and 3. In a supplementary part of the present study we investigated the 
association between these MR gene variants and subjectively perceived chronic stress and 
neuroendocrine as well as autonomic responses to acute experimental psychosocial stress. We 
selected a small but well characterized sample of healthy school teachers, since the teaching 
profession has been repeatedly described as a potentially stressful occupation (Guglielmi and 
Tatrow, 1998), which is reflected in high rates of early retirement among German school teachers 
(Weber, 2004). Furthermore, it is important to note that this cohort is independent of the samples in 
which the previously reported associations between MR gene polymorphisms and HPA axis 
regulation have been observed (van Leeuwen et al., 2010; DeRijk et al., 2006). The clear weakness 
of this cohort is its rather modest sample size and this holds in particular for the subsample that was 
exposed to the TSST also the lack of a second cohort to confirm the findings is a limitation of the 
study. Therefore, all reported association findings have an exploratory character. However, given 
this limitation, the observed associations between MR gene haplotypes and biological stress 
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responses have been remarkably consistent across the different indices. Individuals carrying two 
copies of haplotype 2 (CA) showed higher salivary cortisol, plasma cortisol, ACTH as well as heart 
rate responses to acute psychosocial stress, compared to individuals with only one or zero copies of 
this haplotype. Despite the small sample at least the global effect for salivary cortisol responses did 
survive bonferroni correction for multiple comparisons (corrected for four HTR procedures) and 
some of the GLM p-values are remarkably small. The distinct mean ACTH and cortisol response 
differences shown in Figure 4a and 4b were not caused by single subjects with extreme response 
patterns. As a further consequence of the sample size it was not possible to compute a separate 
analysis for males and females. We did, however, control for sex effects statistically, we did only 
include females who did not take oral contraceptives and premenopausal females were tested in the 
luteal phase of the menstrual cycle.  
 
The association between MR gene haplotypes and perceived chronic stress could be investigated in 
a larger, but still modest sample of 166 subjects. HTR models revealed significant associations 
between the MR haplotype structure and the TICS subscales “social overload” and “excessive 
demands at work”. On the one hand, these effects surely have to be interpreted with caution as the 
TICS comprises nine subscales and the observed effects do not survive a statistical correction for 
multiple testing.  
 
On the other hand stress is conceptualized as a multidimensional construct arising from person–
environment interactions (Mcewen and Stellar, 1993; Lazarus and Launier, 1978) and different 
stress dimensions are assumed to be influenced by personality and other trait factors to different 
degrees, which in turn could explain different genetic effects. In line with this speculation, in a twin 
study (Federenko et al., 2006) we found clearly differing heritabilities varying between 5% and 
45% for different stress scales. It appears plausible, that associations between genetic 
polymorphisms become visible for some facets of perceived chronic stress, but not for others. 
Therefore, our results suggest an association between MR gene haplotypes and some aspects of 
perceived chronic stress, but this finding needs to be confirmed in a larger sample. 
 
Combining the neuroendocrine and perceived chronic stress data, haplotype 2 appears to be 
associated with higher neuroendocrine stress-responses and better stress handling. A previous study 
showed that the MR -2 C variant associates with lower basal non-stress levels of cortisol in an 
elderly population (Kuningas et al., 2007). Thus one can speculate that a more reactive HPA axis 
with lower basal cortisol levels is beneficial for coping with stressors, as has been proposed (de 
Kloet et al., 2007). Moreover, the in vitro data show that haplotype 2 increases MR-expression, 
again adding to the notion that higher MR-expression is beneficial. This is further substantiated by 
animal research showing that increased MR-expression in the forebrain of mice results in less 
anxiety-like behavior (Rozeboom et al., 2007). With respect to the HPA axis response, the MR is 
involved in tonic inhibition of cortisol / corticosterone levels. Furthermore, during the ageing 
process, a loss of MR-expression in the brain is observed which coincides with less sensitivity 
towards ACTH in the Brown Norway rat (Van Eekelen et al., 1992). Also in MR forebrain knock 
out mice, less adaptation of the HPA axis response to stress is observed (Brinks et al., 2009). This 
indicates that higher MR-expression in the brain leads to a more dynamic HPA axis response with 
lower basal non-stress levels. The precise mechanism how the putative increased MR-expression 
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leads to a more reactive HPA axis responses and resilient behavior to stressors is unknown. MR-
expression is essential for neuronal protection and stability of neuronal circuits (Lai et al., 2009; de 
Kloet et al., 2007).  
 
Haplotype 3 is the only haplotype containing the MR180V (G). The mechanism behind the 
observed decrease in transactivation with this allele is not yet elucidated, this polymorphism causes 
an aminoacid change in the protein but ligand binding and protein expression are not influenced, 
this makes it difficult to speculate about a mechanism in vivo. We previously showed in a different 
cohort that the G allele carriers have higher TSST responses however in this cohort MR180V (G) 
seems to have no effect on the TSST response since the largest difference is observed between hap 
1 and hap 3. Furthermore MR180V (G) has previously been associated with more feelings of 
depression in elderly while we see lower scores on the stress scales with hap 3. Our group sizes are 
small therefore our finding is purely explorative and more research should be performed to first 
elucidate the molecular mechanism of MRI180V and secondly the effect on perception of stress and 
the consequences. 
 
The recent discovery of a MR located in the membrane, in addition to the nuclear MR, has further 
implications (Karst et al., 2005). This low affinity membrane form of the MR becomes activated 
during stress-levels of cortisol and increases excitatory glutaminergic transmission while decreasing 
post-synaptic after-hyperpolarization (Joels et al., 2008). This rapid excitatory MR-mediated effect 
may very well underlie the non-genomic actions exerted by cortisol on neuroendocrine, emotional 
and cognitive processes (Brinks et al., 2009). Therefore, it will be a challenge for future research to 
dissociate during a psychosocial stressor the genomic and non-genomic effects mediated by the MR 
on processing of stressful information resulting in HPA axis reactivity and behavior. The MR 
haplotypes identified in this study may be very helpful in this respect. 
In conclusion, in vitro assays demonstrate large differences in transactivation between the 
haplotypes. The molecular mechanism of these differences is only partly elucidated. In vivo, 
individuals with two copies of MR haplotype 2 (CA) had the most dynamic response to an acute 
psychosocial stressor, both the HPA axis and autonomic responses were higher in these individuals. 
Furthermore, our data suggest involvement of MR gene variants in perceived chronic stress. All 
together, it is concluded that these MR haplotypes may contribute to individual differences in the 
neuroendocrine response during coping with psychological stress. 
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 Summary  
 
Stress causes activation of the hypothalamic-pituitary-adrenal (HPA)-axis, resulting in the secretion 
of cortisol, which feeds back on stress-induced HPA activation and facilitates behavioral adaptation. 
These effects exerted by cortisol are mediated by two brain corticoid receptor populations, i.e. the 
mineralocorticoid receptors (MR) and the glucocorticoid receptor s(GR), MR and GR operate in 
complementary fashion in control of the HPA axis and behavior. MR is mainly expressed in limbic 
brain structures regulating predominantly the initial reaction to psychosocial stressors, which is 
subsequently suppressed by the ubiquitous present GR. 
 
Dysregulation of HPA-axis reactivity has frequently been reported in patients with mental 
disorders. In addition, the personality trait “neuroticism” is regarded as a vulnerability factor for 
depression. Twin studies demonstrated that cortisol levels, psychopathology and neuroticism are 
heritable. Previously, it was demonstrated that genetic variation in the MR is functional in vitro and 
influences responses to a psychosocial stressor.  
 
In the current study, involvement of the MR in neuroticism and psychopathology was tested by 
measuring common genetic polymorphisms in the MR-gene in a cohort of healthy controls (n=50) 
and patients with mood and/or anxiety disorders (n=100). In this relatively small cohort there was 
no difference in MR genotype distribution between patients and controls. However, the genetic 
variation in the MR appeared to be associated with neuroticism in patients (p=0.02). 
 
In conclusion, these preliminary findings suggest that genetic variation in the MR associates with 
neuroticism, indicating involvement of the MR in human behavior. This finding is in support of 
previous evidence from animal studies linking variation in MR function with emotional and 
cognitive aspects of the stress response. 
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Introduction 
 
Stress causes activation of the hypothalamic-pituitary-adrenal (HPA)-axis, resulting in the secretion 
of cortisol, which facilitates behavioral adaptation. Dysregulation of the HPA-axis has frequently 
been reported in patients with mental disorders. Patients with severe depression often have elevated 
cortisol levels. Furthermore, the personality trait “neuroticism” that is characterized by chronic 
negative affect is regarded as a vulnerability factor for depression (Weinstock and Whisman, 2006; 
Ormel et al., 2004; Clark et al., 1994).   
 
Although the magnitude of heritability differs largely between studies, it is clear that cortisol levels, 
mood and anxiety disorders and neuroticism are heritable (reviewed by (Flint, 2004). In addition 
several studies showed that cortisol levels are positively correlated with neuroticism. Therefore 
genetic variability in factors regulating the stress system might underlie differences in neuroticism 
and susceptibility to psychopathology.  
 
Central in the regulation of the HPA-axis by cortisol are two brain corticoid receptor population, the 
high affinity mineralocorticoid receptor (MR) and the low affinity glucocorticoid receptor (GR). 
GR is expressed throughout the whole body and mediates via the elevated cortisol levels the 
metabolic, immunological, cardiovascular and behavioural adaptations in response to stress. MR 
binds in the limbic brain not only cortisol but also aldosterone with high affinity, but since the 
concentration of cortisol is much higher the brain predominantly sees the latter steroid. In 
aldosterone target tissues such as sweat glands, distal colon, kidney and salivary glands cortisol is 
converted to inactive cortisone by 11β hydroxy steroid dehydrogenase type 2.  Brain MR is in 
particular involved in the regulation of basal HPA-axis pulsatility and in the onset of the stress 
response.  
 
Several studies using animal models have demonstrated MR-mediated effects on behaviour. MR 
blockade clearly influenced coping with stressful challenges (Oitzl and de Kloet, 1992), observed as 
a change in the initial search strategy for an escape route in the Morris water maze. Other studies 
demonstrated that the MR blockade inhibits the onset of aggressive behaviour in male rats (Haller et 
al., 1998) and rainbow trout (Schjolden et al., 2009). Furthermore, transgenic mice with increased 
levels of MR in the forebrain showed decreased anxiety-like behaviour and enhanced memory 
(Rozeboom et al., 2007; Lai et al., 2007). In humans, MR-blockade impaired e.g. selective attention 
and mental flexibility, behavioural responses that represent the inital behavioural response to a 
stressor (Otte et al., 2007).  
 
Involvement of genetic variation in the human MR in HPA-axis regulation is reported for two 
single nucleotide polymorphisms. One of these SNPs, designated MRI180V or rs5522 is located in 
exon 2. The SNP results in an isoleucine to valine amino acid change in the N-terminal domain of 
the protein and influences the transactivation capacity of the MR in vitro (DeRijk et al., 2006; Arai 
et al., 2003).  MR180V is associated with enhanced cortisol, and autonomic responses to an acute 
psychosocial stressor measured with the TSST in young male twins (DeRijk et al., 2006).  
However, the enhanced cortisol response to the TSST was not found in a smaller study; instead an 
association between MR180V and higher ACTH responses and anxiety was observed during the 
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second TSST performed in this group (Ising et al., 2008). In addition, more feelings of depression 
have been observed in a cohort consisting of very old predominantly female individuals  (Kuningas 
et al., 2007).  
 
A second SNP tested in the MR is MR-2G/C or rs2070951, located two nucleotides before the first 
translational startsite of the MR. The C allele of the SNP creates a stronger translation site resulting 
in more MR protein expression compared to the G allele (this thesis chapter 3). An in vitro study 
demonstrated a change in transactivational capacity (van Leeuwen et al., 2010; Arai et al., 2003). 
Furthermore, the C variant of MR-2G/C is associated with lower basal cortisol levels in an elderly 
cohort (Kuningas et al., 2007).  
 
In this study we aim to show involvement of the MR gene variants in neuroticism and mood 
changes in both controls and patients. Therefore we tested SNPs and haplotypes in the MR for 
associations with personality, mood and anxiety disorders in a cohort containing healthy controls 
and patients. 
 
Materials and Methods 
 
Subjects 
Hundred patients (mean age 33.1 SD 11.2 years, 65 females) with a depressive and/or anxiety 
disorder were recruited from the outpatient department of the mental health center Rivierduinen in 
Leiden, the Netherlands. Fifty healthy controls (mean age 35.7 SD 14.0, 47 females) were recruited 
by advertisement. History of neurological or endocrine diseases, serious medical conditions, 
substance or alcohol abuse, pregnancy ovariectomy, psychotropic medication except a low dose of a 
benzodiazepine (equivalent to 30 mg oxazepam daily) and corticosteroid, estrogen, thyroid 
hormone, or herbal medication use were exclusion criteria. All subjects were subjected to a routine 
physical examination. Written informed consent was obtained from all participants. The study was 
approved by the ethics committee of the Leiden University Medical Center. 
 
Psychopathological and psychological measures 
All patients were diagnosed with the Diagnostic and Statistical Manual of Mental Disorders, Fourth 
Edition. Diagnoses of the patients and absence op psychiatric illnesses in healthy controls was 
confirmed by trained interviewers using the Dutch version of the Mini International 
Neuropsychiatric Interview Plus 5.0.0-R (van Vliet and de Beurs, 2007; Sheehan et al., 1998). 
All subjects completed the Dutch translation of the Brief Symptom Inventory (BSI) and the mood 
and axiety symptom questionnaire (MASQ). The BSI is a shortened version of the Symptom 
Checklist (SCL-90), that is used to measure psychological complaints or symptoms (de Beurs et al., 
2007). The total BSI-score generates an overall measure of psychopathological symptom severity. 
Internal consistency of the BSI is very good (Cronbach's α = 0.96), and validity is sufficient  (de 
Beurs et al., 2007). The MASQ measures three scales of General Distress: depressive symptoms (12 
items), anxious symptoms (11 items) and mixed symptoms (15 items), it has a anxiety-specific 
scale (Anxious Arousal, 17 items) and depression-specific scale (Anhedonic Depression, 22 items). 
The reported internal consistency for each scale is excellent with coefficient alphas ranging from 
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0.78 to 0.92 (Buckby et al., 2007). For both BSI and MASQ (sub)scales, higher scores reflect more 
symptoms.  
Neuroticism was assessed with the neuroticism subscale of the NEO Five Factor Inventory (NEO-
FFI)(Costa and McCrae, 1992).  
 
Genotyping 
DNA was extracted from EDTA blood samples using a QIAgen DNA blood maxi kit according to 
the manufacturer’s protocol (QIAgen, Venlo, the Netherlands). All subjects were genotyped for 
rs2070951, rs5522, rs5525, rs5534, rs6535578 and rs6535579 with matrix-assisted laser 
desorption/ionization time-of-flight (MALDI-TOF) mass spectrometry (MS), using the Sequenom 
MassARRAYtm methodology (Sequenom Inc., San Diego, CA, USA). Amplification reactions and 
parameters were based on the manufacturer's instructions and 10% of the samples were measured in 
duplicate. With this method it was not possible to measure rs2871 therefore SNPs rs65365578 and 
rs6535579 were measured instead since there is high LD between these SNPs and rs2871 accoring 
to the HAPMAP database. In addition, SNPs MR-2G/C and MRI180V were also genotyped using 
the TaqMan pre-designed SNP genotyping assays, assay ID C12007869_20 and C1594392_10 
respectively, in combination with TaqMan universal PCR master mix (Applied Biosystems, 
Nieuwerkerk a/d IJssel, The Netherlands). 
 
Statistical analysis  
Haploview (Barrett et al., 2005b) was used to calculate Hardy Weinberg equilibrium (HWE) and 
linkage disequilibrium between the SNPs (estimated with D’ and r2). Haplotypes were estimated 
and assigned to each individual using SNPHAP.  
 
All other statistical analysis was performed with SPSS 16.0 (Chicago, IL, USA). To test if the MR 
genotype and haplotype distribution is equal between the patient and control group 2 tests were 
computed. One-way ANOVA was used to compare BSI and neuroticism scores between patients 
and controls and regression analysis was carried out to analyze the effects of MR haplotypes on BSI 
or neuroticism scores. 
 
Results 
 
MR genotypes and haplotypes 
All samples were genotyped for the three SNPs in the coding region, rs2070951, rs5522 and rs5525 
and three intronic SNPs rs2070950, rs6535578 and rs6535579 using the Sequenom MassARRAY 
methodology (Table 1). The exonic SNP rs2871 could not be measured therefore the two intronic 
SNPs rs6535578 and rs6535579 were measured instead. The two previously reported SNPs MR-
2G/C and MRI180V were additionally genotyped with a Taqman genotyping assay yielding 
identical results. All genotypes were in Hardy Weinberg equilibrium (data not shown). LD and 
haplotype analyses revealed two haplotype blocks. One, containing the SNPs in the first intron and 
exon 2. The other, containing SNPs in exon 9 and the preceding intron (Fig. 1a and b). 
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Table 1. Genotype frequencies (in %) in patients and controls and the statistical comparison of 
genotypes between patients (n=100) and controls (n=50) 
SNP variation homozygotes heterozygotes homozygotes -
square 
  patients controls patients controls patients controls p-value 
rs2070950 C/G 29.4 26.0 42.2 54.2 28.4 20.0 0.352 
rs2070951 G/C 29.4 26.0 42.2 54.2 28.4 20.0 0.352 
rs5522 G/A 77.5 78.0 18.6 22.0 3.9 0.0 0.340 
rs5525 T/C 77.5 78.0 18.6 22.0 3.9 0.0 0.340 
rs5534 G/A 31.4 28.0 51.9 54.0 15.7 18.0 0.886 
rs6535578 A/C 46.1 38.0 42.2 46.0 12.7 14.0 0.429 
rs6535579 A/G 10.8 12.0 40.2 46.0 48.0 40.0 0.506 
 
 
 
Fig. 1a. haplotypes in the MR 
Fig. 1b. LD between MR SNPs 
measured in r2 Black squares 
indicate r2= 1 and shades of grey 
indicate  r2<1 
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Psychopathology 
The genotype distribution of the seven different MR SNPs was not significantly different between 
the patient group and the control group (Table 2). Also the haplotype frequencies were not 
significantly different between the patient two groups (2= 5.0 p=0.167; Table 3).  
 
Table 3. Haplotype frequencies in patients (n=100) and controls (n=50) 
 Haplotype Block 1  Haplotype Bock 2 
 1 2 3  1 2 3 4 
Patients 45.9 42.9 11.2  54.8 30.1 12.0 2.0 
Controls 50.0 36.7 13.4  53.1 36.7 9.2 1.0 
 
The total score on the Brief Symptom Inventory (BSI) was significantly higher in the patients 
compared to the controls (patients 1.31 0.69 versus controls 0.18 0.18) and also on the eight 
different subscales the patients scored significantly higher (data not shown). There were no 
significant associations between the haplotypes and BSI total scores or subscale scores (all p>0.05), 
although there was a trend towards significance (F1,98=3.34 p=0.071) that patients carrying the 
haplotype 2 of block 1 had a higher score on the anxiety subscale of the BSI (carriers 2.17 0.54 
versus non-carriers 1.29 0.096). Also general distress, anhedonic depression, anxious arousal 
measured with the the mood and anxiety symptom questionnaire (MASQ) were not associated with 
MR haplotypes or single SNPs (all p>0.05) 
 
Neuroticism 
Neuroticism scores were significantly higher in the patient group compared to the control group 
(patients 44.17.9 versus controls 27.47.0) therefore both groups were analyzed separately. In the 
patients there was a significant association between both MR haplotype blocks and neuroticism; 
patients carrying one copy of allele 3 of haplotype block 1 (MR 180V carriers) had lower scores 
than non carriers and the scores were even lower in the patients carrying two copies of allele 3 (p= 
0.04; Table. 4.). In block 2 homozygote carriers of allele 2 had lower scores of neuroticism 
compared to patients without allele 2 or only one copy of allele 2 (p= 0.02; Table 4.).  There was no 
effect of the MR haplotypes on neuroticism scores in healthy individuals (p>0.05).  
 
Table 4. Neuroticism scores in patients carrying 0, 1 or 2 copies of a haplotype  
Haplotype Number of copies  
Block 1 0 1 3 p 
1 44.1 (±7.9) 43.6 (±8.4) 45.0 (±7.2) n.s. 
2 42. 7 (±8.0) 44.7 (±7.8) 46.3 (±7.3) n.s. 
3 45.3 (±7.4) 41.1 (±8.5) 37.3 (±7.1) 0.02 
Block 2     
1 38.6 (±8.9) 45.5 (±7.6) 44.8 (±6.5) n.s. 
2 44.5 (±7.0) 45.4 (±7.3) 35.1 (±10.1) 0.02 
3 44.1 (±8.1) 44.0 (±7.2)  n.s 
 
 
 
92 Chapter 6 MR haplotypes associate with neuroticism 
Discussion 
 
We described two haplotype blocks in the human MR-gene, which were associated with 
neuroticism but only in depressed and/or anxiety patients. However, the SNPs and the haplotype 
blocks in the MR gene were not associated with mood and/or anxiety disorders.  
 
Neuroticism 
Neuroticism was associated with both haplotype block 1 and 2 in the patient group; this is the first 
study showing that genetic variation in the MR is associated with neuroticism. Previous studies 
demonstrated heritability of neuroticism, associations between cortisol and neuroticism, 
involvement of the MR in behavior and a role for genetic variation in stress responsiveness 
reviewed by (Flint, 2004). The effect of the MR was only observed in the patient group, which as a 
total had significantly higher neuroticism scores. A depressive state amplifies the personality profile 
and the scores can be interpreted as an accurate reflection of the current condition of the person 
(Costa, Jr. et al., 2005). Therefore it is likely that the observed effect is only visible in this group 
with amplified scores. Another explanation why the effect is not observed in the control group 
might be the relative small group size (n=50) as compared to the patient group (n=100). However, 
also in another cohort consisting of healthy individuals from the German population we also did not 
observe an association between the current described MR haplotypes and neuroticism (data not 
shown). 
 
Mood and anxiety 
In this study we did not find an association between MR SNPs and haplotypes with mood and/or 
anxiety disorders. A previous study did report an association between the MR180V SNP and 
feelings of depression in a cohort consisting of healthy elderly (Kuningas et al., 2007). The large 
difference in age between the two groups might explain the discrepancy between the two findings 
since it is known from animal studies that MR expression decreases with aging and we 
demonstrated that MR haplotypes influence MR functionality and expression in vitro (van Leeuwen 
et al., 2010). It is possible that the effect of the MR haplotypes is only observed in elderly were the 
MR expression is probably already low. The relatively small group sizes, the patient group 
consisted of hundred individuals and the control group consisted of fifty individuals, might also be 
a reason why we did not find an association. 
 
Mechanism 
Although the mechanism of the SNPs in block 1 is partly known from previous in vitro 
experiments, it is difficult to explain the in vivo consequences based on these in vitro changes. In 
block 1 haplotype 3 is the allele associated with neuroticism, this is the only allele in our cohort 
containing the minor allele of MRI180V which leads to a lower transcriptional efficiency, without 
influencing the MR expression. The C allele of MR-2G/C is present in both haplotype 2 and 3 and 
is increasing the transactivational capacity by increasing the MR protein expression compared to the 
G allele of MR-2G/C present in haplotype 1(van Leeuwen et al., 2010). It seems that in block 1 
MRI180V or the in vitro not tested SNP rs5525 causes the effect on neurotisicm.  How this effect is 
mediated needs further investigation since both haplotypes 1 and 3 affect transactivation. In 
haplotype 1 this is mediated by the C allele of MR-2G/C, in haplotype 3 it is mediated by the G 
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allele of MRI180V while only haplotype 3 is associated with neurotiscism. Interestingly haplotype 
4 which should contain both alleles that result in the lower transactivation, the G allele MR-2G/C 
and the G allele of MRI180V, is not observed in our population. This might occur by chance but 
one can speculate that this combination has negative consequences for a person’s health and is 
therefore not passed on from generation to generation in the population. 
  
In block 2, allele 2 is the allele associated with neuroticism. The SNPs in this block are not yet 
tested for functionality but computer screenings revealed that one of the SNPs rs2781 promotes 
loop formation of the mRNA and this will probably alter the mRNA stability. By influencing 
mRNA stability SNPs can increase or decrease expression of MR protein, if the mRNA is present 
for a longer period more protein can be formed and subsequently, more protein will lead to a higher 
transcriptional activity. 
 
Furthermore, although there are no SNPs in the coding regions in the two described haplotypes 
blocks there are many SNPs in the intronic regions between the two blocks (described in more 
detail in chapter 7, the general discussion of this thesis). The intronic SNPs might affect the MR by 
influencing RNA splicing or transcription of the MR by changing binding of cofactors. We can not 
rule out that a SNP in such region is causing the effect on neuroticism.  
In conclusion, there are two main haplotype blocks in the MR, these blocks were not associated 
with mood and/or anxiety disorders but there was an association with neuroticism in the patient 
group indicating involvement of the MR in human behavior. 
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Stress causes activation of the hypothalamic-pituitary-adrenal (HPA)-axis, resulting in production 
and secretion of corticosteroids which facilitate physiological and behavioural adaptation. These 
effects exerted by corticosteroids are mediated by two brain corticosteroid receptor types, the 
mineralocorticoid receptor (MR), with a high affinity already occupied under basal conditions and 
the glucocorticoid receptor (GR), with a low affinity only activated during stress. The HPA axis 
response to stressors is highly variable between individuals. These individual differences are partly 
inherited and probably underlie the individual’s vulnerability or resilience to stress-related 
psychopathology. The MR is at least involved in two important systems in the human body, the 
HPA axis and the renin-angiotensin-aldosterone-system while animal studies demonstrated that a 
complete knock-out of the MR is not compatible with life. 
 
This project was designed to identify and characterize genetic variation in the MR and to test the 
effect of the genetic variation on the stress response in healthy individuals and the role of this in 
psychopathology. In addition, effects of genetic variation in MR on the renin-angiotensin-
aldosterone system were investigated. 
 
1. Location of genetic variation in the MR 
Single Nucleotide Polymorphisms (SNPs) are common variations at the DNA level; by definition 
the frequency of SNPs in the normal population is more than 1%. In the MR, SNPs are located in 
the transactivation domain, the intronic regions and the untranslated exonic regions. There are no 
SNPs found in the DNA and the ligand binding domain of the MR. In contrast, mutations,  genetic 
variation with a frequency of less then 1% in the population, are predominantly located in the DNA 
and ligand binding domain (previously reported and in this thesis described SNPs and mutations are 
shown in figure 1).  
1β 2 3 54 6 87 91α
rs2070951
MR-2 GC
rs5522
I180V
1st and 2nd
ATG stop
rs2871
rs5534
Rs6535578
rs5525
rs2070950
rs6535579
N-terminal 
602 amino acids
DNA binding 
66 amino acids
Ligand binding
251amino acids
Intron 2
rs1490453
rs10034789
rs17484259
rs3846322
rs3857080
Intron 4
rs4835491
rs6535584
rs3843410
rs6844155
DNA
protein
C436X C645XG633R Q776R S810L R947X L979P
 
Figure 1. structure of the MR gene, intronic 
DNA regions are displayed as the black line 
in the middle, exonic regions are displayed as 
the boxes on the line. SNPs are indicated 
below the DNA, while the protein structure 
and mutations are displayed above 
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The differential distribution of SNPs and mutations in the MR can be explained by their importance 
for the functioning of the receptor. Mutations in the DNA or ligand binding domains of the MR can 
lead to pseudohypo-aldosteronism type I (PHA1). Individuals with PHA1 have severe problems in 
maintaining electrolyte balance and untreated this will lead to death. In the genome there is a SNP 
approximately every 200 nucleotides. However, in the DNA and ligand binding domain of the MR, 
consisting of 950 nucleotides (this thesis, chapter 1), no SNPs have been observed. This is a second 
example demonstrating that genetic variation in those regions is probably too severe to be spread 
throughout the population.  
 
Although SNPs in the MR have more subtle effects compared to mutations, their impact on general 
health might be considerable because of their high frequency in the population.  
 
2. Haplotypes in the MR 
In the human genome some regions show little historical recombination and subsequently within 
these regions only a few SNP combinations are observed. These SNP combinations are called 
haplotypes and the regions containing those haplotypes are called haplotype blocks. The boundaries 
of blocks and the specific haplotypes they contain are highly correlated across populations and are 
formed by recombination hotspots, sequences in the DNA where recombination occurs frequently.  
 
The fact that two SNPs on nearby sites occur more often together due to the lack of recombination 
between the SNPs is called linkage disequilibrium and is measured in D’ or r2. Both measures 
range from 0 (SNPs do not occur more frequently together) to 1. D’ is defined in such a way that it 
is equal to 1 if just two or three of the four possible haplotypes are present and is <1 if all four 
possible haplotypes are present. The measure r2 is the statistical correlation between the two SNPs 
and a value of 1 means that only 2 of the four possible haplotypes are present. Intermediate values 
of the measures are difficult to interpret and to compare.  
 
The existence of haplotypes and linkage disequilibrium is an important factor in genetic studies 
because when an association is found between a SNP and a phenotype it does not necessarily mean 
that there is a causal relationship. The SNP can be in linkage disequilibrium with the causal SNP 
that is located in the same gene or even in an adjacent gene. Thus when studying the mechanism 
and physiological function of genetic variability, it is crucial to take haplotypes into consideration. 
 
Measuring SNPs in the promoter and exonic regions of the MR gene revealed two haplotype blocks 
(Fig 2 and chapter 5 of this thesis).  
 
However, analyzing the complete MR gene including the intronic region in data from the HAPMAP 
consortium, an organization with the goal developing a haplotype map of the human genome, 
results in more haplotype blocks, the two blocks we identified but also blocks in between those two 
blocks containing intronic SNPs. 
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Linkage disequilibrium between the SNPs described in this thesis, located in and before exon 2 (5’ 
of the gene) and in and just before exon 9 (3’ of the gene) and previously reported SNPs located in 
intron 2, 3 and 4 was calculated in the HAPMAP data (Fig 3).  
 
Figure 2. The hMR gene with SNPs and the two haplotype blocks formed by these SNPs. Intronic DNA regions are 
displayed as the black line on top, exonic regions are displayed as the boxes on the line. SNPs are indicated below the 
DNA and the haplotypes formed by the SNPs are indicated under the SNPs. 
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Block 2 Block 1
 
 
 
 
The SNPs reported in this thesis, captured in haplotype block 1 and 2 appeared to be unrelated to 
the previously reported SNPs. Therefore the associations between MR SNPs and blood pressure 
previously found (Zemunik et al., 2009; Tobin et al., 2008) are probably not mediated by the SNPs 
described in this thesis and vice versa the associations described in this thesis are not mediated by 
the intronic SNPs 
 
3. Predicting functionality of SNPs and haplotypes 
Putative functionality of a SNP can be predicted based on the location. For example, an amino acid 
changing SNP is more likely to be functional than a synonymous coding SNP. Other putative 
functional SNPs include SNPs located in regulatory regions, regions involved in mRNA stability, 
RNA splicing regions and micro RNA binding sites. Web based computer programs which detect 
those specific regions can help in predicting the functionality of the SNPs. The different computer 
programs are listed in table 1.  
Figure 3. Linkage disequilibrium between the MR SNPs previously reported and reported in this manuscript. 
Black squares indicate r2= 1 and shades of grey indicate  r2<1 
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Table 1. Computer programs used for predicting functionality of SNPs 
Sequence detected program website 
Amino acid change  http://www.ncbi.nlm.nih.gov/snp/ 
Transcription factor binding site TFsearch  
(Heinemeyer 1998) 
http://www.rwcp.or.jp/papia/  
Splice site  http://www.fruitfly.org/seq_tools/splice.html 
mRNA stability Mfold 
(Zuker, 2003) 
http://mfold.bioinfo.rpi.edu/ 
Micro RNA binding site Target scan http://www.targetscan.org/ 
 
Four previous studies report associations with MR SNPs but only two studies specifically tested the 
putative functional SNPs. Table 2 summarizes MR SNPs and their predicted effect based on 
location predicted by the different computer programs. 
 
Table 2. Putative function of SNPs in the MR 
SNP variation Location Putative function literature 
rs7671250 T/C  No transcription factor site Chapter 5 this thesis 
rs6814934 C/G  Possible TATA, Th1E4, ETS site Chapter 5 this thesis 
rs7658048 C/T  T possible GATA-2 site Chapter 5 this thesis 
rs2070950 C/G  No transcription factor site Chapter 5 this thesis 
rs2070951 G/C Exon 2 
5’UTR 
In Kozak translation regulatory 
region 
Van Leeuwen 2010, 
this thesis 
rs5522 G/A Exon 2 Amino acid change DeRijk 2006 
rs5525 T/C Exon 2 No aminoacid change  Chapter 5 this thesis 
rs1490453  Intron 2 No effect on splicing Zemunik 
rs10034789 G/A Intron 2 No effect on splicing Tobin 2008 
rs17484259 T/G Intron 2 No effect on splicing Tobin 2008 
rs3846322 C/T Intron 3 No effect on splicing Tobin 2008 
rs3857080 G/C Intron 3 No effect on splicing Tobin 2008 
rs4835491 C/T Intron 4 No effect on splicing Tobin 2008 
rs6535584 T/C Intron 4 No effect on splicing Tobin 2008 
rs3843410 C/A Intron 4 No effect on splicing Tobin 2008 
rs6844155 C/T Intron 4 No effect on splicing Tobin 2008 
rs5534 A/G Exon 9 No aminoacid change  Chapter 5 this thesis 
rs2871 T/C Exon 9 
3’UTR 
Possible loop formation mRNA 
Close to miRNA binding site 
Chapter 5 this thesis 
 
4. Testing SNPs and haplotypes in vitro 
In the classical view the MR functions as a transcription factor, when ligand binds to the MR in the 
cytoplasm, the MR dimerizes with either GR or MR and translocates to the nucleus. In the nucleus 
the MR binds to specific DNA sequences and influences transcription of specific genes. Different 
aspects in this process can be influenced by genetic variation. The two SNPs MR-2G/C and 
MR180V were extensively studied for their functionality in vitro (table 3). 
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Table 3. In vitro effects MR-2G/C and MRI180V  
SNP mRNA protein Ligand 
binding Kd 
Ligand binding 
Bmax 
Transactivation Literature 
-2G/C No effect C  ↑ MR 
protein 
No effect C  ↑ B max C  ↑ transactivation 
with cort, aldo and 
dex 
This thesis 
 
     C  ↓ transactivation 
with aldo 
Arai 2003 
       
I180V No effect No effect No effect No effect V  ↓ transactivation 
with cort and dex 
This thesis 
 
     V   ↓ transactivation 
with cort 
no effect with aldo 
DeRijk 
2006 
     V  ↓ transactivation 
with aldo 
Arai 2003 
 
4.1.  MR-2G/C 
As predicted based on the location in the first Kozak region of the MR, the C allele of MR-2G/C 
results in more MR protein due to increased translation. The mRNA was not affected by the SNP 
therefore it is only the translation that is influenced and not the mRNA synthesis. Although there 
are two translation  start sites in the MR resulting in respectively MR-A and MR-B, the COS-1 cells 
that were transfected with human MR only expressed MR-A. The existence of MR-B in other cell 
lines and in vivo remains to be elucidated. As far as we know, MR-B is only detected with in vitro 
translation, a method where the complete translation process is performed in a reaction tube. There 
are no studies showing MR-B expression in vivo or in transfected cells. The increased MR protein 
expression with C allele subsequently leads to the observed increase in transactivation and the 
increased binding capacity of the MR.  
 
However, the increase in transactivation was not observed in all studies. In contrast Arai et al 
reported a decrease in transactivation with MR-2 C (Arai et al., 2003). The methodology between 
the studies differs on several points and this probably accounts for the inconsistency of the studies. 
The main discrepancy is the concentration used. In our study using similar cells, a wide 
concentration range starting at 10-13M to 10-8M was used and maximal transactivation was already 
observed at 10-10M aldosterone (this thesis chapter 4 Fig. 2.a.). In the study by Arai et al the lowest 
concentrations used were 10-11M and 10-10M therefore it might be possible that the real maximal 
transactivation is not observed because the concentrations were too high. It is difficult to relate the 
concentrations used in vitro with concentrations observed in vivo because in vivo only 10-20% is 
unbound and biological active. In blood reference values for cortisol are 0,2 - 0,6 µmol/l in the 
morning and  0,1 - 0,4 µmol/l in the afternoon, of which 10-20% of this circulating cortisol is 
unbound and active. One study reported cortisol levels in cerebro spinal fluid (CSF) that were 16.5 
nmol/l (Raubenheimer et al., 2006) and one study reported cortisol levels in post mortem brain, the 
levels were on average 0.65 µmol/l (Karssen et al., 2001) 
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4.2. MRI180V 
MRI180V results in an isoleucine  valine amino acid change in the transactivational domain of 
the MR. DeRijk et al demonstrated a ligand dependent effect on transactivational capacity. 
MR180V leads to a lower transactivational capacity but this effect was only observed when cortisol 
was used as a ligand. The effect was not observed with aldosterone in this experimental set up. In 
contrast, Arai et al demonstrated significant differences in transactivation using aldosterone (Arai et 
al., 2003). As described in the previous paragraph for MR-2G/C differences in methodology might 
account for this.  
 
The effect on transactivation of MRI180V was not mediated by differences in expression of the MR 
or ligand binding since those were not influenced by the SNP (this thesis chapter 4).  However, it is 
known that co-factors influence binding of the ligands but we did not assess ligand binding in the 
presence of human co-factors. Therefore it is still possible that co-factor binding is influenced by 
the MRI180V resulting in the observed difference in the transactivation assay with cortisol and 
aldosterone, this mechanism remains to be elucidated. 
 
Several other possible mechanisms of action of MRI180V are currently being investigated. 
Preliminary data indicate that the translocation of the MR 180V from the cytoplasm to the nucleus 
is less efficient as compared to the MR I180 (DeRijk, Weij and van Leeuwen, in preparation). In 
addition the transactivation of endogenous genes is currently being tested (deRijk). Furthermore, in 
vivo the MR dimerizes with either MR or GR. All in vitro experiments were performed in cell lines 
with no or very low endogenous MR or GR expression. The influence of MRI180V in combination 
with GR expression is not being investigated. It is possible that the dimerization with GR is 
influenced by MRI180V.  
 
4.3. Haplotypes 
Previous studies tested the MR SNPs separately; in this thesis we additionally tested the 
combinations of MR-2G/C and MRI180V. The combination of these two SNPs is not the complete 
haplotype 1; the promoter and intronic SNPs were not included in the test. Although both SNPs 
influence the MR there was no significant interaction between MR-2G/C and MRI180V in 
transactivation of the MR and MR protein expression (chapter 4). However, confirmation with other 
assays is needed to completely exclude interaction between the SNPs. 
 
4.4. Conclusion testing SNPs and haplotypes in vitro 
The two MR SNPs that were predicted to be functional based on computer screenings, MR-2G/C 
and MR I180V, were indeed functional in in vitro transactivation assays. MR-2G/C influences the 
translation and thereby protein expression with subsequent effects on transactivation and ligand 
binding capacity. MRI180V influenced transactivation but the underlying mechanism is not yet 
elucidated. In our assays there was no interaction between the SNPs. For further experiments we 
propose to use endogenous MR responsive genes as output measures for MR transactivational 
capacity instead of artificial systems such as the luciferase system. This will give more insight into 
the mechanism affected by the genetic variation. Furthermore we suggest including the GR and co-
factors in the in vitro studies since MR dimerizes with either MR or GR. Genetic variation might 
 
104 Chapter 7 General Discussion 
influence dimerization with the GR or co-factor binding. In addition, genetic variation in the GR or 
co-factors might influence the MR as well. 
 
 
5. Association studies MR 
 
5.1. Overview associations MR 
Several studies, including the studies described in this thesis, reported associations with MR SNPs 
(table 4). The MR is involved in important systems in the body and this is reflected in the 
associations found. On the one hand, there are several associations with blood pressure. This is 
probably mediated by the MR in the renin-angiotensin- aldosterone system, the system regulating 
electrolyte and water balance. On the other hand, there are associations related to the regulation of 
the HPA axis, with the TSST responses and the CAR after dexamethasone administration. In 
addition, we described associations with MR SNPs and feelings of depression and neuroticism 
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Table 4. Associations with MR SNPs and MR haplotypes 
 
SNPs Haplotype block Association literature 
Hap 3 neuroticism  
No association 
psychopathology,  
Hap 2b  trend with  anxiety 
(p=0.072) 
Chapter 5 this thesis  1 
Hap 2 TSST responses  Chapter 4 this thesis 
rs7671250 1 Not tested separately  
rs6814934 1 Not tested separately  
rs7658048 1 Not tested separately  
rs2070950 1 Not tested separately  
GG cortisol awakening 
response after dexmethasone 
males  females  
Van Leeuwen 2009 
G renin angiotensin 
aldosterone system and blood 
pressure  
Chapter 3 this thesis 
No association hypertension Martinez 2009 
No association blood pressure Tobin 2008 
rs2070951 1 
C cortisol in the morning  Kuningas 2007 
V cortisol and autonomic 
responses to the TSST   
DeRijk 2006 
V only ACTH and anxiety  
during the second TSST 
Ising 2008 
V more feelings of 
depression  
Kuningas 2007 
V protection hypertension Martinez 2009 
V cortisol awakening 
response after dexamethasone 
 in males in females no effect 
Van Leeuwen 2009 
rs5522 1 
No association blood pressure Tobin 2008 
rs5525 1 Not tested separately  
rs1490453 Between 1 and 2 Fibrinogen levels Zemunik 
rs10034789 Between 1 and 2 Mean night DBP Tobin 2008 
rs17484259 Between 1 and 2 Clinic SBP Tobin 2008 
rs3846322 Between 1 and 2 Clinic SBP Tobin 2008 
Mean night DBP Tobin 2008 rs3857080 Between 1 and 2 
Mean night SBP  
rs4835491 Between 1 and 2 Clinic DBP Tobin 2008 
rs6535584 Between 1 and 2 Clinic DBP Tobin 2008 
rs3843410 Between 1 and 2 Clinic DBP Tobin 2008 
rs6844155 Between 1 and 2 Clinic DBP Tobin 2008 
 2 Hap 2 neuroticism   Chapter 5 this thesis 
rs5534 2 Not tested separately  
rs2871 2 Not tested separately  
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5.2. Associations related to the HPA axis and other brain regions 
The HPA axis can be tested at different levels with different tests; these tests are described in detail 
in chapter 1, the introduction of this thesis. The two functional SNPs MR-2G/C and MRI180V have 
been tested for associations with the outcome measures of HPA axis tests. 
 
Kuningas et al reported an association between MR-2G/C and morning cortisol levels in the elderly. 
However, we did not find an association with basal cortisol levels, the levels without the presence 
of a stressor and MR SNPs in our cohorts, consisting of younger individuals. Also Klok et al. did 
not find associations between the CAR and MR-SNPs (Klok and DeRijk, in press PNEC). 
Differences in age could account for the discrepancies between the studies. It is known from animal 
studies that MR expression alters with age and the associated MR-2G/C influences the expression 
(demonstrated with in vitro assays described in chapter 2 and 3 of this thesis). Therefore, it is 
possible that the impact of MR-2G/C changes with age. 
 
Suppression of the HPA axis was tested with a low dose of dexamethasone. Oral administration of 
0.25mg dexamethasone at 2300h resulted in a significant suppression of the cortisol awakening 
response (CAR). Both SNPs modulated the suppression of the CAR after dexamethasone 
significantly and in a sex-specific manner. There are several explanations how MR gene variation 
can influence dexamethasone-induced suppression of the CAR.  
 
First of all, MR gene variants, might react differently in vivo to stimulation with dexamethasone, as 
we observed in vitro, and thus also differentially affect HPA axis suppression. This is a likely 
explanation, since without dexamethasone there was no genotype effect on the CAR and 
dexamethasone has an appreciable affinity for the MR (Grossmann et al., 2004; Rupprecht et al., 
1993). However, central brain MR is poorly accessible for dexamethasone since Pg-p hampers the 
penetration of the steroid into the brain (Meijer et al., 1998). In spite of this, some dexamethasone 
will pass the blood brain barrier and activate MR, while the pituitary gland also contains some MR.  
 
Secondly, 0.25mg dexamethasone results in lower, but still appreciable levels of saliva cortisol (Fig. 
3). The levels are comparable to the levels normally observed in the afternoon and are probably 
sufficient to activate MR (Droste et al., 2008; Karssen et al., 2005; Meijer et al., 1998) It is 
hypothesized that under these conditions the differential effects of the MR gene variants appear 
with subsequent effects on the input from higher limbic brain regions on the hypothalamic AVP 
(and/or CRH) drive to pituitary ACTH release  (Kovacs et al., 2000; Tajima et al., 1999; Bradbury 
et al., 1994) Since limbic MR has inhibitory effects on the HPA axis, a reduced MR activation may 
result in this enhanced drive (Holsboer, 2000).  
 
Finally, fast non-genomic actions of membrane bound MR might be involved. Membrane bound 
MR has much lower affinity for corticosterone then the classic MR with its genomic actions (Joels 
et al., 2008; Karst and Joels, 2005) and was recently shown in rats to mediate fast feedback during 
the ultradian pulse (Atkinson et al., 2008). These membrane bound MR have low affinity for 
corticosteroids and require rising corticosteroid levels for activation which makes a role for this 
non-genomic mechanism less likely. The possible mechanisms are described in more detail in 
chapter 2 of this thesis and in section 5.4 of this discussion the gender issue will be discussed. 
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Activation of the HPA axis was tested with a psychosocial stressor, the TSST. DeRijk et al 
demonstrated that MR180V enhanced cortisol and heart rate responses to the psychosocial stressor; 
MR-2G/C was not tested in this cohort. Ising et al did report an association between MR180V and 
increased ACTH levels and anxiety but only during the second TSST (Ising et al., 2008). In the 
study described in chapter 4 of this thesis, carriers of 2 copies of Hap 2 from haplotype block 1, that 
is the haplotype containing MR-2C and MRI180, showed higher plasma and saliva cortisol, ACTH 
levels and heart rate. These three studies clearly demonstrate that the two MR SNPs influence the 
response to a psychosocial stressor. The precise mechanism how haplotoype 2, which shows an 
increased MR expression and transactivation capacity in vitro, leads to more reactive HPA axis 
responses and resilient behavior to stressors is unknown. MR-expression is essential for neuronal 
protection and stability of neuronal circuits (Lai et al., 2009; de Kloet et al., 2007). The low affinity 
membrane form of the MR becomes activated during stress levels of cortisol and increases 
excitatory glutaminergic transmission while decreasing post-synaptic after-hyperpolarization (Joels 
et al., 2008). This rapid excitatory MR-mediated effect may very well underlie the non-genomic 
actions exerted by cortisol on neuroendocrine, emotional and cognitive processes (Brinks et al., 
2009). Therefore, it will be a challenge for future research to dissociate during a psychosocial 
stressor the genomic and non-genomic effects mediated by the MR on the processing of stressful 
information resulting in HPA axis reactivity and behavior. The MR haplotypes identified in this 
study may be very helpful in this respect. 
 
Since MR-2G/C and MRI180V were both functional in vitro and influenced suppression and 
activation of the HPA axis effects on psychopathology were expected. The results, however, were 
inconclusive. Kuningas reported more feelings of depression in carriers of MRI180V in a healthy 
elderly cohort but we were not able to find an association between the SNPs and mood and anxiety 
disorders in a cohort containing one hundred patients with mood and/or anxiety disorders and fifty 
healthy individuals (this thesis chapter 5). The small group size in our study is a clear limitation 
since the allele frequency of MRI180V is low, it is only 10%.  Although we did not find an 
association with psychopathology there was an association with neuroticism, a personality trait that 
is regarded as an endophenotype for depression. Future studies using larger cohorts and including 
not only the phenotype depression and endophenotype neuroticism but also environmental factors 
and biological markers are needed for elucidation of the consequences of the MR SNPs. 
 
 
5.3. Associations related to the Renin Angiotensin system 
MR-2G/C influences the expression of the MR and this not only affects cortisol mediated 
transactivation, also aldosterone mediated transactivation is altered by the SNP (in vitro assays 
chapter 4 this thesis). In three different cohorts and with different tests we showed effects of MR-
2G/C on the Renin Angiotensin system (RAS) (chapter 4 this thesis). Individuals carrying the GG 
genotype had higher blood pressure and plasma renin levels as compared to individuals with the CC 
genotype (more details chapter 4 of this thesis). Martinez et al did not report an association with 
hypertension and MR-2G/C but the method of analysis differs between the studies and this might 
explain the discrepancy (Martinez et al., 2009). Martinez et al created haplotypes with SNPs from 
different haplotype blocks and this results in small groups. They reported that the haplotype 
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containing the G allele of MRI180V was associated with a reduced risk of hypertension and 
concluded that MRI180V G was associated with a reduced risk of hypertension. However, in all our 
studies the MRI180V G allele is only observed together with the MR-2G/C C allele therefore it is 
still possible that MR-2G/C is causing the effect in the Martinez study as well but remains 
unnoticed due to the large amount of haplotypes containing the C allele of MR-2G/C. In our studies 
we tested MR-2G/C and MRI180V separately and only MR-2G/C showed the effect. 
 
Previously deRijk et al showed that MRI180V had no effect on transactivation of the MR in vitro 
when aldosterone was used as a ligand. This is reflected in an association study where they showed 
that MRI180V was not associated with different aspects of the renin angiotensin aldosterone 
system; there was no effect of the SNP on blood pressure, renin and aldosterone secretion or 
Weinbergers salt loading test.  
 
Martinez et all showed an association with MRI180V and risk for hypertension but as explained 
before, the analysis is different and this might explain the discrepancy.  
 
In addition, Tobin et al tested 88 SNPs in the MR and showed that 8 SNPs in intronic regions were 
associated with blood pressure. The putative function of the SNPs tested is unclear since computer 
screenings predicted no effects on splicing (table 2). It is possible that these SNPs are linked to 
functional variants and that these intronic SNPs are not causing the effect. However, in their study 
there was no effect of MR-2G/C and MRI180V on blood pressure so those are not the causal SNPs 
in this study. 
 
Considering the different studies it can be concluded that SNPs in the MR influence salt regulation, 
blood pressure regulation and the development of hypertension. However, the causal SNPs in the 
MR are not yet elucidated. Based on predicted function, in vitro effects and our association study 
MR-2G/C is the most likely effect causing SNP but this was not observed in all studies. It is 
possible that other, currently untested SNPs, or combinations of SNPs cause the effect. 
 
5.4. Effect of gender 
Several associations with MR SNPs were gender dependent. For some associations males with a 
specific genotype had the complete opposite association compared to females. Animal studies 
demonstrated that sex hormones influence MR expression e.g. in rats, estrogens decrease the 
expression of the MR in the pituitary (Turner et al., 1990) and progesterone treatment increased the 
activity of the MR promoter in cell lines (Castren et al., 1995). The MR-2G/C SNP also influences 
the MR expression in vitro and it can be hypothesized that this interacts with the effects of the sex 
hormones. In addition, progesterone can bind MR, acting both as an agonist or antagonist. 
Furthermore oral contraceptives bind the MR and this leads to increased total cortisol levels while 
the free cortisol levels are unchanged. Interference of sex hormones was not tested in the in vitro 
assays performed; this should be included in future experiments.  
 
5.5. Interaction with other genes 
Complex diseases, like depression, are not caused by one single gene; several genes in combination 
with environmental factors are involved in the etiology. For optimal HPA axis regulation the 
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balance between MR and GR is important. Furthermore, GR SNPs are associated with the same 
HPA axis measures as the MR SNPs e.g. TSST response and cortisol after dexamethasone (see 
introduction). Therefore the influence of genetic variation in the GR in combination with genetic 
variation in the MR should be tested in vitro and in vivo. In the cohorts tested so far, interactions 
between MR and GR SNPs could not be tested due to the limited group sizes.   
 
5.6. Associations MR SNPs with unknown function 
Computer screenings revealed possible functionality of the SNPs in exon 9 that form haplotype 
block 2, therefore they were included in the association study. The SNPs were associated with 
neuroticism, thus in vitro functionality assays should now be performed to elucidate the underlying 
mechanism. Furthermore, the region between haplotype block 1 and 2 should be screened for SNPs 
and the functionality tested in vitro. There are associations found with SNPs in this region but it is 
unclear what the mechanism is. It is also unclear if the SNPs tested are the functional SNPs or that 
they are in linkage disequilibrium (LD) with the functional SNPs. 
 
5.7. Predicting in vivo consequences based on in vitro studies 
The studies in this thesis showed that it is difficult to predict the exact consequences of a SNP in the 
human body based on the functionality of the SNP in the in vitro assays. For example, most 
associations were gender dependent but interference of sex hormones was not tested in the in vitro 
assays performed. To obtain a better prediction, sex hormones should be included in the in vitro 
studies e.g. binding of the sex hormones might be influenced by the MR gene variants. This can be 
tested with the ligand binding assays we performed for assessing the impact of the MR gene 
variants on cortisol binding. 
 
Furthermore, in the in vitro studies described in chapter 5, the effects of the combination of the two 
MR SNPs MR-2G/C and MRI180V were tested but there are many other SNPs in the MR (shown 
in Fig 1). Interactions of those SNPs were not tested in vitro and also other genes are not taken into 
account in the in vitro assays.  
 
It will be difficult to predict the exact consequence in vivo based on functionality in vitro but the 
chance that a SNP is effective in vivo is higher when it is functional in vitro e.g. the two functional 
SNPs MR-2G/C and MRI180V and the putative functional SNPs in exon 9 showed effects in vivo.  
 
6. Future perspectives 
 
Our studies showed genetic variation in the MR, which appeared in vitro functional in translation, 
transactivation and binding properties of this receptor. Based on the findings in the association 
studies, we postulate that the genetic variants may modulate the stress response and affect in part a 
person's personality structure. Furthermore, the MR variants seem to influence the regulation of 
blood pressure and salt homeostasis. 
 
Hence, one may wonder whether the MR genotype is of relevance for the prediction of either 
vulnerability or resilience to psychopathology. After all, MR mediates the genomic action of 
cortisol, a hormone that communicates stressful environmental influence to brain and body. This 
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implies that processing of environmental information may be genetically modified via central 
processes linked to the MR variants. At a behavioural level, these MR mediated central processes 
involve appraisal of stressful information and the regulation of the initial stress reaction.    
 
Evidence from this thesis and other studies suggests that increased MR-expression is beneficial and 
neuroprotective. This notion is reinforced by the study of Otte et al., who recently showed 
accelerated responses to anti-depressive therapy by using the MR agonist fludrocortisone as add on. 
This finding is in line with our indications that the MR-2C variant, resulting in increased synthesis 
of MR protein, has beneficial effects. Moreover, the MRI180V variant has a remarkable ligand 
dependent enhancing effect on transactivation in vitro; the SNP influences transactivation mediated 
by cortisol, while there is no effect on transactivation when aldosterone was used as a ligand. This 
finding calls for studies to explore the steroid specificity of the MR variants.  
 
The studies described in this thesis mainly focus on the MR. However, for full understanding of 
cortisol action in the brain, the balance between GR and MR needs to be taken into account.  
Antidepressants influence both MR and GR expression and the GR antagonist mifepristone has 
been proposed as medication in severe depression. Moreover, genetic variation in the GR has been 
reported to influence the pathogenesis of depression and the efficacy of tricylcic anti-dpressants. An 
important question for future research is therefore how to reinstate imbalanced GR and MR 
mediated actions as a therapeutic strategy for stress-related disorders such as depression, taking 
their recently discovered genetic variation into account. 
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Summary 
 
A depressive disorder is a common mood disorder characterized by loss of pleasure and a negative 
mood. Many people occasionally feel “depressed” but only if these feelings persist for a longer time 
it is possible that a person is suffering from depression. A major depression is a serious and 
common disease. It interferes with a person’s ability to work, study, sleep, eat and enjoy pleasurable 
activities. Over 15% of the Dutch population experiences depression during their life. Although 
many studies were performed to elucidate the etiology of the disease, the mechanism has still not 
been completely clarified. Stress plays an important role in the etiology of depression and some 
families are more vulnerable, indicating a genetic component. Twin studies in which 100% identical 
monozygotic twins were compared with dizygotic twins, who are on average 50% identical, 
confirm that there is a genetic component involved in the development of a depression.  
Depression is often associated with disturbances in the hypothalamus-pituitary-adrenal (HPA) axis. 
The increased secretion of cortisol from the HPA axis during a stressful situation is essential for 
adaptation to the stressful situation. In addition, cortisol mediates inactivation of the HPA axis by 
negative feedback. Cortisol exerts its effect via binding to a receptor. There are two receptor types 
for cortisol; the mineralocorticoid receptor (MR), having a high affinity and the glucocorticoid 
receptor (GR), having a low affinity for the naturally occurring glucocorticoid. In the brain the MR 
is continuously occupied with cortisol while the GR only becomes activated at high concentrations 
of cortisol. Both the MR and GR play an important role in the regulation of the HPA axis and are 
important for behavioral adaptation. 
The ultimate goal of the research described in this thesis was to investigate whether genetic 
variation in the mineralocorticoid receptor is involved in the development of depression. 
First, the coding region of the MR gene was screened for genetic variation and using computer 
programs linkage between the genetic variation and the possible functionality of the genetic 
variation was tested; this is described in chapter 2. There were seven Single Nucleotide 
Polymorphisms (SNPs) located in the coding region of the MR-gene. A SNP is a variation in one 
nucleotide with a frequency of more than 1% in the population. The SNPs in the MR gene are 
mostly linked and several SNPs are putatively functional. The putative functional SNPs are MR-
2G/C (rs20170951), MRI180V (rs5522) and rs2871. MR-2G/C is located just outside the coding 
region of the gene in the Kozak region and the SNP might therefore influence the translation of the 
mRNA to protein. MRI180V is located in the coding region of the gene in exon 2 and changes the 
amino acid on position 180 from an isoleucine to a valine. Rs2871, one of the SNPs in the non-
coding domain of exon 9, is located in a part of the mRNA that is prone to loop formation and this 
might have consequences for the stability of the mRNA. 
Based on the location and putative function, the SNPs MR-2G/C and MRI180V were selected for 
further research. Functionality of these SNPs was tested with in vitro cell systems. The results of the 
in vitro tests are described in different chapters of this thesis. The C allele of MR-2G/C results in 
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more MR protein compared to the G allele, while the amount of MR mRNA was not influenced, 
this was described in chapter 4. The increased MR expression with the C allele of MR-2G/C lead 
to higher transactivation as descibed in chapter 3 and 4 and increased ligand binding, described in 
chapter 5. MRI180V had previously been tested in transactivation assays, the V allele decreased 
transactivation without changing the expression or ligand binding (chapter 5). 
MR-2G/C and MRI180V were, to a large extent, linked to each other, as described in chapter 2, 3, 
5 and 6. The combination of two (partly) linked SNPs is called a haplotype. Without linkage 4 
different combinations (haplotypes) are possible. In our studies, however, only 3 combinations 
(haplotypes) were observed. The combination MR-2G and MR180V (=G nucleotide) did not occur. 
To exclude the possibility that the two SNPs influence each other’s functionality, the haplotypes 
were also tested in vitro, this was described in chapter 5. The two SNPs did not influence each 
other in vitro. 
In each chapter an association study was performed between genetic variation and one of the 
possible consequences of the variation. 
In chapter 3 involvement of the two in vitro functional SNPs MR-2G/C and MRI180V on the 
regulation of the HPA axis in healthy individuals was tested by using the dexamethasone 
suppression test (DST). Dexamethasone is a synthetic glucocorticoid and, like high concentrations 
of cortisol, it is able to suppress the HPA axis. In our study a low dose dexamethasone (0.25mg) 
was used and this resulted in decreased but not completely suppressed cortisol levels the day after 
intake. The peak in cortisol lasting one hour just after awakening was not influenced by the SNPs 
without dexamethasone. However, after the intake of dexamethasone the previous evening there 
was a clear effect of the SNPs on cortisol levels and this effect was gender specific. The decrease 
was highest in women with the MR-2G/C GG genotype, while men with this genotype showed an 
increase compared to the men with other genotypes. Men with the MRI180V AA genotype had 
higher cortisol concentrations than men with the AG genotype, while this SNP had no effect in 
women. Haplotype analysis did not reveal additional information; the effect was mainly mediated 
by MR-2G/C. 
In chapter 4 the influence of MR-2G/C on blood pressure and salt regulation was tested. In 
addition to the important role of the MR in the HPA axis, the MR is also important in de regulation 
of salt and blood pressure via the renine angiotensine system (RAS). The hormone aldosterone 
binds the MR receptor in the kidney and this results in water and salt retention The G allele of MR-
2G/C was associated with increased activation of the RAS and higher blood pressure. 
In chapter 5 the influence of the MR haplotypes containing MR-2G/C and MRI180V on the 
response to an acute psychosocial stressor and on chronic stress was tested. Individuals 
homozygous for the haplotype containg the MR-C and MRI180 alleles had the highest saliva 
cortisol, plasma ACTH and heart rate during the psychosocial stressor. This haplotype resulted in 
vitro in the highest MR expression and transactivation. Chronic stress was measured with 
questionaires and the subscales “social isolation” and “work overload” were associated with the MR 
haplotypes, however this was mediated by the haplotype with the MR-C and MR180V alleles. 
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Individuals carrying this hapotype reported more chronic stress. The set-up of this study was 
hypothesis generating; the results suggest that more MR protein leads to higher responses on acute 
psychosocial stress and that MR haplotypes influence the perception of chronic stress. 
In chapter 6 two MR haplotypes were tested and described in a cohort consisting of one hundred 
patients with mood and/or anxiety disorders and fifty healthy individuals. Due to the relatively low 
number of patients and controls this study was also explorative in nature and hypothesis generating. 
Association studies were performed with haplotypes in the beginning of the gene (5’, -2 G/C en 
180) and with haplotypes at the end of the gene (3’, in exon 9). The two haplotypes were not 
associated with mood and/or anxiety disorders but in the patient group there was an association with 
the personality trait neuroticism.  
 
Chapter 7 is the general discussion of the thesis.  
First, the location of the SNPs was analyzed. MR SNPs were not located throughout the gene, they 
were mainly located in the promoter region, exon 2 and at the end of exon 9. Genetic changes on 
other locations are probably too severe to be spread through the population. 
Secondly, the predictive value of the in vitro studies was discussed. The in vitro functional SNPs 
were associated with different measures in vivo, therefore it seems important to perform in vitro 
studies. However, generating a detailed hypothesis for in vivo associations based on the in vitro 
results appeared to be complicated. This is illustrated by the gender differences in vivo. Many 
associations were gender specific, the effects being different in men and women. Some associations 
were in the completely opposite direction between men and women. In the current in vitro assays 
there are no sex hormones present. Adding sex hormones in the in vitro studies or testing different 
age groups in vivo might clarify the associations. These and other recommendations for future 
studies are described in chapter 7. 
 
In this thesis the genetic variation in the MR was described. There is genetic variation in the MR 
and this variation is functional in in vitro studies. The genetic variation was associated with cortisol 
levels after dexamethasone, the reaction on psychosocial stress, chronic stress and neuroticism. Due 
to the relatively low number of individuals in each study, these studies were explorative and the 
associations found need follow up testing. We postulate that genetic variation in the MR modulates 
the stress response and affects in part a person’s personality. Furthermore, the genetic variant MR-
2G/C was associated with blood pressure and salt regulation and we were able to confirm this in 
different cohorts. 
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Samenvatting 
 
Een depressie is een stemmingsstoornis die gekenmerkt wordt door verlies aan levenslust en een 
zwaarmoedige stemming. Veel mensen hebben wel eens een dipje maar pas als deze gevoelens 
langdurig aanhouden zou er sprake kunnen zijn van een depressie. Een depressie is een veel 
voorkomende ziekte en de ziekte belemmerd normaal functioneren. In Nederland krijgt 15% van de 
bevolking gedurende zijn leven een of meerdere depressieve episodes. Tijdens deze periodes is het 
vaak niet mogelijk te werken of studeren. Factoren die betrokken zijn bij het ontstaan van de ziekte 
en het mechanisme achter de ziekte zijn veelvuldig onderzocht maar nog steeds niet volledig 
achterhaald. Het is wel bekend dat stress een belangrijke rol speelt. Ook zijn sommige families 
vatbaarder en dat duidt op een genetische component. Tweelingen studies waarbij 100% genetisch 
identieke een-eiige tweelingen vergeleken werden met twee-eiige tweelingen die genetisch 
gemiddeld 50% identiek zijn bevestigen inderdaad dat er een genetisch component aanwezig is bij 
het ontstaan van een depressie.  
Van groot belang is de vondst dat een depressie geassocieerd is met een verstoring van de 
Hypothalamus-Hypofyse-Bijnier-as (HHB-as). Dit is een belangrijk systeem in het lichaam dat de 
reactie op stress coördineert en reguleert. Tijdens stress is de verhoogde secretie van cortisol door 
verhoogde activiteit van de HHB-as van essentieel belang voor de aanpassing aan de stressvolle 
situatie. Cortisol zorgt er via negatieve terugkoppeling ook voor dat het systeem zelf weer 
uitgeschakeld wordt. Cortisol oefent zijn effect uit via binding aan een cortisol receptor. Er bestaan 
twee typen receptoren voor cortisol; de hoog affine zogenoemde mineralocorticoïd receptor (MR) 
en de laag affine glucocorticoïd receptor (GR). De MR in de hersenen is vrijwel altijd bezet door 
cortisol, terwijl de GR pas geactiveerd wordt als er hoge concentraties cortisol in het lichaam 
circuleren. Deze twee receptoren voor cortisol, de GR en MR spelen een centrale rol in de regulatie 
van de HBB-as en zijn daarnaast van groot belang voor gedragsmatige adaptatie.  
Het doel van het onderzoek beschreven in dit proefschrift was te onderzoeken of genetische variatie 
in de mineralocorticoïd receptor betrokken is bij het ontstaan van een depressie. 
Eerst werd het coderende gedeelte van het MR gen gescreend op de aanwezigheid van genetische 
variatie. Vervolgens werd met computerprogramma’s de koppeling tussen de genetische variatie en 
de mogelijke functionaliteit van de genetische variatie getest. Dit is beschreven in hoofdstuk 2. Er 
bleken zeven Single Nucleotide Polymorphisms (SNPs) aanwezig te zijn in het coderende gedeelte 
van het MR gen. Een SNP is een variatie in het DNA die veelvuldig voorkomt in de populatie en 
waarbij 1 nucleotide veranderd is. De genetische variatie in het MR gen bleek voor een groot deel 
aan elkaar gekoppeld te zijn en bovendien bleken een aantal SNPs mogelijk functioneel. Enkele 
mogelijk belangrijke SNPs zijn MR-2G/C (rs20170951), MRI180V (rs5522) en rs2871. De SNP 
MR-2G/C bevindt zich net buiten het coderende gedeelte in de Kozak regio (belangrijk bij eiwit 
productie) van het gen en beïnvloedt mogelijk de translatie van het mRNA naar eiwit. De SNP 
MRI180V bevindt zich in het coderende gedeelte van het gen in exon 2 en verandert het aminozuur 
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op positie 180 van een isoleucine naar een valine. Tenslotte, rs2871, één van de SNPs in het niet 
coderende gedeelte van exon 9, bevind zich in een stuk mRNA dat een ‘loop’ kan vormen en dit 
heeft mogelijk gevolgen voor de stabiliteit van het mRNA. 
De SNPs MR-2G/C en MRI180V werden op basis van de locatie en mogelijke functie geselecteerd 
voor verder onderzoek. De functionaliteit van deze twee SNPs werd getest met in vitro cel 
systemen. De resultaten van de in vitro testen zijn in verschillende hoofdstukken van dit proefschrift 
beschreven. Het C allel van MR-2G/C geeft in de in vitro cel systemen meer eiwit dan het G allel 
zonder dat de hoeveelheid mRNA beïnvloed werd, zoals beschreven in hoofdstuk 4. De verhoogde 
MR expressie met het C allel leidde vervolgens tot een verhoogde transactivatie, beschreven in 
hoofdstuk 3 en 4 en een verhoogde ligand binding, beschreven in hoofdstuk 5. De invloed van 
MRI180V op transactivatie was reeds getest. Het V allel verminderd de transactivatie dit blijkt te 
gebeuren zonder dat de MR expressie of de ligand binding wordt beïnvloed (hoofdstuk 5).  
MR-2G/C en MRI180V bleken voor een deel aan elkaar gekoppeld, dit werd beschreven in 
hoofdstuk 2, 3, 5 en 6. De combinatie van twee (gedeeltelijk) gekoppelde SNPs wordt een 
haplotype genoemd. Zonder koppeling zijn er 4 verschillende combinaties (haplotypes) mogelijk 
terwijl in onze studies maar 3 combinaties (haplotypes) geobserveerd werden, de combinatie MR-2 
G en MRI180 V (=G nucleotide) kwam niet voor. Om uit te sluiten dat de SNPs elkaars 
functionaliteit beïnvloeden werden ook de haplotypes in vitro getest, dit is beschreven in hoofdstuk 
5. De twee SNPs bleken elkaar niet te beïnvloeden in de gebruikte tests. 
Per hoofdstuk werd er met associatie-studies gekeken naar één van de mogelijke functies van 
genetische variatie in de MR. 
In hoofdstuk 3 werd gekeken of de in vitro functionele SNPs MR-2G/C en MRI180V de regulatie 
van de HHB-as kunnen beïnvloeden in gezonde vrijwilligers. Hiervoor werd gebruik gemaakt van 
de dexamethason suppressie test (DST). Dexamethason is een synthetisch gucocorticoïd en kan, net 
als hoge hoeveelheden cortisol, de cortisol productie door de HBB-as onderdrukken. Met 
dexamethason wordt de negatieve terugkoppeling van de HHB-as getest. In onze studie werd 
gebruik gemaakt van een lage dosering dexamethason (0.25mg) en dit leidde tot verminderde maar 
niet geheel onderdrukte cortisol spiegels de dag na inname. De één uur durende piek in cortisol na 
wakker worden werd zonder dexamethason niet beïnvloed door de SNPs maar na inname van 
dexamethason was er wel een een duidelijk effect van beide SNPs aanwezig. Dit effect was 
afhankelijk van het geslacht van de vrijwilliger. De onderdrukking was het sterkst in vrouwen met 
het MR-2G/C GG genotype terwijl mannen met dit genotype juist een verhoging lieten ziet t.o.v. 
mannen met de andere genotypes. Mannen met het MRI180V AA genotype hadden hogere waardes 
dan mannen met het AG genotype terwijl deze SNP geen effect had in vrouwen. Haplotype analyse 
leverde geen aanvullende informatie op, het effect werd voornamelijk veroorzaakt door MR-2G/C. 
In hoofdstuk 4 werd de invloed van MR-2G/C op zout regulatie en bloeddruk getest. Behalve de 
belangrijke rol van de MR in de HHB-as heeft de MR ook een belangrijke rol in zout en 
bloeddrukregulatie via het renine angiotensine systeem (RAS). Het hormoon aldosteron bindt aan 
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de MR in de nier en leidt tot water- en zout retentie. Het G allel was geassocieerd met toegenomen 
activatie van het RAS en hogere bloeddruk.  
In hoofdstuk 5 werd onderzocht of de MR haplotypes, die MR-2G/C en MRI180V bevatten, de 
reactie op acute psychosociale stress kunnen beïnvloeden en of deze haplotypes geassocieerd waren 
met chronische stress. Individuen homozygoot voor het haplotype dat de MR-C en MRI180 allelen 
bevat hadden de hoogste speeksel cortisol, plasma ACTH en hartslag reactie tijdens de 
psychosociale stressor. Dit haplotype gaf in vitro de hoogste expressie van het MR eiwit en de 
hoogste transactivatie. Chronische stress werd gemeten met vragenlijsten en de subschalen “sociale 
isolatie” en “hoge werkdruk” bleken geassocieerd met de MR haplotypes, dit keer was het het 
echter het haplotype met de allelen MR-C en MR180V die in dragers van dit haplotype tot meer 
chronische stress leidde. Deze studie was hypothese genererend van opzet en suggereert dat meer 
MR eiwit tot hogere reacties op acute psychosociale stress leidt en dat MR haplotypes betrokken 
zijn bij de verwerking van chronische stress.  
 
In hoofdstuk 6 werden twee MR haplotypes beschreven en getest in een kleine groep van honderd 
patiënten met angst en/of stemmingstoornissen en vijftig gezonde vrijwilligers. Vanwege de relatief 
kleine aantallen patiënten en controles was ook deze studie exploratief en hypothese genererend van 
opzet. Associatie-studies werden uitgevoerd met haplotypes in het begin van het gen (5’, -2 G/C en 
180) en met haplotypes in het einde van het gen (3’, in exon 9). De twee haplotypes waren niet 
geassocieerd met angst en/of stemmingstoornissen maar in de patiënten groep was wel een 
associatie met het persoonlijkheidskenmerk neuroticisme.  
 
Hoofdstuk 7 is de algemene discussie van het proefschrift.  
 
Eerst werd de locatie van de MR SNPs geanalyseerd, MR SNPs bleken niet in het gehele gen 
aanwezig te zijn, maar voornamelijk voor te komen in het promoter gebied, exon 2 en aan het eind 
in exon 9. Genetische veranderingen op andere locaties veroorzaken waarschijnlijk ernstige 
aandoeningen.  
 
Vervolgens werd de voorspellende waarde van in vitro functionaliteits studies voor effecten in vivo 
bediscussieerd. De in vitro functionele SNPs bleken zoals verwacht geassocieerd te zijn met in vivo 
effecten; het daarom zinvol om in vitro studies uit te voeren. Echter een gedetailleerde hypothese 
genereren op basis van in vitro gegevens blijft moeilijk, wat geïllustreerd wordt met de man – 
vrouw verschillen in vivo. Bij veel associaties waren sexe verschillen in de effecten aanwezig en in 
sommige gevallen was de associatie zelfs tegenovergesteld bij mannen vergeleken met vrouwen. In 
de huidige in vitro testen zijn geen geslachtshormonen toegevoegd om de verschillen tussen 
mannen en vrouwen te onderzoeken en het is dus niet mogelijk om deze effecten te voorspellen. In 
vervolgstudies zou het effect van een geslachtshormoon in de in vitro studies onderzocht dienen te 
worden. Ook zou onderzoek aan andere leeftijdsgroepen in de associatie- studies een optie kunnen 
zijn. Deze suggestie maar ook andere suggesties voor vervolgonderzoek zijn in hoofdstuk 7 
beschreven. 
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Kort samengevat, in dit proefschrift werd genetische variatie in de MR beschreven. Er is genetische 
variatie in de MR aanwezig en deze variatie is functioneel in in vitro studies. De genetische variatie 
was geassocieerd met cortisolspiegels na dexamethason, de reactie op psychosociale stress, 
gedurende chronische stress en bij neurotisisme. Gezien de kleine groepen deelnemers in de studies 
waren deze studies exploratief en zouden de gevonden associaties verder bestudeerd moeten 
worden. Wij postuleren dat genetische variatie betrokken is bij de reactie op stress en in gedrag. 
Verder bleek de genetische variant MR-2G/C geassocieerd te zijn met bloeddruk en zoutregulatie; 
deze laatste associatie hebben we reeds kunnen bevestigen in meerdere cohorten. 
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